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Abstract
Microfluidic droplet systems have shown great promise in the study of biological
systems. In this thesis I explore the application of a microfluidic droplet system to
the study of small bacterial populations and their growth response to antibiotics.
This thesis comprises of three primary results sections. The first section details
the development and fabrication of a custom microfluidic system. This microflu-
idic system is designed to study the growth dynamics of small Escherichia coli
(E. coli) bacterial communities. The second section presents an image process-
ing and analysis workflow that is designed to be used in conjunction with the
microfluidic device to extract quantitative growth data of confined bacterial com-
munities with single cell precision. The third section details a study that uses
the microfluidic system to measure the growth dynamics of E. coli communities
encapsulated within microfluidic droplets whilst uninhibited and under the effect
of the antibiotic streptomycin.
In the first section, I present the development, design and fabrication of a two-
part microfluidic device that is later used to study the growth dynamics of E. coli
bacteria. The first part of the microfluidic device consists of droplet generating
microfluidic geometry that is designed to encapsulate small communities of E.
coli bacteria (typically 1-5 cells in size) within microfluidic droplets around 30
µm in diameter. The second part of the microfluidic device is composed of a mi-
crofluidic reservoir that is designed to store microfluidic droplets. By imaging the
droplets in the storage reservoir with a combination of brightfield and fluorescence
microscopy, the growth dynamics of the encapsulated bacterial communities can
be described.
In the second section of the thesis, I present the development and operating princi-
ples of my image processing and analysis workflow. This workflow automatically
extracts quantitative bacterial growth data from a gridded array of brightfield
and fluorescence microscopy images taken across the microfluidic device during
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experimentation. The analysis algorithm is capable of processing upwards of 200
fields of view across 80 time frames. This makes it possible to detect, track and
measure the size of upwards of 1000 encapsulated bacterial communities with sin-
gle cell precision. Droplet boundaries are detected using brightfield microscopy
images and each droplet is tracked from one time step to the next using a modified
particle tracking algorithm. Bacterial community sizes are measured by counting
individual bacteria in thresholded fluorescence microscopy images.
In the final section of this thesis, a study of E. coli bacteria was conducted
using the microfluidic device. Small communities of bacteria, typically 1-5 cells
in size, were confined in microfluidic droplets and observed for 8 hours. The
bacteria were grown in the absence of antibiotic, as well as in the presence of the
antibiotic streptomycin at various concentrations. A number of metrics of the
growth dynamics are extracted from the study and compared with traditional
bulk growth techniques.
It is shown that in the absence of streptomycin, the final droplet population size
distributions feature extended tails due to large, fast growing bacterial popu-
lations. The tails of these distributions are reduced in length in the presence
of streptomycin at a concentration below the Minimum Inhibitory Concentra-
tion (MIC). A positive correlation is found between initial and final bacterial
population size, however this correlation is weak, indicating a highly stochastic
growth process. It is also shown that at moderate streptomycin concentrations
both around and above the MIC, some bacterial populations are inhibited in
a non-lytic manner, whilst other populations underwent lysis. It is also shown
that at moderate antibiotic concentrations around the MIC value, there is a bias
against bacterial lysis in droplets with large populations. Finally, at low antibi-
otic concentrations below the MIC, it is shown that some bacterial populations
are inhibited but not lysed, whereas some populations are not inhibited.
The microfluidic device and image analysis workflow described in this thesis is a
novel experimental system with widespread applicability. The system is able to
partition an aqueous solution into a large number of small, compartmentalised
liquid volumes and analyse these volumes using both brightfield and fluorescence
time-lapse microscopy. This could be used to study the population dynamics
of a variety of bacterial strains, and could also be used to explore more general




Traditionally, bacterial research is carried out by growing bacteria in containers
between 0.1 ml and 100 ml in volume. This means that when we study how a
bacterial population behaves under certain conditions, we are actually studying
the behaviour of a bacterial population of over 10 million cells.
This is a problem as bacterial infections can begin with just a single bacterial
cell, and single bacterial cells may respond differently to a drug or antibiotic
when compared to a large population of 10 million cells.
In this thesis, we designed and fabricated a specialised experimental tool that
allowed us to place hundreds of small bacterial populations in microscopic droplets
less than one tenth of a millimeter in diameter. By doing this, we were able to
measure how small populations of bacteria grew in the presence of an antibiotic.
This thesis can be separated into 3 main sections.
The first section of this thesis is dedicated to the design, development and fabri-
cation of a specialised experimental system that allows us to place small bacterial
populations in microscopic droplets and study them. This system is made up of
two separate devices. The first device places the small bacterial populations in
the microscopic droplets at a rate of up to 40 droplets per second. The second de-
vice stores these microscopic droplets in an imaging chamber. Once the droplets
are stored in the imaging chamber they can then be imaged using a microscope so
that the number of bacteria in each droplet can be counted and tracked over time.
This experimental system was designed specifically so that it can be fabricated
and operated by scientists that have not used this type of system before.
The bacteria that are stored in the droplets have been modified so that they glow
brightly when a special type of light is shone upon them. By taking images of
the bacteria as they glow, it is possible to count the number of bacteria in each
droplet. In the second section of this thesis, we discuss the development of a
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computer program that we wrote to automatically count the number of bacteria
in over 1000 microscopic droplets for up to 8 hours.
The final section of this thesis presents the results of an experiment that utilised
the experimental system and computer program that were covered in sections
one and two. We first measured how quickly bacterial populations grew in the
microscopic droplets. It was found that on average the bacterial populations
grew at a similar rate to bacterial populations that were grown using traditional
techniques, this meant that the bacteria were healthy and able to reproduce
in the microscopic droplets. An antibiotic called streptomycin was then added
to the droplets at a variety of concentrations. Once streptomycin was added, we
studied how the droplet populations grew at each antibiotic concentration. It was
found that streptomycin affected the droplet populations differently depending
on its concentration. It was also found that even at the same streptomycin
concentration some droplets reacted differently to the antibiotic. It is currently
not known why streptomycin affects certain droplets differently, but it is hoped
that with further experiments we might be able to understand this behaviour and
even predict it.
The experimental system designed in this thesis allow measurements of bacterial
populations to be taken that are not possible using many other techniques. It
is possible that this system could be used to study different types of bacteria,
different types of antibiotics, or even study different biological systems where it
would be useful to store things in microscopic droplets.
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The discovery of antibiotics transformed modern medicine. With their widespread
introduction in the early 1940’s, they provided effective treatment to many dis-
eases prevalent at the time[1]. Since then, the list of known antibiotic compounds
has expanded massively due to extensive research and their revolutionary positive
impact on clinical outcomes. At present, antibiotics underpin the treatment of
almost all bacterial infections and are vital in complex clinical procedures such as
highly invasive surgeries and chemotherapy. Whilst global antibiotic consump-
tion was not originally tracked or quantified, it is known that antibiotic use was
initially accelerated due to their effectiveness at treating cocci bacterial infections
during World War II[2]. This increase in antibiotic use continued throughout the
twentieth century, and statistics show that antibiotic consumption from 2000-
2015 increased by 39%[3].
Unfortunately, because of this increase in antibiotic use, the prevalence of bacte-
rial infections that are resistant to antibiotics has similarly skyrocketed. As the
rate of antibiotic discovery has slowed over the last 20-30 years, the rate at which
bacteria are becoming resistant to these antibiotics has not. It has been suggested
that we are currently in the depths of an antibiotic crisis and may be fast ap-
proaching a regression back to the “pre-antibiotic” era due to a lack of antibiotics
that are able to treat resistant infections. Evidence suggests that healthcare costs
are likely to rise rapidly as we require newer, more complex and more expensive
therapies for extended hospital admissions[4]: this is unsustainable in the long
run.
1
As such, continued and renewed effort into antibiotic research is increasingly
necessary; by furthering our understanding of how antibiotics work and their
impact on bacterial populations, it is hoped that the impending clinical crisis can
be averted.
Antibiotic research is usually conducted using bulk growth techniques. This
means that when bacterial populations are cultured they are grown and stud-
ied in large volume containers, such as conical flasks. These methods of bulk
culture mask the true heterogeneity of a bacterial population, as individual cells
within a given population can vary significantly in their morphology and be-
haviour. This means that any quantitative measurement extracted from a large
population cultured using bulk growth techniques will be an ensemble-average of
the entire population. This naturally extends to measurements detailing antibi-
otic inhibition. This is relevant as clinical infections can begin with just a handful
of bacteria from the same bacterial strain in a small biological niche such as the
interior of a host cell. The success or failure of the infection or the antibiotic treat-
ment may rest on the dynamics and responses of just a few highly heterogeneous
bacteria, as opposed to the ensemble behaviour of a large population.
The aim of the work completed in this thesis was to develop and fabricate a device
that encapsulates small bacterial populations within individual, non-interacting
environments that mimic in vivo biological niches such as eukaryotic cell interiors.
This was achieved using a custom-designed microfluidic system that encapsulated
bacterial populations within monodisperse emulsion droplets less than 100 µm in
diameter. These emulsion droplets were then incubated and imaged using bright-
field and fluorescence microscopy. Using these microscopy images, each droplet
was tracked over time and its respective bacterial population was measured. By
studying large numbers of small bacterial populations simultaneously, we aimed
to develop a system that could extract statistical information regarding the het-
erogeneity of the response of bacterial populations to antibiotic agents.
• Chapter 2 provides background and context for the work completed in this
thesis. An overview of bacterial growth and biological microscopy is given.
The basic principles behind continuous flow and droplet-based microfluidics
are outlined and previous work in the field is discussed.
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• Chapter 3 details the materials, methods, equipment and protocols used
explicitly in the fabrication and use of our microfluidic system. Emphasis is
placed on why each material was chosen in relation to the outlined research
objectives. Experimental preparation methodologies are also discussed.
• Chapter 4 outlines the iterative design process used in the development of
a custom microfluidic system to be used in the encapsulation and incubation
of small bacterial communities.
• Chapter 5 introduces and summarises the Matlab-based image processing
and analysis workflow that was developed to extract quantifiable data from
our experimental system.
• Chapter 6 reviews the testing and validation processes that were com-
pleted to ensure the accuracy and integrity of data generated using our
microfluidic system.
• Chapter 7 presents the results of a study into the effects of streptomycin
on small Escherichia coli populations grown in microfluidic droplets. This
study fully utilises the microfluidic system whose development was detailed
in the first half of the thesis. The complete experimental protocol used for
this study is also outlined.
• Chapter 8 highlights the key outcomes and findings derived from the work





In this chapter I will outline the ideas and theories that underpin the work com-
pleted in this thesis. Key concepts will be established that should allow the reader
to correctly understand and interpret the results and methodologies presented in
this research project.
Firstly, bacteria will be discussed, followed by an introduction to Escherichia
coli and its role as a model organism in the field of microbiology. I will then
provide an overview of bacterial growth dynamics, including a short introduc-
tion to traditional techniques that are used to measure bulk growth. After this,
antibiotics will be introduced, focusing on a ribosome targeting antibiotic called
streptomycin that is studied in this thesis.
Moving on from bacteria, I will pivot to microscopy. The fundamental operating
principles of compound microscopes will then be reviewed before a more technical
discussion outlining brightfield microscopy, fluorescence microscopy and biolog-
ically relevant fluorophores. After this, I will briefly discuss several pioneering
microscopy techniques that are used in microbiological research.
The field of microfluidics will then be examined, beginning with an introduction
to basic microfluidic theory. Current and historical applications of continuous
flow microfluidics will be reviewed, with a focus on their use in microbiological
research. The chapter will then end with an introduction to droplet-based mi-
crofluidics, a subset of microfluidic systems that have gained substantial traction
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within the general field of microfluidics. The key principles involved in the de-
velopment of droplet-based microfluidic devices will again be outlined, which will
finally be followed by a review of common academic applications, focusing on
microbiological research.
2.2 Bacteria
Bacteria are single-celled organisms that are members of the prokaryotic domain.
Prokaryotes differ from other single-celled organisms in that they do not possess
a membrane-enclosed nucleus[5] and they lack energy producing organelles[6].
Their DNA is exposed to and part of the soup-like internals of the bacterial cell
that is also made up of proteins and other macromolecules. Bacterial species
used as models in cell biology generally have volumes of around 0.4 - 3 µm3,
however bacterial species that are not used traditionally in the laboratory have
been observed with average cell sizes that vary dramatically. For example, ultra-
microbacteria have been observed with average volumes of 0.013 µm3, whilst a
single marine sediment–dwelling bacteria has been observed with a volume of 2.2
x 108 µm3[7].
Despite their diminutive size, by virtue of sheer numbers, bacterial biomass out-
weighs all other life on earth combined[8]. Humans contain approximately 10x
as many bacterial cells than human cells, and approximately 100x more bacterial
genes than human genes[9]. Bacteria were first identified and studied in a clinical
context due to their sometimes negative impact on human health. However, they
do not simply exist to infect humans, indeed they exert powerful influences across
all facets of the natural world.
2.2.1 Escherichia coli
Bacteria are classified as Gram-negative or Gram-positive (with a few exceptions
that are not discussed here) based upon the structure of their cell envelope[10].
The cell envelope of Gram-negative bacteria consists of a thin layer (2-3 nm) of
the polymer peptidoglycan sandwiched between the outer and inner membranes,
whereas the cell envelope of Gram-positive bacteria consists of a much thicker
layer (≈30 nm) of peptidoglycan but the outer membrane is absent.
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Gram staining
Gram staining is a technique used to distinguish between Gram-positive and
Gram-negative bacteria. The assay is named after Hans Christian Gram,
who developed the technique in 1884 to distinguish bacterial cells from
host tissue cells[11]. The process has three primary steps: cells are first
stained using a crystal violet–iodine complex, they are then decolourised
using ethanol and acetone before a safranin counterstain is applied. The cell
wall structure of Gram-positive cells retains the iodine complex (rendering
them a deep purple), whereas Gram-negative cells readily decolourise and
are subsequently stained by the safranin (appearing pink)[12][13].
Escherichia coli (E. coli) is a rod shaped, Gram-negative bacteria around 2 µm
in length and 1 µm in diameter. It typically inhabits the gastrointestinal tract
of warm blooded animals, and it has been found to colonise the gut of a human
infant within hours of being born[14]. E. coli is usually commensal and will co-
exist within a human host without problem for many years[14]. It is generally the
most prolific facultative anaerobe in the human gastrointestinal tract; however
it is still not fully understood how and by what mechanisms E. coli occupies
this niche so successfully and competitively when compared to other bacterial
strains[14].
It could be argued that more is known about E. coli than any other organism
on the planet, and it is because of this that the E. coli genome was one of the
first candidates suggested for whole genome sequencing[15]. To emphasise this
fact, Jacques Monod, Nobel prize winner famous for his “discoveries concerning
genetic control of enzyme and virus synthesis”, once claimed:
“All that is true of E. coli is also true of the elephant1”
E. coli, in particular the K12 strain, is the most common and popular model or-
ganism across the entire field of biology[16]. K12 was originally isolated in 1922
and rose to prominence for a number of reasons. Firstly, K12 is prototrophic
and therefore easily to grown in defined growth media[17]. Secondly, early stud-
ies revealed that K12 was found to be capable of genetic recombination by both
conjugation and transduction[18]. K12 is popular due to its historical prevalence,
1[translated] - “Tout ce qui est vrai pour le Colibacille est vrai pour l’éléphant”[16]
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metabolic robustness and ease of use in the laboratory. Whole genome sequences
are available for the two most common K12 variants: MG1655[15] and W3110[17].
MG1655 has been maintained as a standard laboratory strain save a small num-
ber of genetic manipulations. Of note, a mutation leads to pyrimidine starvation,
resulting in a growth rate 10-15% slower in pyrimidine-free medium[19]. Further-
more, almost all K12 derivatives carry a mutation that results in the absence of
O-antigen synthesis[15]. The O-antigen is a polysaccharide that is part of the
lipopolysaccharide in the outer membrane of Gram-negative bacteria[20]. It is
highly immunogenic, can be used as a receptor for certain bacteriophages, and it
is a virulence determinant for the bacteria[21].
There is growing criticism of academia’s fondness for K12 as critics argue that
there is strong evidence that modern laboratory strains have diverged far from
their original, free living ancestors. It is believed that with the introduction of
modern high-throughput sequencing, K12 will be removed from its pedestal as
the archetypal E. coli strain. It is hoped by some that E. coli in general will be
better understood as just one of many model organisms in the greater context of
bacterial diversity[16].
2.2.2 Bacterial growth
When a small bacterial population is exposed to a nutrient rich environment, it
will undergo four broadly defined stages of growth. At the point of introduction
to their nutrient rich environment, bacteria do not usually begin to divide straight
away. Instead, they generally first optimise themselves for further growth, gaining
mass as they upregulate protein and ribosome production to maximally exploit
their new nutrient dense surroundings[22]. This initial period of little to no
growth is called the lag phase.
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Once the bacteria have successfully adjusted to their new surroundings they will
begin to divide, and their rate of growth will increase as they enter what is
known as the exponential or logarithmic growth phase. In this phase, growth is
uninhibited by nutrient limitation or waste toxicity. Because of this the number




therefore the population size can be described by simple exponential growth:
N = N0e
kt, (2.2)
whereN0 is the initial number of bacteria, t is the time elapsed and k is the specific
growth rate. The doubling time of an exponentially dividing bacterial population
can be obtained by dividing ln(2) by k. Once the population begins to exhaust
key nutrients in their environment (or waste accumulates to toxic levels), then
the growth rate of the population will begin to decline and the population size
plateaus. This third growth stage is known as the stationary phase. Eventually
bacteria will start to die and the bacterial population size will begin to deplete.
This final growth phase is known as the death phase. These growth phases can
be clearly observed in a bacterial populations growth curve. See figure 2.1 for
further information.
Optical Density
Optical density measurements are commonly used to assess the concen-
tration of bacterial suspensions. According to the Beer-Lambert law, the
attenuation of light passing through a sample is linked to the optical prop-
erties of the attenuating species in the sample material. With correct cal-
ibration, a turbidity measurement can therefore be taken to assess the
concentration of bacteria in a bacterial suspension[23].
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Figure 2.1 Growth curve of an E. coli population, measured using Optical Den-
sity (OD) at 600nm. Log of population size is plotted versus time.
The lag phase can be seen in the initial horizontal section of the
graph (shown here in red), at this stage population size is unchanged
from the initial inoculum. The exponential phase can be seen in the
linearly increasing section of this plot (shown here in green), N0 is
defined as the population size at the start of the exponential growth
phase. The stationary phase can be seen to begin as the curve levels
off to become eventually horizontal (shown here in orange), indicat-
ing slower and slower bacterial growth. Adapted from [22].
Bacterial growth can be quantified experimentally by culturing populations in
liquid growth media. Liquid growth media is generally split into two categories:
undefined and defined media. Undefined media does not have a well defined
chemical composition. As an example, Lysogeny Broth (LB) is a common un-
defined media that is formulated using yeast extract. Defined media has a well
defined chemical composition, this means it is formulated using a precise and
controlled recipe of chemical compounds. Defined media is the preferred choice
when conducting quantitative bacterial growth measurements as the same growth
media can be formulated to the same specification in any laboratory using pure
chemicals off the shelf, ensuring standardisation. Different formulations of de-
fined media can be further categorised based on whether they are considered to
be rich or poor. Rich media supports fast growth, whereas poor media supports
slow growth. A nutrient molecule in rich media provides more energy than a
nutrient molecule in poor media.
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It is also important to consider the growth applications supported by the liquid
media: LB is an ubiquitous undefined and rich liquid growth medium, but it
is also auto-fluorescent and is therefore unsuitable for fluorescence based growth
studies. In our work we used M9 minimal medium, this is a well defined and poor
growth medium, this was chosen as slow growth was convenient when working
with our experimental system.
2.2.3 Metabolism and respiration
Bacterial metabolism refers to the set of biochemical reactions that occur in a
bacteria. This encompasses the reactions that break down substrate molecules, as
well as the reactions that uptake and utilise compounds required for growth and
maintenance of the cell[24]. Bacteria are highly specialised energy transformation
systems that are able to generate high-energy compounds such as adenosine 5’-
triphosphate (ATP) by breaking down substrate molecules. These high-energy
compounds store energy in the form of phosphate bonds, which can then be easily
processed to provide energy for many different cellular operations.
Across all bacteria, there are a wide variety of metabolic substrates and reactions
that can be used to generate energy. Furthermore, a single bacteria can change
the metabolic pathway it uses to extract energy dependent on its immediate en-
vironment and the availability of different nutrients[25]. Heterotrophic bacteria
obtain their energy through the oxidation of organic compounds, such as carbo-
hydrates, proteins and lipids. The carbohydrate glucose is most commonly used
to study heterotrophic metabolism. Aerobic bacteria are able to oxidise glucose
through the following chemical reaction:
C6H12O6 + 6O2 −→ 6CO2 + 6H2O + energy,
Where glucose is oxidised completely to CO2 and H2O. In aerobic respiration,
molecular O2 acts as the electron acceptor. Practically, aerobic respiration is
an efficient (≈55%[24]) energy generation process that oxidises environmental
organic substrates and produces primarily carbon dioxide and water.
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2.3 Antibiotics
Antibiotics are defined as compounds that inhibit bacteria. Bactericidal antibi-
otics are defined as antibiotics that kill bacteria with an efficiency of >99.9%[26],
whereas bacteriostatic antibiotics prevent further bacterial growth but do not
cause cell death[27]. Antibiotics are able to target bacteria by inhibiting or dis-
rupting processes that are unique to prokaryotic cells, such that the eukaryotic
cells of the host are not affected. Although this sounds ideal, many bacteria are
beneficial to the host’s health and wellbeing. This means that a course of antibi-
otics can significantly change the internal distribution of useful bacteria within
a host that are sensitive to a given antibiotic, and it was only recently realised
that antibiotics can have long lasting effects on the infected host well beyond the
time frame of the initial infection[5].
At the turn of the 20th century, antimicrobial agents were discovered by screening
basic synthetic chemicals, with a focus on microbiological dyes and stains[28].
With the discovery of penicillin by Sir Alexander Fleming in 1928[29], these
basic chemicals were superseded as a number of bacterial and fungal metabolites
were proven to efficiently treat bacterial infections with minimal side-effects[30].
Beginning in the early 1940’s, a number of protocols were established in the field
of natural drug development and discovery, including the Waksman platform[31]:
a screening strategy for the discovery of antibiotics using soil-dwelling bacteria.
The method of determining an antibiotics minimum inhibitory concentration in
rich media was also standardised during this time.
Minimum inhibitory concentration
The Minimum Inhibitory Concentration (MIC) of an antibiotic is defined as
the minimum concentration required to inhibit visible growth of a bacteria
after overnight incubation[32].
From the 1940’s through to the mid-1960’s, many new antibiotics were discov-
ered in what is dubbed the ’golden age’ of antibiotic discovery. It is during this
time that the majority of known antibiotic classes were discovered[30]. By the
mid-1960’s antibiotic resistance was becoming a problem in the treatment of bac-
terial infections, whilst newly discovered antibiotics were becoming increasingly
difficult to implement in a clinical environment due to negative pharmacological
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or toxicological properties. The golden era of antibiotic discovery gave way to an
era of medicinal chemistry, where improved synthetic versions of existing natural
antibiotics were the main source of new antibiotics. Whilst lacking in revolu-
tionary discovery, the antibiotic derivatives discovered during this time brought
about lower doses, wider generality and the continued avoidance of resistance[30].
For reference, the quinolone class of antibiotics was discovered in the 1960’s, it
then took over 20 years for the next class of antibiotics to be discovered, with
linezolid being approved for use in the United States in 2000[33]. From roughly
2000 through to 2015, antibiotic discovery methods were underpinned by ge-
nomic data and high-throughput screening technology, with a distinct focus on
target-based antibiotics and the discovery of broad spectrum antibiotics. Whilst
not a complete failure, this approach proved to be relatively unsuccessful and
in recent years a paradigm shift has refocused efforts on complex combinatorial
treatments that more accurately reflect the inherent complexity of in vivo bac-
terial infections. These screening approaches utilise unconventional and unique
drug discovery strategies[34].
2.3.1 Antibiotic resistance
As discussed in chapter 1, antibiotic resistance is a global health issue that if
left unchecked could have disastrous consequences. Antibiotic resistant bacterial
strains were observed almost immediately after the introduction of the first an-
timicrobial agents[35]. Streptoccoccus pyogenes bacteria resistant to sulfonamide
emerged in the late 1930’s[2], whilst Staphylococcus aureus bacteria resistant to
penicillin emerged in the late 1940’s[36]. This was followed by streptomycin resis-
tant Mycobacterium tuberculosis, that were observed just four years after strepto-
mycins discovery[37]. Bacteria resistant to multiple antibiotics (E. coli, Shigella,
Salmonella) were observed in the 1960’s and 1970’s[38], and since then the rate
of antibiotic resistance has been consistently outpacing the rate of antibiotic dis-
covery[1].
Some bacteria are intrinsically resistant to certain antibiotics by the nature of
their physiology. For example, Gram-negative bacteria are generally more resis-
tant to antibiotics, as many of these compounds are unable to cross their outer
membrane[39]. Lipopeptide daptomycin is ineffective against Gram-negative bac-
teria, as the lower proportion of anionic phospholipids in the membrane of Gram-
negative bacteria reduces the insertion of the antibiotic into the cell[40].
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There are many mechanisms by which bacteria can develop or attain resistance to
an antibiotic. These molecular mechanisms are encoded in the DNA of resistant
bacteria, and there are multiple ways in which this DNA can be shared amongst
bacteria[41]. These resistance mechanisms generally fall into one of three cate-
gories[41]. Firstly, bacteria can reduce the intracellular concentration of antibi-
otic, either by reducing the permeability of the cells membrane, or through active
antibiotic efflux. Secondly, bacteria can alter the antibiotic target site through
genetic mutation to reduce antibiotic affinity. Thirdly, bacteria can directly in-
activate the antibiotic by either destroying the antibiotic molecule or modifying
the structure of the antibiotic. An example of this third resistance mechanism
was recently reported in Campylobacter coli, where genetic material was found
that encoded six aminoglycoside-modifying enzymes that confered resistance to
multiple aminoglycoside antibiotics[42].
Whilst understanding these molecular mechanisms gives us valuable insight into
how bacteria respond to antibiotic agents, it is essential to recognise that micro-
biological processes (including those that govern antibiotic resistance) are inher-
ently stochastic in nature. As such, it has been shown that antibiotic resistance
is a heterogeneous property of a bacterial population[43]. It is critical that we
understand this heterogeneity if we hope to effectively improve the clinical appli-
cations of both current and future antibiotics. It is the heterogeneous aspect of
bacteria-antibiotic interaction that the research project presented in this thesis
aims to explore.
2.3.2 Ribosome targeting antibiotics and streptomycin
The ribosome is the most complex piece of enzymatic machinery found in nature.
Ribosomes exist within all living cells and their primary purpose is to synthesise
proteins[44]. The bacterial ribosome consists of two primary subunits and more
than 50 different protein and RNA components. The ubiquity of the bacterial
ribosome makes it a prime target for antibiotic inhibition. Furthermore, whilst
the eukaryotic ribosome is structurally similar to the bacterial, the size and exact
makeup of each subunit is critically different[45]. This means that antibiotics
that target bacterial ribosomes do not affect eukaryotic ribosomes, and therefore
human cells.
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Ribosomal protein synthesis can be divided into 4 primary stages. In the initi-
ation phase, the large and small subunit of the ribosome assemble on a specific
region of an mRNA molecule. In the subsequent elongation phase, the mRNA
transcoded as it passes through the ribosome and a polypeptide chain is built.
Once the ribosome encounters a stop codon, the elongation phase ends and the
process undergoes termination. Once complete, the ribosome subunits detach
and mRNA is released, completing the final recycling phase [46]. Ribosome tar-
geting antibiotics bind to the ribosome and inhibit this protein synthesis, with
the bulk of clinically relevant antibiotics disrupting the elongation stage[47].
Streptomycin is a bactericidal ribosome targeting antibiotic that binds irreversibly
to the 30S ribosomal complex (the smaller ribosomal subunit consisting of≈50,000
atoms larger than hydrogen). This binding inhibits the initiation stage of protein
synthesis[48]. We chose to study bacterial inhibition by streptomycin in this re-
search project as work completed by Greulich et al. suggested that E. coli may
respond differently to streptomycin inhibition at the level of individual cells[48].
In this theoretical work, a bistable dependence of growth rate on antibiotic con-
centration is predicted at the individual cell level in the limit of near-irreversible
antibiotic binding (as is the case with streptomycin). This means that across a
distinct range of extracellular antibiotic concentrations, two stable growth rate
states exist. In this bistable regime, a large fraction of the population grow at a
stable rate, whilst a smaller sub-population grow at a comparably reduced rate.
This prediction of a bistable growth regime is purely theoretical, and no experi-
mental evidence for its existence was presented by Greulich et al. This provided
motivation for us to study streptomycin inhibition using our microfluidic system.
We hoped that heterogenous growth behaviours may be experimentally observed
and quantified using our microfluidic device, which is not possible to observe




Microscopy is an experimental technique that is utilised extensively in the work
conducted in this thesis. Standard brightfield microscopy is used here in the
detection of microfluidic droplet boundaries, whilst fluorescence microscopy is
used when counting cells for the purpose of cell growth measurements. In this
section I will discuss the basic principles behind brightfield microscopy, before
moving onto fluorescence microscopy.
2.4.2 Microscopy fundamentals
The fundamental purpose of a microscope is to produce an image of an object
that is too small to resolve with the naked eye. This is achieved by using a series
of lenses to manipulate light travelling from a sample to an observer such that the
observer perceives a magnified virtual image. A compound microscope attains
this magnification using two lens systems, the eyepiece and the objective lenses.
Light is emitted from an illumination source (through a condenser lens) and
passes through the sample. This light is then collected by an objective lens, which
(after being passed through a tube lens) then forms the light into a magnified
real intermediate image. The eye and eyepiece lens then operate in conjunction
to form a real image on the retina. This is perceived as a magnified virtual image
by the observer[49]. This arrangement can be seen in figure 2.2.
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Figure 2.2 (Left) ray diagram of the basic optical train of a microscope, high-
lighting how the eye perceives a magnified virtual image. (Upper-
right) ray diagram of the optical train for a finite tube length micro-
scope. (Lower-right) ray diagram of the optical train for an infinity
corrected microscope. Whilst the tube length of microscopes was tra-
ditionally standardised to 160 mm, many newer objective lenses are
infinity corrected to allow for the introduction of additional optical
components, such as prisms and polarisers, into a parallel optical
path. Taken from [49].
Although the basic principle of microscope operation is shown above, modern
compound microscopes are somewhat more complex. Compound microscopes
use two conjugate planes of light when imaging a sample. Conjugate focal planes
exist when a sample is in perfect focus in one of the planes whilst it is perfectly
unfocused in the other[50]. By ensuring the illuminating light source is maximally
out of focus at the sample location, whilst the sample is optimally in focus, any
variations in the light source are smoothed out and therefore changes in light
intensity are entirely the result of the sample. These two light planes are named
the illumination and the image-forming planes. Ray diagrams of the imaging
focal plane and the illumination focal plane can be seen in figure 2.3.
16
Figure 2.3 (a) Ray diagram of the imaging focal plane. (b) Ray diagram of the
illumination focal plane. Taken from [49].
2.4.3 Brightfield microscopy
Brightfield microscopy is the most simple form of microscopic imaging. Light
is transmitted through or reflected from a sample, and then collected by an ob-
jective lens. Different parts of a sample will absorb different amounts of light
and it is this contrast that distinguishes the details within a brightfield image.
Brightfield imaging often suffers from poor contrast as portions of a sample may
not differ significantly in transparency, despite their biological or chemical differ-
ences. Historically, stains have been used to improve microscopic contrast, and




Fluorescence microscopy is a form of imaging that utilises photon emission from
electrons that have been transiently raised into a higher molecular energy state.
When an electron is excited from its ground state to a higher energy state, it
can collapse back to its original state via internal and external energy processes
which in turn can emit a photon of light. The process of adsorption and emission
occurs over a time period of 10−9-10−12 seconds[49]. This initial excitation can be
triggered intentionally by irradiating a sample with light at a specific wavelength,
if a photon is subsequently emitted it usually has a longer wavelength than the
exciting photon that was first absorbed[49].
By irradiating a sample with light of a fixed wavelength that is known to excite
a specific fluorescent compound, the subsequently emitted light can be filtered,
collected and then formed into an image. This is usually achieved using a filter
cube containing a dichroic mirror (see figure 2.4). Fluorescence images are highly
valued in biological microscopy due to their high signal:noise ratio, as well as
their power to selectively illuminate structures within a sample.
Figure 2.4 (a) Cutaway diagram of an inverted microscope designed for the pur-
pose of both brightfield and fluorescence microscopy, taken from [50].
(b) Illustration of a filter cube containing a dichroic mirror. Light
from a broad spectrum source is first filtered and reflected onto a
sample, light subsequently emitted from fluorphores within the sam-
ple is then filtered through the dichroic mirror to be collected by the
objective lens. Taken from [49].
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2.4.5 Fluorophores
Molecules and compounds that possess the ability to fluoresce are defined as flu-
orescent. The term fluorophore is used for macromolecules that have been tagged
with a fluorescent compound. Fluorophores are primarily defined by their excita-
tion and emission spectra. The difference in wavelength between the peak values
of these spectra is known as the Stokes Shift, this value can range from 25 nm to
over 200 nm[49]. Fluorophores are also classified using a number of criteria such
as their quantum efficiency (ratio of emitted photon quanta to absorbed pho-
ton quanta), aqueous solubility and resistance to quenching and photobleaching,
which both act to reduce total fluorescence.
Fluorescent proteins
The first example of a naturally occurring fluorescent protein to be isolated was
Green Fluorescent Protein (GFP), which was isolated from the North Atlantic jel-
lyfish Aequorea victoria[51]. After their discovery, naturally occurring fluorescent
proteins quickly became important markers of gene expression[52].
GFP is cylindrical in nature with 11 β-strands forming the walls of the cylinder,
with an α-helix inside and helical segments capping the ends of the cylinder.
Once formed, GFP is highly stable, requiring treatment with 6M guanidine hy-
drochloride at 90°C or pH of <4 or >12 for denaturation to be observed[53]. This
stability has been attributed to its novel “β can” structure which acts to protect
the enclosed chromophore.
These proteins are genetically encoded, allowing fluorescent protein gene expres-
sion to act as a reporter of cellular function when transferred into the sequence
of another gene. Genetic transfer from one bacteria to another occurs through
one of three processes: transformation, transduction or conjugation. Transfor-
mation is the process whereby bacteria incorporate naked DNA found in their
environment. Transduction is the process of horizontal gene-transfer where a
bacteriophage encapsulates a segment of a host cells DNA and acts a vector for
the DNA’s injection into a recipient cell. Conjugation is a DNA transfer mech-
anism that relies on cell-cell contact[54]. Fluorescent proteins offer a number of
advantages over other fluorophores due to their compatibility with existing biolog-
ical molecules and structures, their ability to fluoresce independently of external
triggers, their low phototoxicity and their inherent ability to achieve subcellular
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localisation[49][55]. As no exogenous triggers besides illumination are required to
obtain this fluorescence, fluorescent protein expression is often used to monitor
gene expression and protein localization in living organisms. The E. coli strain
used in this thesis produces Yellow Fluorescent Protein (YFP). It was created
using transduction, and the YFP gene is controlled by a genetic promoter that
does not respond to external stimuli and therefore expresses YFP continuously.
Whilst useful, naturally occuring or “wild-type” fluorescent proteins exhibit some
less than ideal experimental characteristics. To address these failings, a number
of mutant proteins have been developed for use in the laboratory. Enhanced
GFP (eGFP) is a fluorescent protein that features chromophore mutations that
improve emission intensities by 35 times over wild-type GFP[52]. Furthermore, it
features shifted excitation and emission spectra that more closely matches stan-
dard fluorescein isothiocyanate (FITC) excitation-emission filter sets[56]. Lastly,
it is codon optimised for higher expression in mammalian cells[52]. GFP+ fea-
tures mutations and DNA shuffling that improves folding efficiency above 25°C,
enhancing brightness of cells by 16 times at 37°C, additionally protein aggrega-
tion is reduced and diffusability inside cells is increased[57]. GFP+ also exhibits
a 35 times increase in fluorescence when excited at 488 nm.
The red fluorescent protein DsRed, which was isolated from the coral, Discosoma,
has also been improved through genetic mutation. The obligate tetramerisation of
DsRed historically hindered its used as an encoded fusion tag, as this caused the
aggregation of almost anything to which DsRed could be covalently bonded[58].
Monomeric red fluorescent protein (mRFP1) is a mutant variety of DsRed that
does not form a tetrameric structure[59]. MRFP1 also improves upon the time it
takes for DsRed to become fully fluorescent after synthesis, this is known as the
fluorescent proteins maturation time. The maturation time is a key experimental
parameter that is usually beneficial to minimise[58].
2.4.6 State-of-the-art Microscopy
Whilst only standard brightfield and fluorescence-based microscopy techniques
were used in this thesis, there are many more microscopy techniques used in the
field of microbiology.
20
A technique commonly used when imaging biological samples is confocal mi-
croscopy. This technique can be used to construct high resolution three dimen-
sional images of a biological sample. Whilst a number of other methods have been
developed to image biological samples in three dimensions, they all generally op-
erate by imaging multiple shallow image planes, building up a stack of image
slices in the z-axis. Confocal microscopy achieves this by selectively illuminating
and imaging small volumes of the sample in three dimensions using a focused
scanning laser beam and a combination of pinhole apertures[49][60]. A complete
image of the sample in three dimensions is then reconstructed computationally.
This confocal arrangement is shown in figure 2.5.
Figure 2.5 Schematic diagram of a confocal microscope. Using a combination of
multiple pinhole apertures and a laser point source, only fluorescent
light from a single shallow plane reaches the photomultiplier tube
(PMT) detector. Light from above (blue dots) and below (green dots)
the focal plane is largely unable to reach the detector. Taken from
[49].
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More recently, a focus has been placed on superresolution imaging. The reso-
lution of a microscope at a fundamental level can be described in terms of the
ability to distinguish two objects that are in close proximity to one another. In a
standard light microscope this resolution is limited by the diffraction of light, and
the lateral resolution is limited at around 200-250 nm. To overcome this diffrac-
tion limit, state-of-the-art techniques use single-molecule localisation to resolve
features down to less than 10 nm[49][61]. This is usually achieved by repeatedly
imaging a single field of view which contains fluorescent molecules that stochas-
tically photoswitch using low-power lasers[62]. As the molecules stochastically
photoswitch from one image frame to the next, each of the individual localised
molecule centres can be determined using statistical fitting techniques. Through
this repeated imaging, it is possible to construct a superresolution image by plot-
ting the centroid positions of all observed fluorescent probes[61]. This process is
shown in figure 2.6.
Figure 2.6 Diagram detailing the imaging sequence used in STORM superreso-
lution microscopy. In this case a hypothetical object labelled with 6
red fluorophores is being imaged. The red fluorophores photoswitch
to a bright state using a green laser, and a dark state using a red
laser. In each imaging/switching cycle, a green laser pulse is used to
stochastically switch on a small fraction of the fluorophores, whose
centres are accurately determined, before a red pulse then switches
them off. This process is repeated numerous times until near all
fluorophore positions can be determined with high accuracy and a
superresolution image is constructed. Taken from [61].
Two highly similar techniques that achieve superresolution in this manner are
Photo-Activated Localisation Microscopy (PALM) and Stochastic Optical Re-
construction Microscopy (STORM). Example STORM images are compared to
conventional fluorescence images in figure 2.7.
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Figure 2.7 Microcopy images showing the increased resolution obtained using
STORM superresolution microscopy when compared to conventional
fluorescence microscopy. Microtubules in rat kangaroo kidney cells
are imaged using conventional fluorescence microscopy (a) and using
STORM superresolution microscopy (b). The boxed section of the
image seen in (a) is enlarged in (c), (d) shows a STORM image of
the area shown in (c). Scale bar (a) and (b) = 5 µm, Scale bar (a)
and (b) = 1 µm. Taken from [49].
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2.5 Continuous flow microfluidics
In this section I will discuss the field of continuous flow microfluidics, focusing on
the fundamentals of microfluidic theory followed by an overview of microfluidic
research and its applications.
2.5.1 Microfluidic theory
Microfluidics is the study of small volumes of fluids (10−9 to 10−18 litres)[63]
and the systems used to manipulate these small volumes of fluids. Microfluidic
systems generally use a series of channels with primary dimensions less than 100
µm to direct microfluidic flows. To understand how these microfluidic systems
can be used in creative and novel applications, and the benefits they provide over
more traditional fluid manipulation techniques, it is useful to first understand the
theoretical principles commonly used to describe and characterise microfluidic
flow.
The behaviour of a fluid system is governed by a number of different physical
forces that compete with one another for dominance. This competition and its
eventual winners dictate the emergent behaviour of the system. To more easily
understand the mechanics of a fluid system, a number of dimensionless quantities
have been established to quantitatively evaluate the importance of these forces
relative to one another. Many of these forces scale with a characteristic length
scale of the system. This scaling is critically important when discussing mi-
crofluidic systems as these almost always operate at length scales not commonly
encountered in the academic laboratory, therefore their behaviour can appear
counter-intuitive unless properly understood.
Before discussing these dimensionless quantities, it is important to review the di-
mensional parameters that govern fluid flow, and the fundamental equation that
underpins microfluidic flow: the Navier–Stokes equation. Fluids are continuous
materials, and as such are not generally described using discrete quantities. In-
stead, continuous fields such as density and force density are used (which are
described per unit volume). The velocity field for a fluid obeys the Navier-Stokes
equation, which can be described as Newton’s second law for fluid particles[64].
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The incompressible fluid regime is assumed for microfluidics, therefore the Navier–Stokes
equation takes the following form:
ρ(∂tv + (v · ∇)v) = −∇p+ η∇2v + f, (2.3)
where ρ is fluid density, v is fluid velocity, p is pressure, η is the fluid viscosity and
f are body force densities due to external forces such as gravity[64][65]. Inertial
acceleration terms appear on the left hand side of the equation, whilst force
terms are gathered on the right hand side. When inertial forces are dominated
by viscous forces (a condition normally satisfied by microfluidic flow), the non-
linear term can be neglected. Under this regime, fluid flow is described by the
Stokes Flow equation:
ρ∂tv = −∇p+ η∇2v + f. (2.4)
The Navier-Stokes equation is famously difficult to solve. It is however possible
to derive analytical solutions for a small number of simple and idealised cases[64].
These solutions provide a basic and intuitive understanding of fluid flow in mi-
crofluidic channels, and it is this fundamental understanding that forms the basis
for the dimensionless quantities discussed in the following section.
Dimensionless Quantities
The first and most well known dimensionless quantity associated with microfluidic








where ρ is the density of the fluid, U is the velocity of the fluid with respect
to the channel, L is a characteristic length scale over which the fluid forces are
influencing and η is the dynamic viscosity of the fluid. Re is the ratio between the
inertial forces and viscous forces acting upon a fluid flow. Low Re values imply
that viscous fluid forces are dominating over inertial forces. When Re is small
the non-linear terms in the Navier-Stokes equations become vanishingly small,
resulting in linear, non-turbulent flow.
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This means Re is most generally used as a predictor for the transition between
laminar and turbulent flow regimes. Although a useful quantity more generally,
Re is a poor tool for the evaluation of microfluidic flows, as almost all microfluidic
flows operate in the small Re regime. This means that virtually all microfluidic
flow is linear and laminar in nature. Interestingly, this has the implication that
almost all cellular processes in nature occur in a low Re environment. This
concept is explored brilliantly in the talk “Life at Low Reynolds Number” by E.
M. Purcell[66] - an excellent primer on the sometimes counter-intuitive dynamics
of fluids operating in the low Re regime.
Whilst the Reynolds number is used to compare the inertial and viscous forces
that act upon fluid flows, there are a number of other dimensionless quantities that
are also used to characterise microfluidic flow. The Peclet number, for example,
compares diffusive and convective forces within a microfluidic flow. Calculation of
the Peclet number indicates that diffusion is dominant in almost all microfluidic
flows. The laminar nature of microfluidic flows means that mixing can only occur
via diffusion. Practically this means that to achieve decreased mixing times in
microfluidic flows, one must use carefully chosen microfluidic geometries. Other
dimensionless quantities include the Capillary, Weissenberg, Deborah and Weber
numbers, which compare the relative magnitudes of different fluid forces and
properties such as interfacial tension and polymeric relaxation times. Each of
these numbers is used to describe the dynamical behaviour of specific microfluidic
systems or geometries, and both the Capillary number and Weber number will
be detailed in section 2.6 as they are useful in the characterisation of droplet
microfluidic systems.
Hydraulic Resistance
Beyond the dimensionless quantities discussed in this section, two key quanti-
ties that must be considered when developing microfluidic systems are hydraulic
resistance and conductance. These quantities are defined below, in the Ha-
gen–Poiseuille law:




where ∆p is the pressure drop of a flow of constant rate Q, with proportional-
ity constants Rhyd (hydraulic resistance) and Ghyd (hydraulic conductance)[64].
26
Equation 2.6 is analogous to Ohm’s law, which links the voltage drop across a
current carrying wire given an electrical resistance. As electrical resistance can
be described in terms of energy loss due to heating, hydraulic resistance can
be described in terms of energy loss due to mechanical energy dissipation due
to internal fluid friction. To further the analogy, it is possible to calculate the
hydraulic capacitance of a system (known as the compliance). This compliance
is due to the fact that the fluids and materials used to construct a microfluidic
device are not perfectly incompressible or rigid, herein energy can be stored.
Furthermore, it is possible to apply the basic laws of circuit theory that de-
scribe coupled resistors and capacitors (as described in Kirchhoff’s laws) to a
microfluidic network[64][67]. This allows good estimates to be made of the total
hydraulic resistance of complex microfluidic lab-on-a-chip systems, without the
need for numerical simulations. The hydraulic properties (flow rate, hydraulic
resistance/conductance, pressure etc.) of a microfluidic system can be related to
channel geometry (cross-sectional shape, height, width and length)[67].
Whilst explicit calculations of hydraulic resistance were not made in this thesis, an
intuitive understanding of how channel geometry impacted hydraulic properties
such as flow rate and pressure was vital in the design of our microfluidic system.
2.5.2 Continuous flow microfluidics - general applications
Complex microfluidic designs are now being integrated into experimental systems
to conduct research across many academic fields[63]. These microfluidic systems
have furthered the experimental capabilities of many research groups, often im-
proving upon or condensing traditional experimental techniques.
Perhaps the most common and developed application of continuous flow microflu-
idics is in experimental screening, where many samples are tested for a particular
property of interest. For example, a number of microfluidic systems have been
developed to benefit the field of drug development, as high-throughput screening
techniques are an essential part of the drug discovery pipeline. The integra-
tion of multiple reaction steps onto a single microfluidic chip means that serial
analysis is attainable in flowing systems[68]. Furthermore, these serial reactions
can be parallelised extensively[69]. Microfluidic systems have also been coupled
with conventional mass spectroscopy systems to screen laboratory separations[70].
Microfluidic devices also lend themselves well to single molecule detection stud-
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ies[71]. These devices can be used in the identification and counting of newly
synthesised compounds and could have widespread applicability, especially in
bio-analytical fields[72]. Microfluidics devices have also found extensive use in
the synthesis and preparation of chemical compounds. By integrating a large
number of individual processes into a single “lab on a chip” that sequentially
automates a number of complex techniques, it has been possible to synthesise
sensitive compounds with a high yield and purity. It is possible for all of this to
be accomplished in a shorter time frame than current standardised techniques[73].
Whilst the the numerous applications of continuous flow microfluidics are clearly
far reaching and diverse, the field of microbiology is perhaps the greatest bene-
factor of this experimental technology. Bio-specific microfluidic applications will
be introduced and examples detailed in the following section.
2.5.3 Continuous flow microfluidics - biological applica-
tions
Microfluidics have proved themselves an invaluable tool in the study of (mi-
cro)biological systems[65][74][75][76]. This is in part due to their ability to accu-
rately and reliably manipulate fluids on length scales matching those of in vivo
biological niches. Another benefit of the microfluidic platform is the ability to
integrate a number of preparation and analysis processes into a single “lab on a
chip”: this has been used to simplify complex biological assays. Finally, the small
physical size of microfluidic devices make them suitable for Point of Care (POC)
diagnostic devices. This has been taken even further with the introduction of
low-cost paper-based microfluidic systems, which in the future may be used in
clinical applications in developing nations[77].
By way of example, stem cell researchers have designed a flow based sorting sys-
tem based on the principles of hydrodynamic filtration to sort marrow-derived
mesenchymal stem cells[78]. This approach allows for the rapid sorting of stem
cells without damage. Multiple advances have also been made in the field of neu-
rology due to studies using microfluidic devices. One group has developed a mi-
crofluidic multi-electrode array that could perform high-resolution extra-cellular
recordings of brain slices whilst remaining optically compatible with calcium
imaging - this had not been possible using traditional macro-scale experimen-
tal systems[79]. Minimal “organs on chips” have also been developed to closely
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replicate the environments inside functional organs so that bio-mimetic research
can be completed. Jang et al. mimicked a kidney using a simple multi-layer
microfluidic device consisting of microfluidic channels and a porous membrane
substrate. It was found that renal tubular cells developed inside the artifical
kidney grew as they would in vivo, suggesting that the microfluidic organ emu-
lated the target biological conditions well[80]. This study could have practical
implications in the fields of drug screening and tissue engineering.
More relevant to the work completed in this thesis, microfluidics can be used
to manipulate and immobilise individual cells for imaging in ways that were
previously impossible using more traditional microbiological techniques. A simple
and effective example of this can be seen in the popular “mother machine”[81][82],
a microfluidic geometry that constrains cells in long channels wide enough for just
a single cell to pass through. When bacteria are confined in these long channels,
daughter cells can be tracked with relative ease and lineage monitoring is possible
for over 200 generations. This is a 10x improvement in observation time over
traditional methods using agar pads[81]. Lee et al. have adapted this design in
a microfluidic dissection platform for yeast cells. In this adapted design, yeast
cells are trapped between PDMS-based microfluidic pads and a glass cover slip.
Fresh media is then passed over the cells, simultaneously providing nutrients to
the trapped mother cells and removing the smaller daughter yeast cells. This
supersedes a 50 year old technique described as “laborious and time-consuming”
where individual yeast cells are manually extracted and dissected at different
stages in the yeast cell lifespan[83].
Microfluidic systems are becoming popular in the study of bacterial population
dynamics, often with the aim of using microfluidic geometries to mimic biological
niches. For example, Austin et al. fabricated a linear array of coupled, micro-scale
growth “patches” that were inoculated with bacterial populations[84]. Nutrients
and waste were exchanged with an external reservoir using nano-scale slits and
stress could then be applied to each of the populations by restricting nutrient
exchange. It was found that growth patches and their associated bacterial popu-
lations interacted through extinction and colonisation processes, and by varying
stresses across the growth patch landscape, adaption was seen in high stress ar-
eas. Another prominent study published by the same group took this design
further by fabricating a microfluidic device consisting of 1200 hexagonal growth
chambers[85]. The growth chambers were connected by 10 µm wide channels that
allowed for bacterial movement from one chamber to the next. Antibiotic could be
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applied uniformly across all growth chambers, or as a gradient across the growth
chambers, using nano-scale slits at the perimeter of the microfluidic device. This
artificial set of linked environments mimics a number of micro-scale biological
niches well; porous materials, large cells and biological emulsions are examples
of micro-environments that confine bacteria but also allow interaction through
diffusion. It was found that bacterial growth was completely inhibited under uni-
form antibiotic application, however antibiotic resistance rapidly emerged when
the antibiotic was applied as a gradient. By further studying this rapid emer-
gence of antibiotic resistance across heterogeneous growth landscapes, it may be
possible to better understand in vivo bacterial infections.
Although these studies are but a tiny fraction of the current research being com-
pleted in the field of biologically oriented continuous flow microfluidics, they
nonetheless reveal the positive disruptive impact that microfluidics is having on
current techniques in experimental microbiology.
2.6 Droplet microfluidics
2.6.1 Introduction
Droplet-based microfluidics is a rapidly expanding field within the more general
domain of microfluidics. These types of microfluidic systems use specialised chan-
nel geometry to generate and manipulate droplets with diameters typically in the
range of 10-100 µm. These droplets are suspended in a secondary immiscible con-
tinuous phase and due to the low-Reynolds number behaviour that characterises
microfluidic systems, it is possible to quickly generate upwards of 1000 droplets
per second with a diameter polydispersity of less than 3%[86].
In this section I will introduce two commonly used dimensionless quantities that
can be used to quantitatively describe droplet-containing microfluidic flows. I will
then detail two experimental microfluidic geometries that are commonly used in
the generation of microfluidic droplets. Lastly, I will summarise a number of




When considering the behaviour of fluids in microfluidic droplet devices, we al-
most exclusively discuss interactions occurring in the low Re regime. As is stan-
dard with fluid dynamics, the behaviour of droplets generated and manipulated
in a microfluidic device can be generally characterised using a variety of dimen-
sionless numbers. These numbers are designed to compare the relative strengths
of the physical forces and interactions that govern microfluidic flow.
Although I have already described some of these dimensionless quantities in the
previous section, there are two numbers often used when describing droplet mi-
crofluidics specifically.
Dimensionless Quantities
The Capillary number (Ca) compares viscosity to interfacial tension, and is per-






where µ is generally the viscosity of the most viscous fluid, U is the characteristic
fluid velocity and γ is the interfacial tension. When Ca is low, this implies that
interfacial stresses are dominating over viscous stresses. In this scenario droplets
will attempt to minimise their surface area, resulting in spherical fluid interfaces
wherever possible. At large values of Ca, viscous stresses are dominating over
interfacial stresses. This results in droplets deforming into non-spherical, asym-
metric shapes. This will become highly relevant when discussing methods of
droplet generation.
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The Weber number (We) compares inertia to interfacial tension, and is generally






where ρ is the density of the continuous fluid, U is the fluid velocity, l is the
characteristic length of the system (usually droplet diameter) and γ is the inter-
facial tension. This dimensionless number is usually small in microfluidic flow,
but inertial effects can become relevant in high speed flows. The Weber number
is often used to characterise droplet breakup processes when viscous stresses are
dominated by capillary pressures and inertial forces[87], and it has been experi-
mentally linked to the transition between droplet generation regimes[88].
In summary, these dimensionless quantities are very useful in describing the mi-
crofluidic flow of droplet generation and offer a convenient method of mapping
the transitions between droplet generation regimes.
2.6.3 Droplet generation
Generally, the most complex and dynamic process within a microfluidic droplet
device is the generation of the droplets themselves, i.e. the point at which two
immiscible phases first interact to form an emulsion of dispersed droplets within
a continuous fluid phase. Devices for droplet generation are usually based around
the principles of co-flowing or cross flowing geometries.
T-junction
Of the many geometries designed to generate a monodisperse emulsion of mi-
crofluidic droplets, the T-junction (a form of cross flowing geometry) is the most
popular, most likely due to its inherent simplicity[87][89][90][91]. This method of
monodisperse microfluidic droplet generation was first demonstrated by Thorsen
et al.[92]. The T-Junction droplet generating geometry operates by flowing
one fluid into a second, cross flowing immiscible fluid at an orthogonal junc-
tion[93][94][95]. A basic schematic of the T-junction geometry is shown in figure
2.8.
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Figure 2.8 Schematic displaying the basic geometry of a cross flowing T-
junction microfluidic droplet generator. The dispersed phase (bot-
tom) can be seen entering the cross flow of an immiscible continu-
ous phase (left). As the dispersed phase enters the cross flow, the
head distorts downstream until the neck thins and breaks, resulting
in droplet formation.
The generation of droplets in a cross flowing T-junction is deceivingly complex.
First, the dispersed phase enters the flow of the cross flowing continuous phase
and an increasing pressure [89] and shear gradient is established [93]. These
gradients cause the head of the dispersed phase to elongate into the direction
of the continuous phase flow. As the head of the dispersed phase is distorted
along the channel, the neck of the dispersed phase thins and breaks, generating
droplets[89].
It has been observed that when generating monodisperse microfluidic droplets,
the T-junction geometry usually operates under one of two regimes. In the first
dripping regime, the continuous phase channel width significantly exceeds that
of the dispersed phase channel width. The capillary number is large, which gen-
erally signifies a fast flowing continuous phase. Under these circumstances, the
droplets are formed before the head of the dispersed phase can span the continu-
ous phase channel, breaking off when viscous shear stresses dominate over inter-
facial stresses[96]. When the channel width ratio of the two phases approaches
one, and the capillary number is reduced (signifying a lower continuous phase
velocity), the T-junction transitions into the squeezing regime[89]. Here the dis-
persed phase is able to almost completely span the continuous phase channel. A
rapid increase in upstream pressure forces the fluid interface to pinch off, forming
a plug-like droplet[96].
33
Whilst I will mention a number of studies that explore this process in more
detail, it should be noted that there are currently no empirical or theoretical
treatments that accurately predict the transition between the various droplet
generating regimes. Scaling laws that predict the rate of droplet production have
been proposed that agree well with experiments[97]. Despite this, there are no
studies that accurately describe droplet size or rate of production of a generalised
cross flowing droplet generating system[96].
A numerical investigation of the dripping to squeezing transition has been com-
pleted by Menech et al. This found that the squeezing regime operated largely
independently of material properties such as fluid viscosities, but they observed
that the dripping regime was far more fragile and only functioned correctly across
a small range of capillary numbers[98]. Garsteki et al. predicted that the droplet
length would be independent of the continuous phase viscosity across a wide range
of values[89], but more contemporary numerical[99] and experimental[97][100]
studies have shown the viscosity ratio can be influential in cross-flowing droplet
generation under certain conditions. Steegmans et al. noted that whilst the chan-
nel depth and the capillary number impacted generated droplet size, the dispersed
phase velocity was largely unimportant[101]. An experimental study completed
by Guillot et al.[102] found a transition from droplet generation to stable parallel
flows could not be predicted by capillary number alone.
I have acknowledged here just a handful of studies that attempt to provide insight
into the generation of droplets using a cross flowing microfluidic junction. Despite
the intense investigation into this method of droplet generation, there is still no
general consensus on the exact physical parameters that govern the mechanics of
droplet breakup at a T-junction.
The T-junction method of microfluidic droplet generation is often used due to
its simple design, but once this geometry has been finalised this approach offers
limited control over droplet size. This has been addressed in designs that im-
plement additional moving elements such as mechanical[103] or pneumatic[104]
microvalves, or by tuning internal surface tensions and viscosities through the
integration of heating elements[105]. Despite these innovations, these complex




Another effective method of microfluidic droplet generation is through the use of
a flow-focusing junction. In this geometry three separate fluid flows are simulta-
neously passed through a constricting orifice. The dispersed phase is fed through
a central channel, whilst the continuous phase occupies two channels either side
of the central channel[76][106], as illustrated in figure 2.9.
Figure 2.9 Flow-focusing geometry for droplet generation in a microfluidic de-
vice. Three channels are positioned beside one another, the outer
channels (top, bottom) carrying the continuous phase whilst the cen-
tre channel (middle, left) carries the dispersed phase. Each phase is
simultaneously forced through a constricting orifice. Droplet gener-
ation can occur upstream, downstream or within the confines of the
constriction.
As the dispersed phase flow is squeezed between the two continuous phase flows,
increasing pressure gradients cause symmetric shearing forces as all three flows
pass through the constricting orifice[94]. Viscous stresses and pressure cause
droplets to be formed in elongation-dominated flows[103].
It has been shown that flow-focusing droplet generating junctions optimally op-
erate in one of two droplet generation regimes[93][107][108]. The dripping regime
can be characterised by droplets being generated within one orifice-diameter of
the constricting orifice[109], and the generated droplet diameters being smaller
than the constricting orifice. The droplets generated in this regime are also
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highly monodisperse (less than 2% polydisperse)[87]. The jetting regime occurs
when droplets are generated at a point over three orifice-diameters from the con-
stricting orifice [109]. The outer continuous phase wraps around the elongated
neck of the dispersed phase, stabilising it such that it stretches downstream of the
constriction (likened to a jet) and this neck eventually breaks into droplets. Com-
paratively large and polydisperse droplets are formed under this regime[108]. A
number of additional breakup regimes have also been observed [87]. Understand-
ing the transition from the dripping to jetting generation regime is non-trivial.
Multiple studies have aimed to both qualitatively and quantitatively describe the
underlying physical phenomena that trigger this transition. Utada et al. argue
that the dripping regime will transition to the jetting regime when the timescale
for visco-capillary pinchoff roughly matches the timescale for growth of the jet,
leading to a critical transitional capillary number[109]. In similar fashion, Zhou et
al. argues that dripping will transition to jetting when interface disturbances are
convected downstream before amplification occurs[88]. Zhou’s approach predicts
a critical scaling behaviour, but this has not been tested empirically[87]. Physical
parameters such as droplet generation rate, droplet spacing and droplet velocity
have also been investigated and empirical relationships between these variables
have been predicted successfully using geometrical arguments[110].
A predictive model for the generated droplet size does not exist[93], but multiple
studies have shown that droplet size is affected by junction geometry, flow rates,
viscosity and interfacial tension[93]. As inertial contributions are typically negli-
gible in microfluidic flows, it has been hypothesised that a combination of viscous
stresses and capillary pressures primarily control droplet generation processes[93]
[103].
Despite the increased geometrical complexity demanded by the flow-focusing
junction (in comparison to the passive T-junction geometry), the effective ge-
ometry of the flow-focusing junction can be tuned significantly by adjusting the
dispersed and continuous phase inlet flow rates[111]. This affords a greater flex-
ibility in the generated droplet size alongside reduced polydispersity when com-
pared to the T-junction geometry.
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2.6.4 Droplet microfluidics - general applications
The idea of manipulating small droplets in microfluidic channels is appealing
both academically and industrially. Chemists and biochemists successfully used
droplet emulsions as pseudo-microreactors long before the advent of microflu-
idics[112][113]. Droplet microfluidics builds upon this basic premise by offering
a method of tightly controlling the generation of these droplet emulsions and
further manipulating them in ways that were not previously possible. Addi-
tionally, the contents of microfluidic droplets can be modified through the con-
trolled splitting or fusion of droplets using both passive[114][115] and active meth-
ods[116][117][118].
In many cases, microfluidic droplets are treated as individual “test tubes” - iso-
lated environments that benefit from low reagent utilisation, rapid mixing and
automated droplet manipulation[108]. Whilst both continuous flow microfluidics
and droplet microfluidics lend themselves well to many mutual areas of research,
some applications naturally benefit more obviously from the compartmentalised
nature of microfluidic droplet emulsions. Across the next two sections, I will
discuss a number of studies and applications that utilise microfluidic droplet
technologies.
One of the primary applications of microfluidic droplets is in the area of chemical
synthesis. In this role, droplets behave like compartmentalised reaction vessels
that are able to encapsulate an entire reaction process. Reagent consumption is
heavily reduced due to the sub-nanolitre volumes typical of microfluidic droplets,
and the rapid accumulation of reaction products decreases analysis and detection
times. Scaling reactions down so that they are performed in highly parallelised
micro-reactors also reduces the risk of performing exothermic reactions in bulk.
This allows reactions to be completed more quickly due to shorter diffusion, heat
and mass transfer distances[94]. In the microfluidic literature, there are numerous
examples of microfluidic droplet systems being used as a platform for multiphase
reactions such as titration[119] and precipitation[120]. Ahmed et al. performed a
simple biphasic hydrolysis reaction in a two-phase droplet microfluidic device. It
was found that reaction rate was dependant on multiple factors such as droplet
size and flow rate. When using the segmented microfluidic flow, it was found that
the efficiency was dramatically improved when compared to the same reaction
performed in a single phase conventional reaction flask[121].
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Droplet microfluidics are also finding use in the fabrication of special materials
- mostly solid or gel particles. These fabrication techniques generally operate
using the same basic principles; reactants are first encapsulated within microflu-
idic droplets and then dispersed into a continuous phase, material formation is
then triggered whilst the reactants are encapsulated within the microfluidic de-
vice[111]. These reactions can be initiated using external triggers such as UV ex-
posure, temperature or simple time delay. Winterton et al. presented a novel mi-
crofluidic reactor for the high temperature synthesis of semiconductor nanocrys-
tals. Nanocrystals were synthesised inside of droplets that were passed in and out
of a number of temperature controlled zones that could be tuned to the require-
ments of the synthesis[122]. By tuning the temperature of each reaction zone and
its associated droplet residence time, this droplet microfluidic device could be
used to optimise many forms of chemical processes. More complex mechanisms
of reaction initiation have been demonstrated that utilise droplet injection or co-
alescence to merge a number of reagents during multiphase reactions[111][114].
Frenz et al. demonstrated this in their work producing synchronised droplet
pairs that they mixed using electrocoalescence to fabricate magnetic iron oxide
nanoparticles[123], which have applications in magnetic resonance imaging and
high density data storage.
2.6.5 Droplet microfluidics - biological applications
Whilst both chemical synthesis and nanomaterial fabrication are prolific areas of
research using microfluidic droplet systems, the applications of this technology to
the field of quantitative microbiology are numerous and fruitful.
Biological applications using microfluidic droplets
Droplet microfluidics are well suited to biological screening and digital assays.
Current bottlenecks exist in microbiological research due to the need to screen
large numbers of individual reactions. Molecular screening for the purpose of
drug discovery requires the ability to screen millions of compounds, and this is
typically completed using a high-throughput pipetting robot using a 1536 well
plate, at a rate of ≈1 Hz, with minimal sample volumes of 100 nL[76]. Due to
these limitations, it is financially impossible to use molecular screening analysis
for all but the most valuable research targets [124]. Droplet microfluidics offers
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the ability to screen reactions at an ultra-high-throughput with rates reported
above 1 kHz using ≈1 pL of reagant per reaction[125][126]. This high-throughput
methodology coupled with increased sensitivity due to the small volume/high
density regime means that droplet microfluidics can dramatically increase the
productivity of bioassays and combinatorial biochemical reactions. An example
is provided by a study completed by the Weitz group, where droplet microfluidics
were used for the directed evolution of the enzyme horseradish peroxidase. The
study found mutants of the enzyme that exhibited catalytic rates ten times greater
than that of their parent. Furthermore the entire assay was completed in less
than one thousandth of the time and one millionth of the cost of the comparable
state-of-the-art robotic screening system[127].
Polymerase chain reactions (PCR) are an effective and reliable method of DNA
amplification, a process often harnessed in biological diagnostics. Whilst PCR
was first reported by Mullis et al. in 1987[128], the technique has been signif-
icantly improved in multiple ways using both continuous flow and droplet mi-
crofluidics[129]. Droplet-based PCR is capable of single-molecule DNA analysis,
enabling the rapid detection of rare mutation sequences without the signal being
washed out by more abundant DNA sequences[93]. DNA fragments can also be
isolated, stored and amplified without the possibility of recombination. Droplet
PCR is perhaps the most commercially successful application of droplet microflu-
idics to date [108] - multiple companies currently offer microfluidic droplet systems
tailored toward PCR[130].
Biological applications studying cells encapsulated within microfluidic
droplets
It has been shown that monodisperse microfluidic droplets can act as micro-
environments for the purpose of growing living cells[43][131]. Through the use of
biocompatible oils and surfactants, it has been shown that bacteria and eukaryotic
cells can survive droplet encapsulation for days[126]. This is done by passing
a suspension of cells in aqueous growth media through a microfluidic droplet
generator.
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where P (λ;n) is the probability of n cells being found in a droplet given the
average number of cells per droplet is λ. This is because bacteria suspended in
a liquid growth media will arrive at a microfluidic droplet generating junction
randomly and independently of one another. Furthermore, the average bacterial
arrival rate is fixed per unit time, and can be determined from the density of
the initial bacterial suspension[133]. Experimentally λ is tuned by adjusting
the concentration of the initial suspension, this allows the study of low-density
bacterial populations in microfluidic droplets. Moreover, by carefully selecting
the concentration of the initial suspension it is possible to obtain a distribution
of droplets which contains droplets encapsulating single cells. To surpass the
inherent Poisson efficiency limitations imposed by random loading, a number of
groups have taken advantage of both active techniques and passive hydrodynamic
phenomena to increase single cell loading efficiency up to ∼80%[132][134][135].
Whilst methods have been developed to improve single cell loading efficiency,
many studies choose not to employ these complex geometries[43][131][136][137],
instead empty droplets are removed in additional sorting steps or simply ignored
in further analysis. Whilst this produces a large number of empty droplets when
studying small bacterial populations, this is generally not a problem due to the
high-throughput nature of microfluidic droplet production and screening[138].
The ability to quantitatively study large populations of cells has revolutionised
our understanding of stochastic cellular functions and has found increasing use in
diagnostics[138]. Cells with desired characteristics can be detected using fluores-
cence markers that are used to determine protein expression and these can then
be isolated using Fluorescence-Activated Cell Sorting (FACS)[139]. This method-
ology is unfortunately limited if the “detection molecule” (usually the product
of an internal cellular process) is released by the cell. This limitation is removed
if each cell is instead encapsulated within a microfluidic droplet, as the reagents
and secreted molecules are contained in a diffusionally opaque compartment.
Shim et al. designed a microfluidic device that encapsulated bacteria in mi-
crofluidic droplets and analysed the gene expression and enzymatic activity of
each droplet using fluorescence measurements. They demonstrated the use of the
device in the context of directed evolution.
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Their microfluidic device gave them the ability to study the statistical hetero-
geneity of cells that were cultured identically[136].
Köster et al. demonstrated the encapsulation of single mammalian cells in mi-
crofluidic droplets for the purpose of antibody detection. It was shown that anti-
body secretion from single cells reached detectable levels within 6 hours, moreover
the cells were recoverable from the droplets post-encapsulation and were fully vi-
able[138]. Each of the individual processes that constituted the experimental
workflow (encapsulation, incubation, detection) were separated onto individual
microfluidic chips that were linked after fabrication. This modular design meant
that the assay could be customised with the exchange/addition/removal of indi-
vidual microfluidic sub-devices. This “microfludic toolbox” approach to device
design is advocated by a number of groups[126], and we followed this philosophy
when designing our own microfluidic device.
In recent years, one of the most innovative applications for microfluidic droplets
is in the field of ultra-high-throughput single-cell RNA sequencing. In this ap-
plication, a cell suspension is prepared using a tissue sample and the individual
cells are encapsulated using microfluidic droplets. In the droplets, each cell is
encapsulated with a companion microparticle that is tagged with an identifying
DNA-barcode. The cells are then lysed and the mRNAs of each cell bind to their
companion microparticle. These mRNAs are then reverse transcribed and ampli-
fied, and through the use of the bound DNA-barcode, each mRNA transcript can
be linked to a single cell-of-origin. The Drop-Seq[140], inDrop[141] and Genomics
Chromium[142] systems are three popular platforms that are capable of perform-
ing this ultra-high-throughput single cell analysis[143]. Whilst the purpose of each
system is largely the same, each of them differ subtly in the materials they use
and the order in which the steps of their protocol are completed. In their seminal
paper, Macosko et al. demonstrated this ultra-high-throughput single-cell RNA
sequencing process by analysing complex neural tissue[140]. 44,808 cells were
processed and 39 distinct cell populations were detected, each of which consisted
of closely related cell types. This cutting edge implementation of microfluidic
technology improves upon existing techniques by over two orders of magnitude
in both speed and cost. Beyond the simple identification of cell types, it is hoped
that this RNA sequencing process will provide a high-throughput method of con-
necting specific gene function and expression to the diverse families of cellular
sub-populations that compose a given tissue.
41
Biological applications studying bacteria-antibiotic interactions within
microfluidic droplets
Finally, and of critical relevance to the work completed in this thesis, microfluidic
droplets have also been used to study bacteria-antibiotic interactions in small bac-
terial populations. Studies that utilise microfluidic droplets for this purpose are
discussed below. Ultimately, there is considerable overlap in the objectives of the
research discussed below and the work completed in this thesis, so it is important
to consider the relative strengths and weaknesses of the different experimental
approaches and methodologies.
Tang et al. have developed a microfluidic device to detect small sub-populations
of bacterial cells that naturally exhibit resistance to a given antibiotic; a phe-
nomenon known as heteroresistance[43]. To measure this heterogeneity a bacte-
rial population is dispersed into a microfluidic droplet emulsion and the resulting
droplets are then incubated and later measured for growth. Droplets contain-
ing initially resistant bacteria will multiply into a healthy bacterial population.
This microfluidic system combined 3 separate devices to achieve its goal. First, a
flow focusing microfluidic droplet generator encapsulated an aqueous mixture of
bacteria and antibiotic solution within a droplet emulsion dispersed within a con-
tinuous fluorocarbon oil phase. After incubation, these droplets are then passed
to a second device that uses pico-injection to inject a dye into the droplets that
indicates cell viability. After a final incubation, the droplets are then passed to
an ultra-high-throughput fluorescence detection device that uses fluorescence of
the dye to detect bacterial growth at a rate of around 1600 droplets per second.
This device was successful in the rapid phenotyping of antibiotic resistance with
high resolution, and moving forwards it is hoped that this microfluidic system
will be used to study the evolution of heteroresistance and the conditions that
support it. Clinically, this information might be used to influence therapeutic
decisions, using data more suitable than population-averaged measurements.
A droplet based microfluidic system has been developed by Konry et al. to per-
form phenotypic-based antimicrobial susceptibility testing [137]. This device gen-
erated microfluidic droplets that contained equal parts urine sample (containing
live bacterial cells), and antibiotic solution. Using an initial bacterial concen-
tration of 5 × 104 CFU ml−1, bacteria were distributed amongst the droplets
such that 14% of droplets contained no bacteria, 68% of droplets contained less
than 4 bacteria and 18% of droplets contained more than 4 bacteria. These
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droplets were then passed to a temperature controlled 1000 droplet “docking ar-
ray”, where they were imaged. Bacterial population sizes and cell morphologies
were measured. Changes in bacterial number and bacterial length were calculated
for 50 populations at each experimental condition. This study demonstrated an
early proof-of-concept microfluidic device that was used successfully in antibiotic
susceptibility testing of clinically relevant E. coli. This approach significantly im-
proves upon the readout times of standardised bulk antimicrobial susceptibility
testing which requires more than 16 hours for completion. This microfluidic sys-
tem provided actionable readouts within 1 hour of on-chip incubation. It is hoped
that this microfluidic system could form the basis of a high-throughput platform
for antimicrobial susceptibility testing. Although this device can only test a single
condition at a time, efforts are being made to parallelise this microfluidic testing
platform.
Postek et al. have developed a droplet-based microfluidic device to encapsulate
small populations of bacteria within droplets in order to study an extreme case
of the inoculum effect observed at low bacterial concentrations[131].
Inoculum effect
The inoculum effect is a behaviour observed in antibiotic research where
the MIC of an antibiotic significantly increases with an increase in initial
bacterial inoculum[144].
This was accomplished by using a droplet generating microfluidic device to en-
capsulate bacteria, aqueous growth media and the antibiotic cefotaxime within
microfluidic droplets. These droplets were then incubated off-chip. After incu-
bation, the droplets were introduced to a second microfluidic device that detects
and records a fluorescence intensity value for each droplet, which is used as a mea-
sure of total growth. An inoculum effect was observed in the droplets as initial
bacterial concentration was increased. Bacterial aggregation was also observed
at high antibiotic concentrations. The group believe this device could be used in
a variety of studies to further our understanding of the inoculum effect in small
bacterial populations, as well as find use in more general research that requires a
large number of reaction chambers per set of reaction conditions.
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2.7 Summary
In this chapter, I have summarised a number of core topics that I feel are impor-
tant to the work completed in this thesis.
First, I discussed the importance of antibiotic research and why renewed and
continued efforts into this field are critically significant moving forwards. Moving
on from this, I discussed the principles underpinning brightfield and fluorescence
based microscopy, as well as outlining several state-of-the-art microscopy tech-
niques that are used in quantitative microbiology. I then introduced microfluidics
and some of the basic theoretical concepts that underpin our understanding of
fluid flow at the micro-scale. In the process I defined the dimensionless Reynolds
number, further explaining why flow in the low Reynolds number regime is rel-
evant to microbiology. After this I presented a number of studies that utilised
continuous flow microfluidics as an experimental platform, first focusing on more
general applications before discussing applications with direct microbiological rel-
evance.
I then discussed the field of droplet microfluidics at length - an experimental
technique that takes advantage of the unique properties of microfluidic flow to
manipulate materials encapsulated within micro-scale droplets. This began with
another introduction to microfluidic theory, this time highlighting the Weber
number and the Capillary number: dimensionless quantities that are especially
useful when describing the behaviour of microfluidic droplets. The concept of
microfluidic droplet generation was explored. The two primary methods of mi-
crofluidic droplet generation: the T-junction and the flow-focusing junction, were
outlined. Emphasis was placed on the numerous experimental and theoretical
studies that have been conducted to further our understanding of these deceiv-
ingly complex microfluidic geometries. Finally, the many applications of droplet
microfluidics were discussed, beginning with more general implementations such
as chemical synthesis before moving onto biologically focused applications and
studies. Three investigations were referenced[43][131][137] that utilised droplet
microfluidics to study the effects of antibiotic inhibition on small bacterial pop-
ulations, these works are of critical relevance to this thesis and will be referred






In this chapter, I present the common materials, techniques and fabrication pro-
tocols used throughout this thesis. To begin, I will outline all of the materials
used in the fabrication of the microfluidic system that we designed for this re-
search project. Similarly, I will summarise all of the materials required to use our
microfluidic system to study bacterial growth in the presence of antibiotic. Along-
side this I will outline the microbiological protocols that are used to prepare these
materials. After this, I will present the fabrication protocol of our microfluidic
master mould, and then the protocols used in the fabrication of the microfluidic
devices that make up our system. Lastly, I will discuss ancillary equipment that
was used to obtain experimental data using our microfluidic system.
Whilst the materials and methods are described here in relative abstraction, they
will provide key context to subsequent chapters. In particular, the materials and
methods that we chose to employ when fabricating our microfluidic system had a




When fabricating a microfluidic device it is important to use materials that com-
plement the objectives of the research that will be conducted using the device. All
the materials used in the fabrication of our microfluidic devices were primarily
chosen to promote the effective generation of microfluidic droplets for the ex-
press purpose of encapsulating biological cells. A secondary emphasis was placed
on ease of fabrication: prioritising the use of techniques and materials that are
readily available to academics working in a non-specialist laboratory.
3.2.1 Polydimethysiloxane
Our microfluidic device is primarily fabricated using Polydimethylsiloxane (PDMS).
PDMS is a silicone elastomer, generally supplied as a base and curing agent that
are mixed at a ratio of 10:1 to produce an elastomeric polymer[111]. PDMS
is often used as the base material in biological microfluidic research due to a
plethora of favourable physical characteristics[76][111]. In particular, PDMS is
optically clear down to 240 nm[145], allowing straightforward operation in con-
junction with a number of microscopy techniques[146]. PDMS also possesses
good bio-compatibility[75] and is non-toxic to cells [146]. It is gas permeable[76],
permitting the exchange of gaseous products with the surrounding environment.
Finally, PDMS is simple to work with: it is soft, flexible and chemically in-
ert[75][76]. PDMS was purchased as Sylgard 184 flowable silicon elastomer in 1.1
kg quantities.
Although PDMS is the most common material used in the fabrication of aca-
demic microfluidic devices, there are a number of alternatives. Silicon and glass
have long been used in the fabrication of microfluidic devices, however the as-
sociated material costs combined with the complex process of chemical etching
results in an expensive fabrication procedure that requires the use of specialist
equipment. The use of other polymeric materials is also commonplace; polyvinyl
chloride (PVC) and polymethylmethacrylate (PMMA) are used frequently in the
manufacture of microfluidic devices. These materials are generally inexpensive,
robust and biologically inert. We felt that whilst many of the properties of these
materials were attractive, there were some significant drawbacks associated with
these materials. For example, fabricating these types of polymeric microfluidic
devices requires the use of specialist equipment not generally available in an aca-
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demic laboratory. They are also gas impermeable, resulting in a device that does
not allow for the exchange of gaseous materials into and out of the microfluidic
device. Furthermore these devices are generally re-used from one experiment to
the next, necessitating the use of additional sterilisation protocols when biological
materials are passed through them.
3.2.2 Carrier oil
Despite the many positive physical attributes of PDMS listed in the previous sec-
tion, PDMS suffers from swelling when introduced to many organic solvents. This
swelling can render a device unusable, therefore in the context of droplet microflu-
idic systems, organic carrier phases such as hexadecane and mineral oil cannot
be used[111]. To avoid this problem, aqueous microfluidic droplet emulsions are
often suspended in a fluorinated oil carrier fluid[147]. Fluorinated oils also benefit
from being biologically inert[148][149], with a low solubility for many biological
reagents. Fluorinated oils also possess a high gas permeability [119][150], allowing
gaseous waste products to diffuse from a droplet whilst allowing oxygen to reach
the droplet interior.
We chose to use FC40 as the fluorinated oil carrier phase in our microfluidic
droplet experiments[137][151][152]. FC40 is a fluorinated oil commonly used as a
carrier phase when encapsulating biological material within microfluidic droplets,
and possesses all of the positive physical characteristics detailed above. FC40 was
purchased from Sigma-Aldrich in 100 ml quantities.
3.2.3 Droplet surfactant
A surfactant is required to stabilise the droplet interface between the FC40 carrier
oil and the aqueous growth media encapsulated by each droplet. This drastically
reduces the rate at which droplets coalesce (even when confined in close contact
with one another), whilst also ensuring biological reagents do not adsorb to the
oil-water interface[148][150]. There are a number of commercially available sur-
factants suitable for use in fluorocarbon systems, as well as literature detailing
the synthesis of specialised fluorocarbon surfactants[148].
We use the commercially available fluorosurfactant Pico-Surf 1[152][153][154][155].
It is a biocompatible fluorosurfactant consisting of a perfluoropolyether tail and
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a polyalkylene oxide unit headgroup[156], it is stable across an extensive range of
temperatures and supports a variety of biological conditions. This has been used
successfully in a number of separate studies and is designed to be compatible with
the Pico-Glide 1 surface treatment we use to ensure channel hydrophobicity (see
section 3.2.4). Pico-Surf 1 was purchased in 10 ml quantities at a concentration
of 5% (w/w), in FC40. It was diluted to a concentration of 2.5% (w/w) using
FC40.
3.2.4 Device hydrophobicity
During droplet generation it important that the aqueous phase does not wet or
pin against the microfluidic channel as this can cause droplet coalescence, or
worse, completely prevent the production of a monodisperse emulsion [90][157].
During droplet storage and imaging, it is crucial that the aqueous droplets do
not wet the surface of the microfluidic channels as this would allow encapsulated
bacteria to interact directly with the channel surfaces of the microfluidic device.
To prevent the aqueous phase wetting onto the channels of our microfluidic device,
it is essential that the walls of the PDMS device are highly hydrophobic and if
possible, fluorophilic.
Freshly cured PDMS is naturally hydrophobic, therefore polar fluids such as water
cannot easily wet its surface. Plasma treatment is required to bond PDMS to
a glass substrate during the fabrication of a microfluidic device. Unfortunately
when PDMS is plasma treated it is rendered hydrophilic[158][159]. This is due to
surface oxidation forming a brittle, silica-like SiOx-rich layer[160][161]. There are
two common methods used to revert the channels of a PDMS-based microfluidic
device to their original hydrophobic state; heat treatment and chemical treatment.
Heat treatment
It has been shown that PDMS will naturally revert to a hydrophobic state after
plasma treatment. This reversal is due to the migration of low molecular weight
PDMS chains from the bulk of the material to the oxidised surface[158]. This
process takes between 200 and 1000 hours[161], however this can be expedited by
baking the PDMS at a high temperature (e.g. 65°C for several days)[76].
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When plasma treating our first generation microfluidic devices, we found that suf-
ficient hydrophobicity was recovered by simply baking our microfluidic devices at
80°C for 24 hours. Unfortunately, as we began testing more complex microfluidic
designs, the aqueous phase began to wet/pin to the surface of some microflu-
idic channels. This was most apparent when passing droplets through highly
constricted microfluidic features with a channel depth of 11 µm. This aqueous
pinning caused droplet coalescence.
Contact angle measurements
Contact angle measurement is a common technique used to quantify the
wettability of a solid by a liquid[162]. The contact angle can be geometri-
cally described as the angle formed by a liquid at the three-phase boundary
i.e. at the intersection of a liquid, solid and gas.
In this thesis, static contact angle measurements were taken using the sessile
droplet method, where droplets of deionised water are delivered to a PDMS
surface using a calibrated syringe and subsequently imaged.
To quantify this change in hydrophobicity, contact angle measurements were
taken of desionised water on the surface of freshly cured PDMS. These measure-
ments were then compared to contact angle measurements of a PDMS surface
that was exposed to oxygen plasma (using the same experimental parameters as
detailed in section 3.4.4) and then heat treated at 80°C for 40 hours. These mea-
surements showed that, as anticipated, freshly cured PDMS is highly hydrophobic
with a contact angle of 118.8° (measured using an elliptical approximation). After
40 hours of heat treatment, plasma exposed PDMS had not fully recovered its
hydrophobic character, with a measured contact angle of 95.4°. This is consistent
with literature measurements which have measured the contact angle of pristine
PDMS to be between 100° and 120°[158][162][163]. These measurements can be




Figure 3.1 Images showing wetting of deionised water on the surface of a PDMS
coated glass slide. (a) and (b) show a droplet of water on a freshly
cured PDMS surface, the contact angle measured using an elliptical
approximation is 118.8°. (c) and (d) show a droplet of water on a
PDMS surface that has been exposed to oxygen plasma (50 seconds at
35 W) and then heat treated for 40 hours, the contact angle measured
using an elliptical approximation is 95.4°.
Furthermore, studies have shown that whilst PDMS surfaces exposed to oxygen
plasma revert back to a hydrophobic state, full recovery to the same level of
hydrophobicity/wettability has not been observed[158][161]. Because of this, we
explored alternative solutions that would promote full hydrophobic recovery of
PDMS after plasma treatment.
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Chemical treatment
It is possible to restore high levels of hydrophobicity to plasma treated PDMS-
based microfluidics using chemical treatments[76][111]. These are generally spe-
cialist solutions that contain surface active species that interact with plasma
treated PDMS surfaces[164] to render them hydrophobic[165]. Generally, these
chemical treatments are flushed through the device as a pre-treatment prior to
use.
“Aquapel” is a chemical marketed as a rain repellent treatment for glass. It
is commonly used as a hydrophobic surface treatment in microfluidic research
due to its low cost and efficacy as a hydrophobic PDMS surface treatment[152]
[166]. Despite its widespread use in microfluidic research, we found Aquapel
to be unsuitable for use in our more complex microfluidic designs. When it is
passed through long channels of low cross-sectional area, prolonged exposure to
air causes the Aquapel to precipitate[152], rendering the channels functionally
useless.
(a) (b)
Figure 3.2 Aquapel precipitation observed in the channels of our microfluidic
system. This was observed most frequently in, or directly after, long
channels of low cross-sectional area.
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Due to this, I instead used a commercially available solution called Pico-Glide 1,
which is manufactured by Dolomite Microfluidics[155][167]. Pico-Glide 1 contains
a fluorinated polyether polymer at a concentration of 0.5% w/w and is chemically
reactive to plasma treated PDMS and glass. During treatment, PicoGlide inter-
acts with microfluidic channels to form a covalently bonded, dense fluorophilic
layer that enhances droplet stability.
Although substantially more expensive than Aquapel, I have found PicoGlide to
be effective at reducing droplet wetting and increasing long term droplet stability.
Pico-Glide 1 was purchased in 10 ml quantities at a concentration of 2% (w/w)
in FC40, and was used as received.
3.2.5 E. coli
The bacterial strain used exclusively in this thesis is an E. coli mutant named
RJA002[168][169]. This mutant was created in the Edinburgh laboratory by Pl
transduction from strain MRR (supplied by the Elowitz lab [170]) and selection
on chloramphenicol. This mutant contains the gene for YFP integrated on its
chromosome at loci intC. The YFP gene is under the control of the phage lambda
Pl promoter, which is constitutively expressed - this means that RJA002 produces
YFP continually.
3.2.6 M9 growth media
M9 minimal growth media (M9) is a liquid growth media commonly used in the
cultivation of E. coli. It is an inexpensive, well defined and minimal media that
needs to be supplemented with a carbon source and can be further augmented
with additional metabolites. M9-based media are preferred in imaging applica-
tions due to their low levels of auto-fluorescence.
M9 X4 salt stock was prepared by mixing 28 g Na2HPO4, 12 g KH2PO4, 2 g
NaCl and 4 g NH4Cl with 1 l dH2O. M9 minimal media was prepared by mixing
100 ml of M9 X4 salt stock with 300 ml dH2O, 800 µl of 1 M MgSO4 and 40
µl of 1 M CaCl2 is then added. 8 ml of 20% w/v glucose is added, bringing the
carbon source to a concentration of 0.4%. Herein M9gl refers to M9 minimal
media supplemented with glucose at a concentration of 0.4%.
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3.2.7 Agarose Plates
Agarose (agar) plates are petri dishes that contain agar supplemented with nu-
trients to form a solid growth medium. Selection pressures can be applied with
the addition of compounds such as antibiotic. Agar plates are seeded with a bac-
terial strain by streaking bacteria across the surface in a controlled manner, this
streaking process is used to reproducibly isolate single bacteria to obtain isogenic
starting populations.
Streaking an agar plate
Streaking an agar plate is a method of isolating, growing and storing small
isogenic bacterial populations. These can then be extracted from the agar
plate and used as starting colonies in experimental microbiological work.
A small volume of frozen bacterial stock is streaked across a subsection of
an agar plate using an inoculation loop. The loop is sterilised and then
streaked through the initial subsection into a fresh subsection of agar. This
process is repeated 4 times in total, each time streaking through the previ-
ously streaked subsection. Correctly streaking a plate should result in the
growth of individual colonies on the final path of the inoculation loop.
Agar plates supplemented with M9gl were used for the mid-term storage of iso-
genic bacterial stocks. These were made by mixing M9 X4 salt stock with 300 ml
of liquid agar preheated to a temperature of 60°C. MgSO4, CaCl and glucose was
then added in quantities matching those given for the liquid growth media. Once
the liquid agar had been prepared, multiple plates were made simultaneously by
pouring the agar mixture into plastic petri dishes to a depth of ≈5 mm. These
were then covered with their respective lids and allowed to cool for 30 minutes.
Once the agar had solidified, the petri dishes and lids were inverted and placed
in an oven at ≈40°C until all condensation had evaporated. The plates were then
sealed using plastic paraffin tape, stored at 4°C, and used within 6 weeks.
Bacteria were added to the plates by streaking with the required strain taken from
freezer stock. They were then sealed with plastic paraffin tape and incubated in
a stationary incubator until individual colonies were visible (usually between 24
and 36 hours). The plates were then stored at 4°C, and used within 2 weeks.
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3.2.8 Streptomycin
Stock streptomycin solutions were prepared by mixing streptomycin sulfate salt
with dH2O to a concentration of 500 µg ml
−1. These stock solutions were then
sterilised using a 0.22 µm filter, stored at -20°C and used within 3 months. Further
stock solutions of streptomycin at lower concentrations were prepared for each
experimental run from the original 500 µg ml−1 stock. These were stored at -20°C
and discarded after 3 freeze-thaw cycles or after 3 months, whichever came first.
3.3 Fabricating a PDMS-based microfluidic de-
vice
3.3.1 Overview
In this section, I will outline the protocol that was developed to fabricate our
microfluidic system. This is split into two primary sections: the fabrication of a
microfluidic master mould using a photomask, and the fabrication of a fully func-
tional microfluidic device using this microfluidic master mould. A microfluidic
master mould, herein referred to as a microfluidic master, is a mould that can be
used to repeatedly cast a microfluidic device from an elastomeric material.
Soft lithography refers to a set of techniques that can be used to fabricate struc-
tures from elastomeric materials, and it is used heavily in the fabrication of our
PDMS-based microfluidic devices. This multi-stage process is outlined in figure
3.3.
The fabrication protocol used to produce the microfluidic devices developed in this
thesis contains multiple critical stages that must be completed correctly to pro-
duce a functioning microfluidic system. Faults and defects introduced during the
fabrication process can result in immediate and obvious device failure, although
some faults may only become apparent under device operation. It was vital that
a reliable fabrication protocol was developed and followed to avoid wasting both
time and resources on the fabrication of a faulty microfluidic device.
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Figure 3.3 Diagram outlining the soft lithographic process used when fabricat-
ing a PDMS-based microfluidic device. In (a) - (d), a microfluidic
master mould is fabricated using a photomask. In (e) - (g) a PDMS-
based mircofluidic device is cast using the master mould. In (h) and
(i) a microfluidic device is bound to a glass substrate and prepared
for use. Taken from [152].
3.3.2 Fabrication protocol - photomask and master mould
The fabrication of a microfluidic master is a highly technical process that involves
the use of a custom microfluidic photomask. This is the only procedure in our
fabrication protocol that requires the use of specialist equipment not generally
available to those working in an academic laboratory. The custom microfluidic
photomask that we used in the master fabrication process was made by JD-
PhotoData. It is a 4′′ low reflective chrome photomask printed onto a 1.5 mm
soda lime glass base substrate at a resolution of 128k DPI.
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Our final microfluidic design required the fabrication of two microfluidic masters,
one with a channel depth of 34.5 µm and the other with a channel depth of 11.5
µm. The microfluidic masters were fabricated in collaboration with the Scottish
Microelectronics Centre.
They were made by first spin coating SU8-3010 on a 4′′ silicon wafer. The SU8-
3010 was spun for 2 minutes at 2000rpm to achieve a channel depth of 34.5 µm
and for 2 minutes at 4000rpm to achieve a channel depth of 11.5 µm. Following
spin coating, the wafers were pre-baked for 1 minute at 65°C followed by a soft
bake for 10 minutes at 95°C. After this, the wafers were exposed to UV light
through a photomask for 2 minutes and then baked a second time for 1 minute
at 65°C and then 2 minutes at 95°C. Finally, the microfluidic masters were rinsed
in propylene glycol methyl ether acetate (PGMEA) until only the crosslinked
SU8-3010 remains, usually after around 4 minutes.
3.3.3 Fabrication protocol - PDMS-based microfluidic de-
vice
Making microfluidics for this application does not require the use of a clean room,
but care does need to be taken to reduce contamination at all stages of device
fabrication. All microfluidic devices were stored in sterile disposable petri dishes
when not being handled directly.
To make a device, 30 g of PDMS was prepared by mixing the 2 part product in a
ratio of 10 parts elastomer to 1 part crosslinking agent. The two components were
mixed thoroughly for 5 minutes, ensuring the crosslinking agent was completely
combined with the elastomer. Care was taken to avoid contamination of the liquid
PDMS as dust mixed into the PDMS can cause issues when using the microfluidic
device. Bubbles of air introduced during the mixing process were removed by
placing the PDMS mixture under vacuum for 30 minutes. The vacuum was
vented every 5 minutes as this acts to burst the bubbles of air once they have
risen to the surface of the PDMS. The microfluidic master was placed into a glass
petri dish. The PDMS was then poured to a depth of 15 mm over the master
and then placed under vacuum until all bubbles on the surface of the microfluidic
master had been removed. The master was covered using the petri glass lid and
then baked for 90 minutes at 80°C until fully cured.
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A scalpel was used to remove the excess PDMS from each of the microfluidic
designs. Inlet and outlet holes were then punched into the microfluidic designs
using a biopsy punch. 20 mm lengths of glass capillary were then inserted into
the freshly punched holes, leaving the excess length of capillary protruding from
the opposite face of the PDMS to the microfluidic design. Contaminating debris
from the punching process was removed from the inlets and outlets by flushing
the capillaries with compressed air. The surface of the PDMS devices featur-
ing the design were then cleaned using compressed air and the repeated, gentle
application of adhesive tape.
A microfluidic design and glass microscope slide was placed into a Diener Zepto
plasma oven, feature side exposed. These were then exposed to an oxygen plasma
for 55 seconds at a power of 35 W. The plasma oven was then vented and the
contents were removed. The feature side of the microfluidic design and the ex-
posed face of the glass slide were brought together. With the gentle application
of pressure the two surfaces were permanently bonded to one another. Once the
microfluidic device had been bound to the glass substrate, the perimeters of the
glass capillaries were sealed to the PDMS with the application of a 2-part epoxy
resin.
The final stage in device fabrication was to treat the device with PicoGlide, a
chemical treatment that makes the surfaces of the microfluidic channels both
highly hydrophobic and fluorophilic. 500 µl of PicoGlide was manually flowed
into the device using a 1 ml syringe. The channels were filled completely and the
device was left for 60 minutes. The channels were then flushed free of PicoGlide
and the device was stored in a sealed, clean environment until use.
3.4 Equipment
3.4.1 Microscope and camera
The microscope used in this project was a Nikon Eclipse Ti epi-fluorescent in-
verted microscope. For all imaging, a Nikon Plan Fluor 20x/0.5 objective was
used. The camera used for both brightfield and fluorescence microscopy was a
Hamamatsu Orca-Flash4.0 V2 (C11440-22CU). This camera uses a CMOS image
sensor that has a 6.5 µm x 6.5 µm pixel size and 2048 x 2048 imaging pixels. A
2 x 2 pixel binning regime was used, reducing image size to 1024 x 1024 pixel2.
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The exposure times for brightfield and fluorescence imaging was 10 ms and 50 ms,
respectively. When using fluorescence microscopy to image bacteria expressing
YFP (E. coli strain RJA002), illumination was provided by a broad spectrum
Mercury lamp used in conjunction with a Chroma EYFP filter (λem = 500 nm,
λem = 535 nm).
A computer controlled motorised microscopy stage was used to automatically scan
across the microfluidic reservoir device during imaging. The microcopy stage used
was a Prior Scientific H117 motorized precision stage (H117P1N4/F), this stage
has a travel range of 114 mm x 75 mm, a resolution of 0.01 µm and a mean
uni-directional repeatability of ±0.2 µm. The microscope stage was controlled
by a Prior Scientific ProScan III controller in conjunction with a Prior Scientific
PS3J100 Interactive Control Centre.
3.4.2 Microfluidic device mount
The high gas permeability of PDMS is useful as it allows gaseous waste products
produced by bacteria (see section 2.2.3) to escape from a PDMS-based microflu-
idic device. Unfortunately, a consequence of this gas permeability is that it allows
for the evaporation of the aqueous phase from the microfluidic device[145][171].
Evaporation is a significant problem when culturing bacterial populations as even
small reductions in droplet volumes can significantly increase the osmolality of the
confined aqueous environments. This is problematic as changes in osmolality can
significantly disrupt important cellular functions such as growth rate, metabolism
[172] and gene expression[173].
In initial testing, we immediately noticed this aqueous evaporation. When storing
our microfluidic droplets, they would steadily decrease in volume, losing more
than half their volume over the course of a few hours. To retard this evaporative
effect, many groups seal their microfluidic devices using sticky tape or some other
non-permeable material, or prime their device by storing the device in water
before/during experimentation[174]. We chose to utilise the second method as
it afforded us an additional benefit: by submerging the device in a temperature
controlled water bath we could eliminate droplet evaporation whilst regulating
the temperature of our microfluidic system during experimental runs.
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To accomplish this goal, we designed a custom microscope mount that incorpo-
rated a reservoir we could couple with an external temperature controlled water
bath. The device mount was designed and modelled in FreeCAD. We chose to
3D-print the device mount for multiple reasons. Firstly, 3D-printing is highly
time efficient; by using this fabrication technique it was possible to repeatedly
and rapidly prototype multiple iterations of a design with turnaround times of
less than a day. Secondly, the process is labour efficient; we did not require a
university workshop for repeated fabrication of prototype designs. Finally, 3D
printing is cheap and scalable at the academic level: material costs can be a frac-
tion of those for traditional fabrication techniques and once the design has been
finalised it is available for others to print and use themselves.
(a) (b)
Figure 3.4 Images of the microfluidic device mount. (a) Shows the 3D model of
the device mount that was sent to the 3D printing service, (b) shows
the final printed device mount, in this example image a microfluidic
device has already been mounted and sealed.
3.4.3 Syringe pumps
As discussed in chapter 2, the size distribution of droplets generated in a flow
focusing junction is intrinsically linked to the fluid velocities of the two fluid
phases. Because of this, it is vital that the flow into the microfluidic device is
steady and controlled to ensure a truly monodisperse droplet emulsion.
Flow rates less than 10 µl hr−1 are commonplace in the field of microfluidics[134],
so the minimum flow rate of 20 µl hr−1 used in this thesis does not require par-
ticular focus or attention. Two “New Era NE-1002X” microfluidic single syringe
pumps were used to control the delivery of the aqueous and oil phases.
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These are designed to provide smooth linear pumping at flow rates as low as 0.008
nl hr−1[175]. During droplet generation the oil phase was pumped at a flow rate
of 80 µl hr−1, whilst the aqueous phase was pumped at a flow rate of 20 µl hr−1.
3.4.4 Plasma oven
Oxygen plasma is used to bond the PDMS microfluidic device to a glass substrate,
thus sealing the microfluidic channels[176]. Oxidised PDMS readily bonds to an
oxidised glass surface upon contact to form an irreversible seal. This seal is
believed to be the result of surface oxidation developing silanol groups (at the
expense of methyl groups). These silanol groups form bridging siloxane (Si - O
- Si) bonds via condensation reactions when brought into contact[162][177]. A
Diener Zepto plasma system was used to bond the microfluidic devices to a glass
cover slip. PDMS and glass components were exposed to oxygen plasma for 55
seconds at a power of 35 W.
3.5 Concluding remarks
The materials and fabrication techniques we used to fabricate our microfluidic
system were chosen as their strengths and weaknesses optimally matched the
experimental objectives of the system. Furthermore, they provided a high degree
of bio-compatibility such that the microfluidic devices we have developed could
be used to study different biological systems in the future. Finally, the materials,
tools and techniques used in the fabrication process did not require specialist
knowledge or understanding of microfluidic fabrication protocols. We believe that
our choices of materials and fabrication techniques are complementary to both




Designing a Microfluidic System
for the Encapsulation of
Bacterial Populations
4.1 Introduction
In this chapter, the design process of our microfluidic device will be detailed. The
development of our microfluidic system was an iterative process which involved
the design, fabrication and testing of multiple microfluidic geometries.
I will first discuss why we chose to design a droplet-based microfluidic system for
our research. After this I will outline a number of key microfluidic design princi-
ples that we found to be important in the creation of efficient, reliable and useful
microfluidic designs. These rules of good practice are tailored towards droplet
based microfluidics, but many of them are also applicable to the optimisation of
any single layer microfluidic design. This will be followed by a chronological ac-
count of the development of our microfluidic device. In this development process
we incrementally improved the design of our device over three generations before
arriving at a device design that we felt was fully appropriate for our research and
needs. Finally, I will detail our final microfluidic device design, focusing on how
we implemented our rules of good practice to produce a device that fulfills our
project requirements whilst remaining reliable and easy to use.
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4.1.1 Continuous flow microfluidics versus droplet microflu-
idics
After reviewing the numerous microfluidic systems discussed in section 2.5, we
chose to use a droplet-based microfluidic system in our research. A key require-
ment of our microfluidic system was that it needed to generate large numbers of
bacterial environments that are identical, and critically, independent. We could
not find a literature example of a single-level, continuous flow microfluidic device
that was able to encapsulate and isolate small bacterial communities. Whilst the
work completed by Austin et al. used continuous flow microfluidic geometries
to study small bacterial populations[84][85], this was in the context of connected
bacterial populations that were able to exchange individual cells. The “mother-
machine” microfluidic system was considered, however in this design each of the
confined bacterial populations are not strictly independent from one another. It
is entirely feasible that nutrient and antibiotic availability to each bacterial pop-
ulation would not be equal and could be affected by other nearby populations.
Likewise, toxic metabolic products from large bacterial populations may begin
to impact the growth dynamics of nearby bacterial populations. Furthermore,
studies have shown that the mechanical forces experienced by bacteria trapped
in the channels of a mother machine cause varying increases in doubling times
when compared to bulk growth techniques[178].
In contrast, it is possible to create thousands of isolated and independent bac-
terial environments using microfluidic droplets. These droplets can be moved,
manipulated and studied using a variety of standard microfluidic geometries and
techniques[76][94]. Additionally, bacterial populations encapsulated within the
droplets are not mechanically confined in the same manner as those stored in the
standard mother machine. As such, we decided that for our use case it was more
appropriate to use a droplet-based microfluidic platform in our research.
4.2 Designing a microfluidic device
The first step in creating a microfluidic device using is the process of designing
its two-dimensional geometry. This design outlines the channels and features of
the microfluidic device from a top-down perspective. There are many factors
to consider when designing a microfluidic device, each of which can drastically
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affect its functionality and experimental reliability. Well designed microfluidic
devices allow for fast fabrication and reliable operation under a robust set of
conditions. Poorly designed microfluidic devices can be difficult to fabricate,
take a long period of time to prepare and only function under a very specific
subset of operating conditions.
4.2.1 Technical detail
For the fabrication of a custom microfluidic photomask, a design file is required
that details the exact dimensions of every channel and feature encompassed within
the microfluidic design. This is usually generated using a CAD-based design
software package.
There are a number of resources available that allow researchers to download
pre-validated microfluidic designs that can be used for a number of purposes[179].
These pre-validated designs were not used in the work completed in this thesis for
two primary reasons. Firstly, the final microfluidic system that we designed for
this project combines a number of standard microfluidic geometries with novel
geometries. It was felt that whilst the aforementioned pre-validated designs may
have served as good starting points for our microfluidic system, they would require
significant modification and integration to fully satisfy our experimental objec-
tives. This is compounded by the fact that our final microfluidic system needed
to be designed to operate in conjunction with the specific equipment available
to our research group. Secondly, we believed that by designing our microfluidic
systems from the ground up, we would derive a far better and more intuitive
understanding of microfluidic droplet behaviour. We hoped that this would allow
us to troubleshoot and diagnose experimental problems more efficiently, whilst
being able to more effectively improve the microfluidic design if necessary.
For these reasons, all of the microfluidic designs used in this thesis were designed
from scratch. We have found the KLayout[180] software package to be a powerful
platform on which to design single layer microfluidics. By taking advantage of
KLayout’s hierarchical drawing structure, it was possible to quickly and efficiently
implement the extensive repeating structures common to microfluidic designs.
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4.3 General design principles
Through the continued iterated improvement of our microfluidic devices, we de-
veloped a set of generalised design principles that ensured our designs produced
efficient and reliable microfluidic devices that were easy to fabricate and use. We
focused on designing robust droplet-based microfluidic devices that could be fab-
ricated and used within a traditional academic laboratory without the need for
specialist equipment, techniques or handling requirements. These design guide-
lines were primarily established during the iterative development of our first two
microfluidic designs. Our final microfluidic design incorporates all of the design
principles detailed below.
4.3.1 Consider channel dimensions and their transitions
Match channel transitions
Generally, when a fluid flows from a channel of lower cross-sectional area to a
channel of higher cross-sectional area, it will experience a decrease in flow velocity.
If this transition is sudden, then droplets being carried in the fluid will experience
a rapid decrease in velocity. This can cause high speed droplet collision and
coalescence. To avoid such droplet collisions, when designing a transition from a
channel of lower cross-sectional area to a channel of higher cross-sectional area it
is important to graduate the transition using a cone/funnel geometry. Likewise,
to avoid droplet compression and coalescence events occurring when transitioning
from a channel of higher cross-sectional area to a channel of lower cross-sectional
area, channel geometry should also be graduated.
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Oversized outlet channels
It was observed that when trying to evacuate large numbers of droplets from
wide (1000 µm) storage channels through narrower (100 µm) outlet channels,
droplets could jam against one another and become immobilised. This caused
droplets to back up toward the inlet and coalesce under compression. In extreme
instances, droplets caused significant channel deformation and the microfluidic
device eventually burst under pressure. As such, it is recommended that outlet
channels have a greater total cross-sectional area than inlet channels to support
a higher flow throughput.
4.3.2 Large inlet/outlet size
When the inlets and outlets of a microfluidic device are fabricated using a biopsy
punch, PDMS in the immediate vicinity can become deformed. Due to the stark
transition in scale when an inlet/outlet interfaces with a microfluidic device, these
PDMS deformations can cause nearby microfluidic channels and features to be-
come permanently warped or misshapen. To ensure this does not happen, it is
important to design large inlet/outlet areas that remove the potential for PDMS
deformations to affect nearby microfluidic structures. In the microfluidic designs
used in this thesis, a minimum inlet/outlet size of 3000 µm x 3000 µm is used.
4.3.3 Minimise hydraulic resistance
Long channels and tight constrictions both act to increase microfluidic flow re-
sistance through a microfluidic device. This high resistance increases internal
pressure, which in turn can cause PDMS channels to deform. This deformation
under high pressure means that changes in flow rates can take an excessive period
of time to equilibrate and stabilise, this causes the microfluidic device to feel unre-
sponsive when changing input flow rates. Therefore, when designing a device the
channel dimensions should be optimised such that experimental objectives can be
accomplished whilst channel lengths and constrictions are minimised. Minimising
resistance leads to a device that is easy to use and responds quickly to flow rate
changes, allowing droplet size adjustments to be made without significant delay.
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4.3.4 Separate designs
It is often beneficial to repeat the structure of a single device multiple times across
a microfluidic photomask, as this allows multiple devices to be fabricated from a
single PDMS cast. If the repeat designs are positioned too close to one another
however, then it can become difficult to manually detach the designs from one
another using a scalpel. This negates the casting efficiency gain by increasing
device fabrication failure rate. I found that a spacing of 3 mm allowed designs to
be detached from one another easily whilst maintaining efficient use of space on
the microfluidic master.
4.3.5 Device support
Channels without vertical support can flex considerably due to the elastic nature
of PDMS. This can cause the “roof” of a microfluidic device to bow upwards due
to internal pressure or sag downwards from the weight of the PDMS above[181].
Measurements have shown that microfluidic channels with a width/depth value
greater than 20 generally require rigid backing support or the addition of support-
ing columns in the microfluidic design to avoid this disruptive phenomena[182].
This deformation can cause problems when imaging a microfluidic channel as
it may allow objects being imaged (typically a droplet) to move unpredictably
along the z-axis, in some cases out of the imaging focal plane completely. To
prevent the roof of our microfluidic structures from flexing, I incorporated pillar
structures into the design where appropriate.
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4.4 Device design evolution
Throughout this project our microfluidic device was repeatedly revised and im-
proved, iterating toward a design that we felt adequately met the needs of our
experimental objectives. Our initial aim was to design a microfluidic device that
could encapsulate small bacterial populations within a monodisperse emulsion
of microfluidic droplets. Furthermore, we needed the microfluidic droplets to be
stored inside the device so that it was possible to image the encapsulated bacte-
rial populations on a droplet-by-droplet basis. It was our intention that through
the use of microfluidics we could significantly improve upon traditional microbio-
logical techniques. Unfortunately, we feel that the widespread adoption of exper-
imental microfluidic systems are currently being hampered by unnecessarily high
barriers to entry. As such, parallel to these experimental objectives, we strived
to create a microfluidic system that was accessible in both design and fabrication
to researchers who have not had extensive experience with microfluidics.
4.4.1 Microfluidic design 1
Our first microfluidic master was an exercise in fundamental droplet microfluidic
device design. The device consisted of multiple smaller sub-designs, each intended
to test a different aspect of droplet microfluidics. The overall design consisted
of two droplet generating designs alongside three designs intended to test how a
monodisperse emulsion of droplets would behave under a variety of conditions.







Figure 4.1 Images detailing the geometries that constitute the first microflu-
idic design, inlets are shown on the left, whilst outlets are shown
on the right. (a) shows the flow-focusing geometry, (b) shows the
T-junction geometry, (c) shows the serpentine channel design, (d)
shows the microfluidic sieve design, (e) shows the microfluidic reser-
voir. Scale bar = 3000 µm.
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It was intended for monodisperse emulsions produced by the droplet generation
designs to be passed to the testing designs by connecting the outlet of one to the
inlet of another. Unfortunately, due to a common design flaw across all of the
designs, this was not entirely possible. It was found that a flow transition from
a highly constricted channel to a larger channel of much greater cross-sectional
area caused a rapid decrease in fluid velocity. This resulted in droplet coalescence
due to high speed droplet collisions. This flow transition occurred at the outlet
of all of the microfluidic sub-designs in our first generation device (see figure 4.2).
Figure 4.2 Microfluidic outlet design of our first generation device. Droplets
flow in the direction of the arrow toward the outlet which is punched
into the device from above. Droplets experience a near-instantaneous
decrease in velocity when moving from the channel of 100 µm width
to the outlet channel of 1000 µm width. Scale bar = 1000 µm.
Despite this limitation, it was still possible to test the droplet generation capa-
bilities of our microfluidic designs as well as some of the more basic properties of
the other test designs.
Figure 4.1(a) shows the first sub-design, a flow-focusing droplet generating ge-
ometry. This microfluidic design was largely a success and was not changed
significantly in subsequent designs. This geometry consistently produced size-
tunable droplets (30-100+ µm) with low polydispersity at rates of up to 42Hz. It
was noted that this design was susceptible to failure if debris blocked the 20 µm
constriction at the droplet generating junction, this was remedied in subsequent
designs. High speed microscopy images of this flow-focusing droplet generation
geometry can be seen in figure 4.3.
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(a) 00.00ms (b) 13.91ms (c) 17.12ms (d) 23.54ms
Figure 4.3 High speed microscopy images of our first generation flow-focusing
microfluidic droplet generator. Droplet generation can be seen in
images (a) - (d), the relative time between each image is shown.
Droplet generation occurs once per 24.61ms, or at a rate of 42Hz.
Channels are 100 µm in width. Scale bar = 100 µm.
Figure 4.1(b) shows the second sub-design, a T-junction droplet generating ge-
ometry. Whilst this design was successful in creating an emulsion of microfluidic
droplets with low polydispersity, it was found that droplet size did not signifi-
cantly change even with considerable adjustments to the flow rates.
Comparing the two droplet generation geometries, we decided that the flow-
focusing geometry was most suited to our research requirements. Droplet size
tunability was highly desirable for our use case, therefore the versatility afforded
by the flow-focusing droplet junction was prioritised. All of our subsequent mi-
crofluidic designs that generated microfluidic droplets used a flow-focusing junc-
tion. The T-junction geometry was not revisited.
Figure 4.1(c) shows the third sub-design, a microfluidic serpentine channel. It has
been shown that the contents of microfluidic droplets passing through a serpentine
channel are mixed rapidly and efficiently[94][183]. Droplets passing from one sec-
tion of a microfluidic device to another via a serpentine channel are also delayed
in time, with the time delay controlled by the length of the serpentine channel.
Despite being unable to pass a monodisperse emulsion of microfluidic droplets
through the channel, we were able to observe thorough mixing of bacterial pop-
ulations inside droplets passing through a serpentine segment. Furthermore the
serpentine channels did not cause further coalescence of the emulsion.
70
Figure 4.1(d) shows the fourth sub-design, a microfluidic “sieve” that was de-
signed to pass droplets through channels of decreasing cross-sectional area. This
was intended to test how resistant droplets were to splitting and coalescence un-
der extreme spatial confinement. Unfortunately testing of this sub-design was
limited due to the fact we were not able to generate a monodisperse emulsion of
droplets at this stage of the project.
Figure 4.1(e) shows the fifth and final sub-design of this microfluidic device which
was the first iteration of a microfluidic reservoir. The reservoir consisted of a
large rectangular reservoir supported by an array of square pillars. The transi-
tion from a channel of low cross-sectional area to a channel of high cross-sectional
area meant that fluid flow rapidly decreased in velocity as it entered the reser-
voir. This caused droplet coalescence at the reservoir entrance. A secondary
design flaw inherent to this design was the use of square support pillars in the
reservoir. It was observed that once droplets came to a halt against the flat side
of a pillar they became pinned, unable to move from this position despite a con-
tinual flow past them. The microfluidic flow then seemed to equilibrate around
pinned droplets, such that they required a significant transfer of momentum from
incoming droplets to be dislodged (see figure 4.4).
Figure 4.4 Microscopy image of droplets pinned against the flat surface of sup-
port pillars despite continuous flow. This phenomena was avoided in
future designs by using support pillars with circular cross-sections.
Scale bar = 200 µm.
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4.4.2 Microfluidic design 2
Our second microfluidic device design integrated a number of the previous sub-
designs into a single device whilst eliminating the flaws observed in the first set
of designs. By integrating the sub-designs into a single device, we hoped that
experimental complexity would be reduced. We also aimed to better match the
transitions between channels of different cross-sectional area and by extension
reduce droplet coalescence. With this design we intended to generate a monodis-
perse emulsion of microfluidic droplets (containing small bacterial populations)
and then store them in a reservoir. We then aimed to observe the encapsulated
bacterial communities using brightfield and fluorescence microscopy. This second
microfluidic design can be seen in figure 4.5.
This design generates a monodisperse microfluidic droplet emulsion using a flow-
focusing junction fed by aqueous phase and oil phase inlets. The droplet emulsion
is then passed through a serpentine channel to a reservoir section. Once the
droplets have progressed through the reservoir, they are then passed into a second
serpentine channel before being removed from the device via a single outlet. By
designing a single inlet for the oil phase that split into two channels, the oil phase
could be pumped into the microfluidic device using a single syringe pump. This
significantly improved ease of use whilst also ensuring that the flow rates of the




Figure 4.5 A detailed view of our second microfluidic design. (a) Shows an
overview of the entire microfluidic design. From left to right: the
inlet, the droplet generation geometry, the first serpentine channel,
the reservoir, the second serpentine channel and lastly the outlet.
Highlighted in red, (b) shows a subsection of the device including the
aqueous inlet, the droplet generating flow-focusing junction and the
first of the two serpentine channels. Highlighted in green, (c) shows
the microfluidic reservoir. Scale bars = 2000 µm.
As can be seen in figure 4.5(b), the inlets featured an integrated filter: small
microfluidic channels 10 µm in width that were designed to stop fabrication de-
bris reaching the flow-focusing junction. In practice the sieve was very fragile;
the channels often broke or collapsed during fabrication, rendering them either
unusable or unable to stop debris from reaching the droplet generating junction.
The flow-focusing junction was unchanged from the previous design.
Extended serpentine channels were also introduced before and after the reservoir.
This ensured the droplets were well mixed before entering the reservoir. It also
delayed droplets arriving and leaving the reservoir for around 10 seconds, this
was beneficial should the flow not immediately halt when the syringe pumps were
turned off. The serpentine channels were found to mix the droplets effectively, but
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it was found that when the syringe pumps were turned off, residual pressure in the
system could maintain flow inside the device for many minutes. As a consequence,
the serpentine channels were ineffective in delaying droplets entering and leaving
the reservoir.
The second generation reservoir design shown in figure 4.5(c) features graduated
transitions at the entrance and exit to better match flow resistance and therefore
flow rate. This gradually changing channel width ensures that droplet velocity
slowly decreases and increases at the entrance and exit of the reservoir. This
decreases the probability of high speed droplet collisions and therefore droplet
coalescence. Additionally, the supporting pillars of the reservoir are circular in
cross section so that droplets cannot become pinned as with our first design.
Despite improving upon the first generation reservoir design in multiple ways, the
second design also did not function entirely as desired. The constricted reservoir
outlet was prone to clogging, as the dense emulsion of monodisperse droplets
stored inside the reservoir would often jam causing the microfluidic reservoir to
rupture under high pressure. To remedy this, an outlet was manually punched
into the reservoir, allowing droplets to easily escape the microfluidic reservoir at
the cost of reducing the storage capacity of the device by over 30%. The presence
of the manually punched outlet also caused droplets entering the reservoir to
disperse poorly, often following a path of least resistance to the outlet, rather
than filling the reservoir efficiently.
Finally, it was with this microfluidic design that we first attempted to generate
microfluidic droplets that encapsulated bacterial populations, transfer them to
an imaging reservoir, and quantitatively measure the size of each bacterial pop-
ulation. Unfortunately, we found that due to the standard 50 µm depth of this
microfluidic device, bacteria were able to swim in and out of the focal plane of the
microscope. This behaviour meant that at any given time an unknown propor-
tion of each bacterial population was not visible, this introduced significant error
to bacterial counting measurements. In an effort to circumvent this problem, an
image processing workflow was developed that used the fluorescence intensity of
each droplet as a proxy for the number of bacteria contained within the droplet.
Unfortunately, this technique failed to accurately measure bacterial counts at the
single cell level (see section 5.2.3 for further details).
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To address the core issue of bacteria swimming in and out of the focal plane,
we also attempted to reduce the channel depth of the entire microfluidic design.
Unfortunately this introduced excessive hydraulic resistance to the system. This
meant that the time required for the pressure inside the system to equilibrate was
significant, and monodisperse droplet generation was not a robust process when
flow rates were altered. Therefore, in the third microfluidic design the reservoir
geometry was separated from the droplet generation geometry. This allowed us to
adjust and optimise the channel depth of each microfluidic sub-design separately.
4.5 Microfluidic design 3
Using the general design principles outlined in section 4.3, I designed our third
and final microfluidic device. This design again incorporated multiple geometries
onto a single microfluidic master: a single droplet generation sub-design and two
reservoir sub-designs. As discussed in the previous section, the decision was made
to separate the sub-designs to make it possible to reduce the channel depth of
one sub-design relative to another. This would allow us to compress droplets
in the reservoir to a depth approximately equal to the focal depth, which was
empirically tested to be 12-14 µm. Although this decision made it more time
consuming to fabricate and use these microfluidic devices, the flexibility afforded
by this decision was invaluable during use. The three microfluidic sub-designs





Figure 4.6 Images showing the three sub-designs that constitute the third mi-
crofluidic device design, inlets are shown on the left, whilst outlets
are shown on the right. (a) shows the third generation droplet gener-
ating sub-design, which consists of two inlets, a central flow focusing
junction followed by a serpentine mixing channel, and finally a single
outlet. (b) and (c) show the third generation microfluidic reservoir
sub-designs. Scale bars = 2000 µm.
Figure 4.6(a) shows the droplet generation sub-design. This was largely un-
changed from the previous version, however the serpentine mixing channel was
reduced in length. This change was made as efficient mixing was observed in
serpentine channels over short distances in previous designs, and by reducing the
length of the serpentine channel we could reduce microfluidic resistance without
repercussion. We actively worked to reduce microfluidic resistance in the droplet
generation design as droplet size tuning relies on fast response times to flow rate
adjustments.
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Figure 4.6(b) shows the first of the two microfluidic reservoir sub-designs. Rather
than storing droplets in a single large reservoir, droplets passing through this
design are stored in four parallel channels. This was done to combat the problem
of droplets not efficiently filling a large single microfluidic reservoir. To further
this aim, the inlet geometry and support pillars were designed to disperse droplets
randomly across the width of the inlet, so that each of the four channels are
equally filled. This dispersion was achieved using teardrop shaped support pillars
that encouraged lateral droplet movement perpendicular to the microfluidic flow
(see figure 4.7). This reservoir design performs well, monodisperse emulsions of
droplets are distributed evenly between the four observation channels. Droplets
freely exit the device from the large outlet, allowing the device to store a large
number of droplets without the possibility of jamming. Once the inlet tubing is
cut, droplet movement is arrested almost completely, improving the accuracy of
droplet tracking significantly.
Figure 4.7 Images showing the inlets of the third generation reservoirs in fur-
ther detail. Both inlets are designed to disperse the incoming droplets
such that the reservoir channels are filled equally. Note the teardrop
shaped support pillars designed to encourage lateral droplet move-
ment within the channel. Scale bars = 2000 µm.
Figure 4.6(c) shows the second microfluidic reservoir sub-design. This design
is similar to the first reservoir design, however separates the incoming droplet
emulsions into twelve 200 µm wide observation channels rather than the previous
four. It was intended for this design to provide an alternative to the first reservoir
design, should the first design suffer from compression or crowding problems due
to its less structured storage environment. Unfortunately, it was found that this
second design was overly constrictive. As the storage channels were approximately
equal to the droplet diameter, droplets within each channel essentially acted as
plugs, meaning that the oil phase could not freely pass around the droplets.
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The unforeseen consequence of this was that the device was sensitive to residual
pressure after the inlet tubing had been severed. Residual flow caused the droplets
in the channels to continue moving after imaging had started, sometimes out
of the device altogether. Coupling an inefficient use of storage space with the
aforementioned design flaw, this reservoir design was not used, with the second
more open reservoir design being utilised instead.
A photograph of the microfluidic master used to fabricate all of our third gener-
ation sub-designs can be seen in figure 4.8.
Figure 4.8 Image of a microfluidic master that features all of our third gen-
eration sub-designs. From top to bottom: two droplet generation
designs (as seen in figure 4.6(a)), two droplet reservoir designs (as
seen in figure 4.6(c)) and lastly two further droplet reservoir designs
(as seen in figure 4.6(b)).
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4.6 Concluding Remarks
Through an extensive design optimisation process, we have developed a microflu-
idic system that satisfies our experimental requirements. This system is com-
prised of two microfluidic devices, the first generates a microfluidic droplet emul-
sion whilst the second acts as a droplet reservoir for the purpose of imaging and
analysing droplet-based bacterial populations. Through the use of tested design
principles, we believe we have designed a device that can be fabricated in an
academic laboratory by a non-expert user, without the need for clean room facil-
ities. The device is easy to use and robust when operated across a wide range of
conditions. The complete microfluidic system design can be seen in figure 4.9.
(a)
(b)
Figure 4.9 Images showing the final, full microfluidic device design. (a) shows
the droplet generation geometry (left) alongside the reservoir geom-
etry (right). (b) shows a partially fabricated microfluidic device with
the two designs cast in PDMS and bound to a glass slide.
The microfluidic system we designed was split into two devices. This was done
so that it was possible to alter the channel depth of the two subsystems inde-
pendently of one another without the need for a multi-layer microfluidic design.
This fabrication technique was avoided as it adds significant complexity to the
design and fabrication process. We desired the ability to change the channel
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depth from one microfluidic sub-system to the next as this would allow us to
generate droplets using a channel depth that does not add excessive resistance
to the flow-focusing geometry, whilst allowing us to store droplets at a channel
depth optimal for microscopy. In the final microfluidic system, the microfluidic
droplet generating device had a channel depth of 34.5 µm and the imaging reser-
voir device had a channel depth of 11.5 µm. We recognise that by splitting the
microfluidic system into two devices, a time delay was introduced when droplets
pass from the generator to the reservoir. We felt that this time delay was a neces-
sary compromise, one that was justified when our goal of designing an accessible
microfluidic system is taken into account.
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Chapter 5
Image Processing Workflow -
From Microscope to Data
5.1 Chapter aims and structure
This chapter discusses the development of an efficient, accurate and reliable image
processing workflow that is designed to be used in conjunction with the microflu-
idic system outlined in chapter 4. The objective of this image processing workflow
is to take brightfield and fluorescent images of bacterial populations encapsulated
in microfluidic droplets (that are stored in a microfluidic reservoir), and extract
quantitative data about their growth. Specifically, this extracted data will pro-
vide the growth and population size dynamics of each bacterial population with
single cell precision over a period of 8 hours, with measurements being recorded
every 6 minutes.
First, I will discuss existing software solutions that are used to detect bacteria in
microscopy images, outlining why these solutions were not fully appropriate for
this project. I will then analyse the difficulties of imaging objects inside spherical
droplets. After this, I will outline the structure of the microscopy images that
are input into the image processing workflow. Moving forwards, I will detail
the full image processing protocol that was developed for this research project,
which is separated into the key stages: image validation, droplet detection and
bacterial counting. Following the conclusion of this protocol, I will briefly review
and discuss the general process of designing and fabricating a full microfluidic
system for the purpose of experimental microbiology.
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5.1.1 Introduction
Our experimental system consists of a reservoir that is able to store 1000-2000
microfluidic droplets. Each of these microfluidic droplets is able to encapsulate
a population of fluorescent bacteria that is trapped within the confines of the
droplet volume. Brightfield images are taken of the droplets to track their position
and size. Fluorescence images are taken of the droplets to detect the bacteria
encapsulated within them.
The complete image processing workflow can be separated into 3 sub-sections that
operate one after another to extract quantitative population size measurements
of the encapsulated bacterial populations. The first sub-process consists of a
manual image validation step that ensures the microscopy images are of a high
enough quality for further analysis. This is followed by an image stitching step
that prepares the images for further processing. The second sub-process takes
the validated brightfield images and detects all droplet positions and boundaries
in them across all time steps. The detected droplet boundaries and positions are
then used to track each droplet from one time frame to the next, over as many time
steps as possible. The third sub-process takes the droplet boundaries detected
from the brightfield images and uses them in conjunction with the fluorescence
images to count the number of bacteria encapsulated by each droplet at each time
step. By combining this information with the droplet tracking data, the growth
dynamics of the bacterial populations within each droplet can be measured to
single cell precision.
5.1.2 Imaging bacteria in droplets
Changes in the refractive index of a sample can cause optical distortions when
imaged using light microscopy[184]. In the context of this research project, this
is a cause for concern when imaging bacteria inside a droplet of a given refractive
index, which is suspended in a carrier fluid of a different refractive index. In their
work studying the radial distribution of motile bacteria in droplets, Poon et. al
modelled the confocal imaging of objects in a droplet of aqueous buffer (refractive
index nw = 1.33) suspended in sunflower oil (refractive index no = 1.46)[185].
In the upper hemisphere, significant distortions were found when imaging the
droplet boundary and when imaging objects inside the droplet. The imaged
droplet boundary had a smaller radius when compared to its actual value, and
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the location of the objects inside the droplet were incorrect. Furthermore, in the
lower hemisphere significant positional errors were observed which increased as
the angle from the central axis increased. This meant that objects at the equator
could be imaged twice. Finally, it was noted that objects near the equator could
also be missed entirely due to “blind regions” that result from light being unable
to enter the droplet beyond a critical angle.
By design, the experimental system designed and used in this thesis negates many
of the issues described above. Firstly, when stored in the reservoir each droplet
is compressed into a disk-like shape, with a diameter of ≈55 µm and a depth of
≈11.5 µm (see figure 5.1). This means that the vast majority of each droplet is
imaged through a flat droplet surface, rather than a spherical droplet surface as
modelled by Poon et. al. This reduces the distorting effect of the aqueous-oil
interface. Additionally, the fluorocarbon oil phase used in this research has a
refractive index of 1.29[186], which is far closer to the refractive index of aqueous
growth media[23] when compared to the sunflower oil (no = 1.46) used in the
model.
For these reasons, we did not believe that the aqueous-oil interfaces present in
our experimental would introduce significant errors to our bacterial counting mea-
surements. To confirm this, high framerate (60 fps) videos were recorded of low
density bacterial populations stored in droplets inside our microfluidic reservoir.
Over multiple ≈30 second videos, the highly motile bacteria swam both in the flat
central area of the droplet and in the curved edge areas of the droplet. Through
manual inspection and the analysis of individual video frames, the number of
bacteria in each droplet was not observed to change at any point. This analysis
reaffirmed our belief that when imaging bacteria inside our compressed droplets,
the bacterial count was not significantly affected by the optical distortions de-
scribed above.
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Figure 5.1 Scale diagram of microfluidic droplets in the channels of the (a)
droplet generating device and (b) reservoir device. Droplets are gen-
erated with a diameter approximately equal to the channel depth of
the droplet generating device (34.5 µm). When these droplets are
stored in the reservoir, they are compressed to the channel depth of
the reservoir device (11.5 µm).
5.1.3 Existing bioimage-processing solutions
Detecting, segmenting and tracking cells in microscopy images is a difficult task
that can be used to gain biological insight from time-lapse recordings of cell
growth, movement and behaviour[187]. Software packages such as Schnitzcells[188],
MicrobeJ[189] and TLM-Tracker[190] are able to segment, track and perform lin-
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eage analysis of low-motility bacteria growing in a 2D plane. These packages are
often used to analyse the behaviours and growth of bacterial populations using
phase-contrast or fluorescence microscopy at high magnification (typically 60x to
100x). Unfortunately, these software solutions are inappropriate for the images
produced by our experimental system, which are (comparatively) low resolution
time-lapse images of highly motile bacteria.
A number of studies have automated the detection of bacteria in droplets. Un-
fortunately, many of these fluorescence measurements are binary in nature, only
capable of detecting whether bacteria are present in a droplet or not[43][131].
Whilst bacterial population sizes in droplets have been measured with single cell
precision, these measurements are completed manually[137]. Due to the labour
intensive nature of manual inspection, these measurements are therefore highly
limited in throughput. The absence of existing solutions to this problem may be
because droplet microfluidic systems generally store droplets in a spherical state,
this means that three-dimensional imaging techniques must be used to accurately
detect the bacteria stored in each droplet. Generally these three-dimensional
imaging techniques are slower, as a specimen must be sampled multiple times
to build up a complete image[191]. As such, this limits the throughput of the
system, negating many of the benefits afforded by using a microfluidic system.
As discussed in section 5.1.2, this problem was circumvented in our system by
compressing the droplets, such that the entire population of a droplet can be
imaged using standard epifluorescence microscopy.
We are not aware of any software analysis package designed to measure and track
droplet encapsulated bacterial populations with single cell precision. Further-
more, we are not aware of any work that has measured droplet-encapsulated
bacterial population size with single cell precision across many (>100) droplets.
As such, we felt it was necessary to develop a custom image processing workflow
to maximally utilise the experimental strengths of our microfluidic system.
5.1.4 Microscope output / image processing input
Before exploring the details of the processing workflow, it is important to consider
the structure of the images produced by the microscope, as these images act as
the data input for the entire image processing workflow that follows.
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As discussed previously, due to the size of the reservoir it is not possible to image
all droplets in a single field of view whilst maintaining the resolution required
to count bacterial populations with single cell precision. The microfluidic device
is therefore imaged by stitching multiple smaller fields of view together. This is
done by scanning across the device along a predetermined grid. A single field of
view images approximately 670 µm x 670 µm. A typical experimental run uses
a field of view grid size of 18 x 14, this corresponds to a total imaged area of ≈1
cm2. A 2 x 2 pixel binning regime was used to ensure a signal-to-noise ratio that
allowed individual bacteria to be resolved accurately.
Pixel Binning
Pixel binning is the technique of combining adjacent pixels on an image sen-
sor to produce a single super pixel. This has the effect of increasing both
the pixel intensity and the signal-to-noise ratio within an image, which is
useful for fluorescence microscopy. However, this process does reduce over-
all image resolution. All images taken using the automated experimental
process in this thesis use a 2 x 2 pixel binning regime, combining every
block of 4 pixels on the camera sensor into a single image pixel.
For each field of view, two images are taken; one using brightfield illumination
and the other using YFP fluorescence. The whole microfluidic reservoir is im-
aged once per 6 minutes and a full experimental run is 8 hours long. Therefore,
each grid position is imaged 80 times in both the brightfield and fluorescence
illumination channels. This protocol outputs a total of 30,000-40,000 1024 pixel
x 1024 pixel images per experimental run, depending on the imaging grid size
used. In principle, the image analysis conducted in this chapter could be com-
pleted manually; however in practice the large volume of data necessitates the
use of multiple semi-automated protocols. The optimisation of these automated
processes is discussed in detail in the upcoming sections.
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5.2 Image processing protocol
5.2.1 Stage 1 - image validation and stitching
A mantra often repeated in the field of image analysis is that the data you extract
from an image is only as good as the image under scrutiny. Even with complex
analysis tools it can be near-impossible to extract accurate and quantitative data
from images of poor quality. With this is mind, before any images are fed into
the processing algorithm they are first checked and validated for experimental
errors and issues that could adversely affect data integrity later on in the image
processing pipeline. Each field of view is checked and validated in both the
brightfield and fluorescence channels, across all time frames. All fields of view
that are flagged as unsuitable in this process are replaced with blank image stacks
such that they do not interfere with the analysis of adjoining fields of view.
During this image checking process, four issues occur most commonly. These are
detailed below and examples can be seen in figures 5.2, 5.4 and 5.3.
• The field of view is out of focus. The microscope is focused manually
at the beginning of each experimental run, this is then maintained using
a hardware-based automatic focusing system. Whilst this system is gen-
erally effective, a small number of imaging fields of view will be focused
incorrectly consistently. When focused incorrectly, brightfield images are
largely unaffected (due to brightfield features being large in comparison to
the focal length), however bacterial fluorescence signals are blurred signifi-
cantly. When this happens it is not possible to resolve multiple bacteria in
close proximity, and single bacteria are able to swim out of focus completely
(both of these issues can result in incorrect bacterial counting). As such, if
a field of view is consistently incorrectly focused in the fluorescence channel
then it is discarded. See figure 5.2.
• The field of view does not image a microfluidic channel. Depending
on the specific positioning of the image grid it is possible that some fields
of view do not contain a microfluidic channel. Whilst not an imaging issue
that would cause problems for subsequent analysis processes, any empty
fields of view can be immediately discarded without loss of information,
thus improving image processing times.
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• The droplets within the field of view are distorted or non-circular.
Droplets can become distorted/non-circular because of spatial compression.
This compression can occur when droplet flow is impeded by debris or un-
even channel depth caused by defects in the microfluidic. Droplets can also
become non-circular if they wet on the internal surface of a microfluidic
channel. This can happen if the hydrophobic character of the PDMS mi-
crofluidic device has not been fully restored after plasma treatment. Droplet
wetting was negligible when the microfluidic device had been treated with
Pico-Glide 1 (see section 3.2.4).
If the droplets are non-circular due to spatial compression or surface wet-
ting, the subsequent droplet boundary identification process will be unable
to fit boundaries to the droplets correctly. Incorrectly fitted droplet bound-
aries will cause significant bacterial population miscounts. The negative
impact that this would have on data accuracy and integrity means that
fields of view containing non-circular droplets are removed. See figure 5.3.
• The field of view is contaminated with debris. During the fabrication
phase, it is possible for debris to contaminate the channels and reservoir of
the microfluidic device. The majority of this debris is flushed from the de-
vice as the continuous oil phase passes through the reservoir. However, some
pieces become trapped and these can cause a variety of issues during image
processing. Debris can cause droplet compression and concomitant devia-
tion from circularity, but most importantly, we observe that some debris
fluoresces under YFP illumination resulting in highly inaccurate bacterial
counts later on in the processing procedure. Fields of view that contain
disruptive debris fragments are therefore removed. See figure 5.4.
By automatically removing fields of view with fluorescent objects sorted
by size/morphology, it may have been possible to automate the removal
of fields of view containing fluorescent debris. However because each field
of view was being assessed for a number of imaging issues (some of which
would have been much more difficult to validate in an automated manner),
it was decided that the implementation of an automated fluorescent debris
check would realistically save very little time.
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(a) (b)
Figure 5.2 Poor focus can disrupt processing for both brightfield and fluo-
rescence channels. (a) Shows a brightfield image of microfluidic
droplets in a reservoir, (b) shows a fluorescence image of the same
field of view at the same focus. Whilst the features visible in the
brightfield image appear to be focused to a reasonable standard, it
can clearly be seen in the fluorescence image that the focusing is in-
correct, and individual bacteria are difficult to resolve. This focusing
issue will cause automated bacterial counts to be incorrect.
(a) (b)
Figure 5.3 The boundaries of distorted droplets cannot be approximated by a
circle of known centre and radius. (a) Shows an unprocessed bright-
field image of spatially distorted microfluidic droplets in a reservoir,
(b) reveals the poor boundary detection that results when images con-
taining non-circular droplets are processed.
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(a) (b)
Figure 5.4 Fluorescent debris can distort nearby droplets and will cause incor-
rect image exposure due to high pixel intensities. (a) Shows an un-
processed brightfield image of microfluidic droplets in a reservoir (a
large piece of debris can be seen in the centre of the image), (b)
shows an unprocessed fluorescence image of the same field of view
(the large piece of disruptive fluorescent debris can be seen more
clearly in fluorescence).
The manual validation of each field of view is a labour intensive process. For each
field of view, the first 10 image frames are checked for the common issues detailed
above. The following 60 frames are then scanned through quickly to ensure that
excessive droplet movement is not observed, which can cause droplet compression
and tracking failures. The final 10 frames are then checked to ensure the lighting
and focal properties of the images have not changed over the 8 hour duration
of an experimental run. As described earlier in this section, a typical dataset
consists of ≈250 fields of view. This validation process takes around 1 minute
per vield of view, factoring in additional time for file management processes, it
was found that the total validation process for a single experimental run takes
around 6 hours.
Whilst this level of manual intervention is not ideal, we felt it was reasonable
considering the high level of automation this process enabled (see section 5.2.2
and 5.2.3). Although it may have been possible to automate these validation
processes, it was decided that the minimal time that would be saved by this
automation (compared to total processing time) did not warrant the significant
additional work that this would involve.
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Once the experimental images have been successfully validated, they are stitched
together to form larger composite image stacks that can be more efficiently pro-
cessed. This step produces two stacks of 2D images, one for brightfield and the
other for fluorescence, containing all fields of view over all time steps for each
channel.
An example frame of an experimental sub-section, shown in brightfield, is shown
in figure 5.5.
Figure 5.5 An example frame of an experimental sub-section, shown in bright-
field. The black square is a field of view that was removed during
the validation stage of image processing.
5.2.2 Stage 2 - Brightfield image droplet detection and
tracking
Once each image has been validated and stitched, the brightfield images are
passed through a circle detection algorithm standard to Matlab - the imfindcircles
function. This is used to detect the locations and size of the microfluidic droplets
in each frame of the image stack.
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The imfindcircles function[192][193] searches for circular objects in an image
using a circular Hough transform[194]. This fits boundaries to the droplets and
outputs a data array describing all circles found in the image - listing their centres
and radii. A sensitivity factor and edge threshold value are adjusted to optimise
droplet boundary detection (see figure 5.6). These variables are optimised man-
ually to ensure that the droplet detection algorithm only fits a single circular
boundary to each droplet that is the correct size and does not overlap with its
neighbours. The detected circles can be further filtered by a minimum and max-
imum radius, allowing for the exclusion of rare non-monodisperse droplets and
circular features in the microfluidic device structure, such as reservoir supports.
Hough Transform
A Hough Transform is a common image analysis technique used to extract
information about certain features in an image. Originally intended as a
method of detecting lines in an image, the classical Hough transform has
been extended to identify a number of shaped features such as circles and
ellipses. The circular Hough transfer searches within an image for objects
with high degrees of radial symmetry, allowing for the detection of even
incomplete circles.
This circle detection algorithm is used to find the droplet boundaries in the
brightfield microscopy images, and is repeated for every image at every time
step such that a data set is produced that contains the position and radius of




Figure 5.6 Correct boundary detection is a vital step in the image analysis work-
flow. (a) Shows an unprocessed brightfield image of microfluidic
droplets in a reservoir, (b) and (c) exhibit poor droplet detection due
to poorly optimised sensitivity factors and/or edge threshold values,
(d) exhibits correct droplet boundary detection.
To accurately measure the bacterial populations in each droplet across all time
steps we also needed to track droplets from one time step to the next. This is
achieved using an adapted particle tracking algorithm[195]. Each image set is
taken 6 minutes apart and during an optimised experimental run the majority
of droplets do not displace themselves by more than their own radius within this
time interval. This allows the tracking algorithm to track the majority of the
droplets stored in the reservoir.
93
Upon completion of both the droplet boundary detection algorithm and the
droplet tracking algorithm, a data array is output. This array contains the cen-
tre position and radius of every droplet across all time steps. In the array, each
droplet is also assigned an identification number that allows it to be followed in
time, from one frame to the next.
5.2.3 Stage 3 - Fluorescence image thresholding and bac-
teria counting
Image thresholding
To automatically count the number of bacteria in a fluorescence image it is neces-
sary to threshold the image. This allows the perimeter of each bacterial cell in the
image to be defined. A binarised thresholded image will consist of islands of con-
nected 1-pixels (which represent detected fluorescent bacteria) on a background
of 0-pixels.
Image Thresholding
Thresholding is an image processing technique whereby a grayscale image
is binarised, such that every pixel within the image is set to either 0 or
1. All pixels with an intensity value above a set threshold value are set to
1, whereas all those whose intensity is below the threshold value are set
to 0. The threshold value can be set to any chosen pixel value, however a
threshold optimisation algorithm is commonly used to define a threshold
value suitable for the application.
Threshold optimisation
An optimal threshold intensity value is essential for accurate counting of bacteria.
If the threshold value is too low then small fluctuations in background fluores-
cence could be miscounted as additional bacteria; too high and bacteria with low
fluorescence will not be counted at all.
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The optimal threshold value changes from one experimental run to the next,
this is because the experimental conditions from one experiment to the next are
not identical. Small changes in experimental details such as optical focus or
background fluorescence will impact the threshold value required to optimally
detect fluorescent bacteria. Because of this, the process of threshold optimisation
is repeated for each experimental run, producing unique optimal threshold values.
To optimise the threshold value the output of the bacterial counting algorithm
must be compared to a “true” value of the bacterial count. This “true” bacterial




Figure 5.7 Choosing an optimal threshold value is vital for the automation of
bacterial counting. (a) Shows an unprocessed fluorescence image
of bacteria encapsulated within microfluidic droplets, (b) shows the
same image thresholded with a value below the optimum, (c) shows
the image thresholded with a value above the optimum, (d) shows the
image thresholded using the optimum threshold value. Note that sin-
gle isolated pixels are not considered to be bacteria by the automated
counting algorithm.
A small change in threshold value can cause a large drop in the accuracy of bac-
terial counting. Therefore it is vital that the threshold value chosen takes into
account the inherent variations in both the ambient and bacterial fluorescence
from one experiment to the next. To ensure this is the case, the following optimi-
sation process is carried out prior to the image processing of each experimental
run.
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1. Select 4 fields of view across the microfluidic device and extract
the corresponding images at a predetermined time frame The time
at which the fields of view are extracted is decided according to the general
behaviour of the bacteria in a given experimental run. By way of example,
if all the bacteria in a given experimental run are driven to extinction by 240
minutes, the fields of view are extracted half way between t = 0 minutes and
this limiting behaviour at t = 240 minutes, i.e. t = 120 minutes. The 4 fields
of view should be representative of the device as a whole. Therefore they
are generally selected from locations that span the microfluidic reservoir.
This is done to account for illumination and fluorescence fluctuations on a
scale greater than a single field of view.
2. Run the droplet detection algorithm on these images. The bright-
field images are passed to the droplet detection algorithm, and the position
and radius of all droplets across the 4 images are recorded.
3. Manually count and record the number of bacteria in the detected
droplets. The “true” bacterial count is obtained by eye by inspecting the
raw fluorescence images with the detected droplet boundaries overlaid. Each
droplet is assigned a bacterial count value.
4. Threshold the fluorescence images. The fluorescent images are ini-
tially thresholded using an arbitrarily low threshold value. Although this
will almost certainly yield an incorrect initial automated bacterial count, it
ensures that the optimal threshold value is eventually found by the optimi-
sation process.
5. Run the thresholded image through the bacterial count algorithm
(described in the following section). The bacterial count algorithm
uses the thresholded image and attempts to measure the number of bacteria
it can detect in each droplet.
6. Compare the automated bacteria count values with the “true”
values. The difference between the “true” bacterial counts and the auto-
mated bacterial counts are calculated for all droplets and recorded. The
smaller the difference between these two values, the better the threshold
value is at accurately counting individual bacterial cells.
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7. Repeat steps 4, 5 and 6 - increasing the threshold value between
each successive pass. As the threshold value is increased, the accuracy
of the bacterial counting algorithm is monitored. By plotting the difference
between the automated count values and the optimal count value as a func-
tion of threshold value, a global optimisation curve is produced. This curve
will feature a single minimum, where the automated count deviates least
from the true count. The threshold value corresponding to this minimum
is designated as the most optimal one.
Once the most optimal threshold value has been discovered, the entire fluorescence
image stack of the experimental run is thresholded using the optimised threshold
value.
Bacterial count algorithm
After the fluorescence images have been optimally thresholded, they are passed
to an algorithm that counts the number of bacteria observed in each droplet.
The automated bacterial counting algorithm functions by overlaying the droplet
boundary information on top of the fluorescence images, and then counting the
number of pixel islands that are not 8-connected within each droplet. Each pixel
island is assumed to be a single bacterium, therefore the number of islands counted
within a droplet is assumed to equal the number of bacteria encapsulated by the
droplet. This is the algorithm used in step 5 of the threshold optimisation protocol
detailed in the previous section. The same algorithm is used with the optimised
threshold value to obtain the final bacterial count results.
Pixel Connectivity
Pixel connectivity is a method of describing how pixels are spatially related
to their neighbours. Describing pixels as “8-connected neighbours” means
that a pair of pixels is described as 8-connected if one of them occupies any
of the 8 pixels that surround the other. This contrasts with 4-connected
pixels that are only deemed to be neighbours if one of the pair occupies
one of the 4 face positions surrounding the other.
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Using the bacterial counting algorithm, the number of bacteria in each droplet,
for each time step, is measured and recorded. As the droplets have been assigned
an individual ID number that tracks them from one time step to the next, it is
then possible to track the growth of the bacterial populations in specific droplets,
with single cell precision, over the duration of a complete experimental run.
Addendum - integrated fluorescence intensity
In early versions of the microfluidic design, it was not possible to count indi-
vidual bacteria within a droplet as the bacteria could swim in and out of the
focal plane. This was due to the fact that earlier versions of of the device had
deeper reservoirs channels. Because of this, alternative methods of measuring
the bacterial population size were implemented, including an algorithm where
the integrated fluorescence intensity of each droplet was used as a proxy for the
number of bacteria contained within the droplet.
This approach assumed that an individual bacteria would emit a constant and
consistent value of fluorescence intensity. Therefore, by integrating the total
fluorescence intensity of a droplet (accounting for droplet size and uniform back-
ground intensity) one should obtain a total intensity which should scale linearly
with bacterial population size. It was found that although the method described
the general growth trends of the encapsulated bacterial communities well, this
method had a low signal-to-noise ratio and failed to accurately measure bacterial
counts at the single cell level. We believe this is due to the inherent heterogeneity
between individual bacteria that can cause a variation in fluorescence intensity
over time, particularly as they leave the exponential growth phase. Since the de-
vice allows us to autonomously image 1000+ droplets at a resolution high enough
to distinguish individual bacteria it was felt a key strength of the system was not
being exploited by using this integrated fluorescence method of measurement.
Therefore, key changes were made to the microfluidic reservoir that allowed for
direct measurement of bacterial population sizes. Critically, the reservoir was
made shallower (reduced to 11.5 µm) to prevent bacteria swimming out of the
focal plane.
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5.2.4 Final data output
Once the image thresholding and bacterial counting sub-process have been com-
pleted, the image processing workflow comes to an end. The final output data
structure contains 6 pieces of information for each droplet found at each time
step - its identification number, (x, y) position, radius, bacterial population size
and finally the time step at which these variables were measured. An example
data structure output from the image analysis pipeline is shown in figure 5.8.
Figure 5.8 An example section of data output from an experimental run. For
each droplet ID at a given time, the x-position, y-position, droplet
radius and the number of bacteria detected in the droplet at that time
is recorded.
5.3 Concluding remarks
The development of an effective image processing protocol was a non-trivial task.
On the one hand, our image processing algorithm required a level of sophistication
that allowed for the counting and tracking of individual bacterial cells confined
within hundreds of microfluidic droplets. On the other hand, our image processing
algorithm must be simple and/or efficient enough to process large volumes of data
within a reasonable time frame.
100
We were limited by the time resolution of our experimental system. Due to the
large number of images that are taken across the reservoir at each time step, every
image taken at a single location is separated by a six minute interval. Whilst this
six minute interval is small enough to accurately track droplets in time (droplets
tend not to move significantly on this time scale), it is far too long to track
bacteria such that individual bacteria can be differentiated from one time step to
the next (bacterial positions lose correlation within seconds).
We have developed an effective image processing workflow that efficiently detects,
tracks and measures microfluidic droplets within our experimental system, as
well as accurately counting the number of bacteria encapsulated by each droplet.
Despite the relative complexity of the image processing algorithm, our image
processing workflow remains computationally minimal: we have found it can be
ran on a standard desktop computer with an entire experimental run taking less
than 4 days to fully process (including manual validation and optimisation steps).
5.4 Designing and fabricating a microfluidic sys-
tem: thoughts and conclusions
When designing and planning our microfluidic device, we sought to satisfy a
particular set of experimental objectives.
1. Encapsulate a large number of small bacterial communities within isolated
micro-environments.
2. Track each of these micro-environments, and by extension, their encapsu-
lated bacterial population.
3. Measure the size of each bacterial population with single cell accuracy, over
an extended period of time.
These objectives were chosen because we wanted to quantify the growth dynam-
ics of small bacterial populations in the presence of antibiotic with high levels
of precision. Due to the inherently stochastic nature of bacterial growth, we
also wanted to obtain parallel repeats of these measurements on a scale not yet
achieved in previous work. This would allow for statistically significant growth
measurements of small bacterial populations that resemble those found in vivo.
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Over the previous three chapters, I have discussed in detail the experimental
processes and procedures that were used to design and fabricate a system that
accomplishes these objective. First, I explored the materials, techniques and ex-
perimental protocols used in the fabrication of our microfluidic system. Second,
I reviewed the iterative design process that was undertaken to produce an effec-
tive and reliable droplet-based microfluidic device. Third, I detailed the image
processing protocol we implemented to extract quantitative growth data from
brightfield and fluorescence images of bacteria that were grown in droplets using
our microfluidic system.
Whilst there are multiple examples of other experimental systems that can track
large numbers of bacterial populations, many of them are not able to measure
the populations with single cell accuracy. These systems often rely on indirect
measurement methods to assess population size; using fluorescence intensity or
the results of a scattering technique as a proxy for cell number[43][131]. Sim-
ilarly, whilst there are numerous experimental systems that can quantitatively
measure the size of small bacterial populations with single cell accuracy, precise
measurements of small bacterial populations are often limited to a small number
of populations in total[137]. This usually results in results that lack statistical
significance, especially when probing a highly stochastic biological growth pro-
cess.
Our experimental system can generate upwards of one thousand microfluidic
droplets which together encapsulate a low density bacterial suspension. The sys-
tem is then able to simultaneously image, detect and track each droplet and the
size of the bacterial population it encapsulates, with single cell accuracy. With
the accomplishment of our original experimental objectives, we believe that we
have developed a device that can offer a unique insight into the stochastic growth





Before I present the results of the experimental work that has been completed
using our microfluidic system, there are a number of experimental validations,
assumptions and caveats that must be discussed to ensure that any conclusions
drawn from our microfluidic system are valid and accurate. Whilst I will use
data and measurements from chapter 7, the analysis will remain as abstract as
possible and context will be included where required.
6.1.1 Experimental identification numbers
For clarity, each experimental run presented in the following two chapters has
been given an identification number. These ID numbers are used to quickly and
clearly distinguish each experimental run throughout the rest of this thesis. The
ID number contains two pieces of information: the streptomycin concentration
used in the experimental, and the repeat number of the experimental run at
that streptomycin concentration. For example, experimental ID “0.50 - 2” is an
experimental run conducted at a streptomycin concentration of 0.50 µg ml−1, and
is the 2nd repeat at this concentration. Furthermore, the antibiotic concentrations
are colour coded according to their growth behaviour to enhance readability (see




0.00 - 1 0
0.00 - 2 0
0.05 - 1 0.05
0.50 - 1 0.5
0.50 - 2 0.5
2.50 - 1 2.5
50.0 - 1 50
Table 6.1 Summary of all experimental identification numbers and the colour
chosen for each experiment to enhance readability throughout this the-
sis. Strep. Conc. gives the final concentration (w/w) of streptomycin
used in each experimental run once added to the M9 growth medium.
6.2 Bacterial counting errors
The process of counting encapsulated bacterial populations in our microfluidic
reservoir is a semi-automated procedure that only requires user input for vali-
dation and variable optimisation, as shown in chapter 5. This semi-automated
workflow is one of the key strengths of our experimental system.
In the image analysis process, bacteria are detected and counted through the use
of image thresholding. Whilst computationally efficient, this process lacks the
complexity required to differentiate between bacteria that are in extreme close
proximity to one another. This is rarely a problem in droplets that contain small
numbers of motile bacteria, as it is highly unlikely that in any given time frame
the bacteria are in close enough proximity to falsely register as a single bacteria.
Unfortunately, our microfluidic droplets do not always exclusively contain small
populations of motile bacteria.
6.2.1 Crowded droplets
Bacterial populations that undergo significant logarithmic growth can form dense
suspensions within the 8 hour time frame of a single experimental run. Under
these crowded conditions, the image processing algorithm will incorrectly assign
a single cell count to multiple bacteria that are in close proximity. This can be
seen clearly in figure 6.1.
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(a) (b)
Figure 6.1 (a) Shows an example of a bacterial population in which all individ-
ual bacteria are well detected using our bacterial thresholding algo-
rithm. Bacteria are highly fluorescent and well dispersed, (true bac-
terial count = 40, automated bacterial count = 40). (b) Shows an
example of a very large bacterial population that is poorly detected us-
ing our bacterial thresholding algorithm. Bacteria are densely packed
and bacteria are in close proximity, making it difficult to differen-
tiate individual bacteria from one another, (true bacterial count ≈
158, automated bacterial count = 129).
Whilst these well-dispersed but dense bacterial populations result in bacterial
miscounts, we are not overly concerned with their impact on the accuracy of
our experimental data. This form of bacterial miscounting will only impact the
extracted data of fast growing, uninhibited bacterial populations that reach high
number densities. Droplet populations of this density are rare (see figure 7.5).
For a well-dispersed bacterial suspension of a fixed cell density, it may be pos-
sible to calculate how likely it is for the individual bacteria in the suspension
to overlap. As such, it should also be possible to calculate bacterial overlapping
probability (and therefore bacterial counting error) as a function of droplet pop-
ulation density. If an acceptable error threshold value was defined, this could
be correlated to an acceptable population density, above which the counting er-
ror of the algorithm used to detect the bacteria would be deemed unacceptable.
Unfortunately, as discussed in section 6.2.2, the counting error introduced by
this proximity-based overlapping is small in comparison to the counting error
introduced by bacterial aggregation.
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Because of this, defining an acceptable error threshold according to a population
density value would not be useful given the larger error introduced by aggre-
gation which is heterogeneous, unpredictable, and not directly proportional to
population density.
6.2.2 Bacterial aggregation
Bacterial aggregation - observations in microfluidic droplets
It has been repeatedly observed that some bacteria will spontaneously stop mov-
ing whilst continuing to fluoresce and replicate. Daughter cells of these immotile
bacteria often remain stationary after replication, and this process continues until
a static bacterial aggregate is formed. In these cases, the extreme close proximity
of progenitor cells causes incorrect cell counting. An example of this behaviour
is shown in figure 6.2.
t = 0 t = 114 t = 234 t = 354 t = 474
Figure 6.2 Example of bacterial aggregation in a droplet encapsulated bacterial
population, aggregation formation can be observed to begin as early
as 60 minutes into an experimental run. Time is given in minutes.
We believe that bacterial aggregation is the primary cause of bacterial count-
ing errors in our experimental system. Bacterial aggregation appears to be a
spontaneous process, with aggregate formation beginning at any time in an ex-
perimental run from 60 minutes onwards. De-aggregation has been observed on
rare occasions, and it is possible for highly motile daughter cells to leave their
birth aggregate. However once an aggregate has begun to form it will generally
remain static and grow until the conclusion of the experimental run. Aggregation
also appears to be experimentally difficult to predict as it has been observed to
occur apparently at random in almost every type of droplet population, regardless
of growth rate or antibiotic concentration.
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We do not see a simple method of resolving the number of bacteria in these
aggregates given the high throughput nature of our microfluidic system. From
an experimental perspective, it is not possible to increase magnification or use a
more complex microscopy technique as this would severely limit the total number
of droplets we could observe with reasonable time resolution. From an image
processing perspective, given that it is not possible to manually count the number
of bacteria contained within some aggregates, it is most likely not possible for any
simple thresholding algorithm to differentiate and count the number of bacteria
within a dense aggregate.
Fortunately, this problem only affects droplets that undergo significant bacterial
growth. If previously motile bacteria in a droplet became attached to a growing
bacterial aggregate, it is possible that bacterial aggregation could cause an ap-
parent net loss in visible bacteria whilst the population was actually undergoing
growth. Fortunately, manual inspection of droplets that contain bacterial aggre-
gates all show an increase in detected population size with time. Furthermore,
the behaviour of a droplet population is usually most dynamic and stochastic at
low population numbers. This means that whilst the automated size count of
a fast growing population may be inaccurate later on in time due to bacterial
aggregation, the more general behaviour of the droplets growth will be recorded
correctly.
Given these reasons, we decided to take a pragmatic approach to the possibil-
ity of bacterial miscounting. Whilst our system has been proven to accurately
count small bacterial populations encapsulated within microfluidic droplets, we
are aware that this accuracy decreases when measuring large bacterial popula-
tions and aggregated bacterial populations. By their very nature, these counting
errors more commonly impact the accuracy of large population size measurements
and rarely influence the accuracy of measurements that are used to quantify key
dynamics that occur early on in an experimental run. Moreover, these mecha-
nisms exclusively cause an underestimation of bacterial population sizes. This
allows these errors to be more easily taken into consideration when conclusions
are being drawn from quantitative trends and measurements of bacterial growth
dynamics.
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Bacterial aggregation - causes and reduction
The surface properties of bacteria such as E. coli vary significantly from one
strain to the next[196]. This variation can affect their adhesive properties to
both surfaces and other bacteria. The surface protein antigen 43 (Ag43) has
been linked to the aggregation of E. coli suspensions. It is hypothesised that
Ag43 molecules on the surface of adjacent bacteria interact in a head-to-tail
conformation - the L-shaped structure of Ag43 enabling “velcro-like” adhesion
between cells, facilitating aggregation[197].
There are a number of techniques that can be used to reduce bacterial aggrega-
tion. Bacterial mutants have been developed that alter the L-shaped structure
of Ag43, these deletion mutants do not exhibit auto-aggregation and bacterial
clumping[197]. Other mutants that feature surface bound fimbriae (rod shaped
organelles approximately 7 nm in width and 1 µm in length) have also been shown
to abolish Ag43-mediated autoaggregation[198]. Outside of strain variation, it is
also possible to retard auto-aggregation through the use of compounds that are
added to aqueous bacterial suspensions.
6.2.3 Threshold optimisation and error estimation
To obtain accurate bacterial counts, the threshold value for each experimental
run must be chosen so that the image processing algorithm can optimally de-
tect bacteria with single cell accuracy. If this threshold value is too low, then
background fluorescence fluctuations will be registered as bacterial counts. If the
threshold value is too high, then weakly fluorescing bacteria will not be detected
at all. Using the threshold optimisation process detailed in chapter 5, an optimal
threshold value is chosen for each of our experimental runs based on a set of
sample images taken from that experimental run. Whilst this threshold value is
optimal given a set of test images, the overall error when the counting algorithm
is applied to a complete experimental run is unknown.
To calculate an error estimate for our automated bacterial counting algorithm,
we begin by selecting 3 fields of view from each experimental run. For each field
of view, the automated bacterial count data is extracted for t = 0 minutes, t =
114 minutes and t = 234 minutes. These times are chosen so that error estimates
can be compared across all experimental runs, including experimental runs 2.50
- 1 and 50.0 - 1 that were stopped after 234 minutes. These images are man-
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ually assessed and the number of visible bacteria in each droplet is measured.
The manually assessed bacterial counts are then compared with the automated
bacterial counts. This process essentially repeats the threshold optimisation pro-
cess detailed in chapter 5, but instead of minimising the output differences with
respect to a set of test images, we are measuring the difference when the process
is applied to a set of random images. Error estimates for all experimental runs
have been calculated using this method. These are tabulated in table 6.2.
It is prudent to note that this error analysis is only capable of estimating errors in
the automated counting process, i.e. it is only able to evaluate the accuracy of the
thresholding process that measures bacterial population sizes using fluorescence
microscopy images. If bacterial cells are not visible in the fluorescence microscopy
images due to poor focus, lack of fluorescence or incorrect droplet boundary
detection, it is not possible for this analysis to quantify these failures. See chapter
5 for further details on the extensive validation processes that were completed to
avoid these issues before the automated counting process was used to obtain data.
Error measurements at t = 0 mins, 114 mins and 234 mins for all experimental
runs are tabulated below.
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Experimental Time Droplets True Auto. Count Percentage
ID (mins) measured count count error error (%)
0.00 - 1 0 33 33 35 2 +6
0.00 - 1 114 33 95 97 2 +2
0.00 - 1 234 31 169 154 -15 -9
0.00 - 2 0 42 14 14 0 0
0.00 - 2 114 42 33 25 -8 -24
0.00 - 2 234 42 74 59 -15 -20
0.05 - 1 0 42 74 70 -4 -5
0.05 - 1 114 42 175 155 -20 -11
0.05 - 1 234 41 276 241 -35 -13
0.50 - 1 0 46 12 12 0 0
0.50 - 1 114 45 7 7 0 0
0.50 - 1 234 46 4 3 -1 -25
0.50 - 2 0 26 50 48 -2 -4
0.50 - 2 114 25 39 37 -2 -5
0.50 - 2 234 26 26 23 -3 -8
2.50 - 1 0 18 26 27 1 +4
2.50 - 1 114 18 16 14 -2 -13
2.50 - 1 234 19 7 5 -2 -29
50.0 - 1 0 44 19 19 0 0
50.0 - 1 114 46 3 3 0 0
50.0 - 1 234 49 1 1 0 0
Table 6.2 Error measurements for all experimental runs, at t = 0, 114 and
234 minutes. Experimental runs are ordered by streptomycin concen-
tration: green experiments are grown in the absence of streptomycin
whilst red experiments are grown at high streptomycin concentrations.
In experimental runs 0.00 - 1, 0.00 - 2 and 0.05 - 1, the total number of visible
bacteria increased from t = 0 minutes to t = 234 minutes. Maximal percentage
errors of -20% and -24% can be seen in experimental run 0.00 - 2, where the
automated counting algorithm underestimated the number of bacteria by 8 and
15 bacteria respectively. It was observed that almost all miscounting errors were
due to aggregation events, further supporting our hypothesis that the primary
source of bacterial miscounts was due to this phenomena.
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In experimental runs 0.50 - 1 through 50.0 - 1, the total number of visible bac-
teria decreased from t = 0 minutes to t = 234 minutes. In these experiments
the maximal count error was -3 (0.50 - 2 at t = 234) where 26 bacteria across 26
droplets were miscounted as 23 bacteria by our automated algorithm. The max-
imal percentage error was -29% (2.50 - 1 at t = 234) where a total of 7 bacteria
across 19 droplets were miscounted as 5 bacteria by our automated algorithm.
The automated counting algorithm was perfectly accurate at identifying droplets
that contained no bacteria. Of the the 493 empty droplets that were manually
assessed across all experimental runs and time frames, 0 were falsely identified as
containing bacteria.
Despite the automated counting error values appearing somewhat random, there
are a number of metrics, trends and observations that can be examined. Firstly,
both absolute and percentage-based bacterial counting errors broadly increase
as a function of time. This is consistent with our intuition that the primary
cause of counting errors is bacterial aggregation, which increases in frequency
and magnitude as time passes. Secondly, automated counting errors are lower
in experimental runs that did not exhibit net bacterial growth. This intuitively
matches our expectations: without net bacterial growth there are simply not as
many bacteria to count incorrectly. Furthermore, due to the lack of growth it is
not possible for bacteria to reach high densities where bacterial overlap becomes
a problem (as discussed earlier in this chapter), and it is also not possible for
large numbers of bacteria to form aggregates. Finally, bacterial counting errors
become increasingly negative as a function of time. At t = 234 minutes none of the
bacterial counting errors are positive, this indicates that the automated bacterial
counting algorithm is underestimating bacterial population sizes at later time
frames. This behaviour is independent of the total number of visible bacteria,
apart from experimental run 50.0 - 1 that ended with only 1 bacteria visible at
t = 234 minutes. This consistent underestimation again supports our hypothesis
that bacterial aggregation is a major cause of automated counting errors.
Whilst it is critical to understand and quantify the errors that exist in our au-
tomated bacterial counting algorithm, the context of these error measurements
must be appreciated. Firstly, when manually assessing the number of bacteria
in droplets that exhibited aggregation, it was often difficult to accurately count
multiple bacteria in close proximity. If it is not possible to manually count the
number of bacteria in an aggregate, it is unreasonable to expect that an auto-
mated algorithm could perform this task more accurately. This means that to
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solve this problem, an attempt to reduce aggregation may be more successful
than an attempt to improve the accuracy of the counting algorithm. Further-
more, in the process of analysing the experimental data presented in chapter
7, the automated counting algorithm will measure the bacterial populations of
over 7000 droplets. These 7000 droplets will be measured up to 80 times per
experimental run, resulting in a total of ≈525,000 population measurements. For
the error estimations calculated here, over 750 droplet populations were manu-
ally assessed, but this still pales in comparison to the total number of bacterial
droplets that the automated counting algorithm will process in the full analysis
of our experimental data. As such these error measurements should be treated
as order of magnitude estimations. These error estimations should serve to guide
the conclusions we draw from any data that is produced using this automated
process.
In summary, automated counting error estimates were calculated at t = 0, 114
and 234 minutes for each of the experiments that will be presented in chapter
7. These counting errors increase as a function of time, and almost exclusively
underestimate droplet population sizes. For this reason, automated bacterial pop-
ulation counts at later time steps should be treated as lower bound estimations.
It has been hypothesised that the primary cause of automated counting error is
bacterial aggregation.
6.3 Droplet polydispersity
So that bacterial populations encapsulated by droplets can be quantitatively com-
pared to one another, the assumption is made that the size of every droplet within
an experimental run is equal. If this is true, then the space and nutrients avail-
able to each bacterial population is consistent from one droplet to the next. To
test this size assumption, the droplet monodispersity for each experimental run
is calculated. A standard measure of droplet monodispersity is the coefficicent
of variation (CV), which is the ratio of droplet diameter standard deviation to
mean[199]. A microfluidic droplet emulsion is considered monodisperse if the CV
value is below 5%[200].
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Given that the droplets are imaged in a microfluidic channel that is 11.5 µm deep,
we first measure an “observed” average droplet radius in pixels for the first time
frame of each experimental run. After converting these radii in pixels to µm,
estimated volumes for these average droplets are calculated by approximating
the droplets as disks 11.5 µm in depth. Using these average droplet volumes,
estimated average spherical droplet radii are then calculated. This was done to
allow our monodispersity measurements to be compared with literature values.
Experimental Observed Observed Estimated Estimated
ID disc radius disc radius spherical spherical
(pixels) (µm) volume (pL) radius (µm)
0.00 - 1 90 ± 5 58 ± 3 120 ± 14 31 ± 1
0.00 - 2 88 ± 5 56 ± 3 115 ± 13 30 ± 1
0.05 - 1 76 ± 4 49 ± 3 86 ± 10 27 ± 1
0.50 - 1 73 ± 3 47 ± 2 79 ± 7 27 ± 1
0.50 - 2 85 ± 6 54 ± 4 107 ± 16 29 ± 2
2.50 - 1 93 ± 6 59 ± 4 127 ± 16 31 ± 1
50.0 - 1 77 ± 7 49 ± 5 87 ± 16 28 ± 2
Table 6.3 Measured and calculated droplet radii values for droplet monodisper-
sity testing, each ID represents a full experimental run.
The CV values for each experimental run ranged between 3% and 7%, sitting at
the the limit of what is considered monodisperse. We deemed these CV values
acceptable for multiple reasons. To start, due to the nature of bacterial loading
into microfluidic droplets, the average size of a bacterial population encapsulated
within a droplet will scale with droplet size. This means that smaller droplets will
on average have smaller initial populations, and larger droplets will on average
have larger initial populations. As a consequence of this, the average space and
nutrients available to each bacteria in a droplet population will remain relatively
consistent, regardless of droplet size.
Secondly, the observed droplet size measurements were recorded when the droplets
were confined within a microfluidic channel that was significantly wider than it
was deep. Small variations in channel height could cause the observed droplet size
to vary considerably. These channel height variations may occur due to defects
in the microfluidic master or because of the elastomeric nature of PDMS: ob-
served droplet size was seen to change significantly when droplets passed through
microfluidic channels with known defects.
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Finally, and perhaps most importantly, one of our experimental aims was to
test the growth of numerous small bacterial populations encapsulated in micro-
environments and compare this to the growth of a single large bacterial population
that is grown using traditional bulk techniques. The difference in volume between
those found in our microfluidic droplets (∼ 1× 10−10 l) and those found in bulk
growth techniques (∼ 1×10−3 l) is considerable. This volume difference dwarfs the
droplet volume variations calculated in table 6.3, therefore the volume variations
can be considered negligible when considering our experimental objective.
6.4 Observation Delay
Prior to droplet generation, 10 ml of fresh M9gl growth media was inoculated
using 25 µl of high density starting culture. This 10 ml volume was then placed
in a shaking incubator (37°C, 200 rpm) for 1.5 hours. This bacterial suspension is
then pumped into the microfluidic device, where it is encapsulated into microflu-
idic droplets. Once these droplets are generated in the first microfluidic device,
they are then transferred into the second reservoir device via a piece of connecting
tubing. This transfer of droplets from one device to the next introduces a time
delay between droplet generation and droplet imaging of around 90-120 minutes.
To assess the impact of this time delay, we use a statistical measure called the
Fano factor. The Fano factor is a measure of the dispersion of a random process
and is defined as the variance divided by the mean. The distribution of bacteria
from a bulk suspension into microfluidic droplets is expected to be a Poisson
process[132], for which the mean and variance of the droplet population sizes
will be equal, and the Fano factor will equal 1. If the droplet populations have
undergone significant changes from encapsulation to imaging, the Fano Factors
for our droplet population size distributions would diverge significantly from 1.
The initial Fano factors for all experimental runs can be seen in figure 6.3.
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t = 0 mins
Figure 6.3 Scatter plot showing the initial population distribution Fano factors
for each experimental run as a function of streptomycin concentra-
tion.
The initial Fano factors for all experimental runs were between 1 and 2.5, a slight
increase over the Fano factor of 1 predicted by a Poisson process. This indi-
cates that the population size distributions at the start of each experimental run
exhibited a higher variance than expected, given the Poissonian encapsulation
process. Given the doubling time of RJA002 in M9gl has been found to be ≈112
minutes[201] (see section 7.5 for further inmformation), this increased variance
is most likely explained by small amounts of growth in the delay between encap-
sulation and imaging. Despite this, we do not believe that this time delay hides
significant population growth dynamics for two principal reasons. Firstly the
growth exhibited during this imaging delay is small in comparison to the growth
that occurs during a full experimental run. Secondly, the small changes in Fano
factor during this imaging delay does not appear to correlate with streptomycin
concentration, whereas the changes in Fano factor during each experimental run
correlate strongly with streptomycin concentration.
For these reasons, we believe that the Fano Factors of our droplet population
size distributions are strong indicators of significant changes in the distribution
of population sizes. Furthermore, we are confident that the time delay discussed
here does not hide important bacterial population growth dynamics. Nonetheless,
we are mindful that this time delay is an inherent property of our microfluidic
system and consider its potential impact when drawing conclusions from the
bacterial growth dynamics observed in our microfluidic droplet populations.
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6.5 Spatial correlation of growth
When interpreting our experimental results, we assumed that all confined bac-
terial populations existed independently. This meant that we assumed zero ex-
change of information or resources from one droplet to the next, and by extension
we assumed that the growth dynamics of one droplet population would not impact
that of another.
This is an important assumption that must be validated. For example, compe-
tition for depleted nutrients and the accumulation of metabolic waste products
could impact the growth of two populations in close proximity. Furthermore,
bacteria have been shown to display co-operative behaviours that could also im-
pact bacterial populations near to one another. Quorum sensing is a phenomena
where individual bacteria release signalling molecules that initiate cooperative
behaviours at high bacterial densities[202][203]. Given the nature of this exper-
imental system, it is plausible that quorum sensing signalling molecules from a
high density population could impact the growth of a different population. This
would invalidate our assumption that encapsulated bacterial populations are inde-
pendent, and we would not be able to treat our droplets as distinct and individual
experimental repeats.
As such, we wanted to explore our assumption that each droplet population is
independent, and that the growth of one bacterial population does not impact
that of another. To do this, we define a metric S that is used to quantify whether
final droplet population sizes are correlated with one another at a given distance,
i.e. whether droplets at a given distance exhibit similar growth behaviours. S is
calculated using the following steps. First, the centre-centre distances between all
droplet pairings in a sub-section are measured. The difference in final population
size is then recorded for each droplet pairing. The droplet pairings are then
binned according to their absolute inter-droplet distance and the differences in
their respective population sizes are summed and normalised according to the
total number of droplet pairings discovered in that distance bin. At this point, a
set of S values has been calculated for a number of inter-droplet distances, for each
sub-section. So that the S values for different sub-sections can be compared, they
are each normalised according to the average value of S for each sub-section. Only
droplets that were detected for all 80 time steps were included in this analysis.
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We chose to calculate S values for experimental runs conducted at streptomycin
concentrations of 0 µg ml−1 (0.00 - 1 and 0.00 - 2) and 0.5 µg ml−1 (0.50 - 1
and 0.50 - 2), as we wanted to check that the population growth in a particular
droplet is independent of the population growth in other droplets both in the
absence and presence of streptomycin. Experimental runs conducted at higher
streptomycin concentrations exhibited almost total net loss of visible bacteria,
meaning that almost no droplets contained bacteria in the final time frames of
those experimental runs. Consequently, the S values for these experimental runs
provided little information and were therefore excluded.
(a) streptomycin concentration = 0 µg ml−1
(b) streptomycin concentration = 0.5 µg ml−1
Figure 6.4 S values plotted as a function of inter-droplet distance, for experi-
mental runs conducted at (a) 0 µg ml−1 (experimental runs 0.00 -
1, 0.00 - 2) and (b) 0.5 µg ml−1 (experimental runs 0.50 - 1, 0.50
- 2). The error bars represent the standard error of S values across
all subsections at a given distance.
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To briefly summarise our interpretation of S :
• If the S value decreases at a given distance, this implies that at that distance
it is more likely for droplets to have convergent population sizes. This may
happen if droplets that finish with large final populations are clustered close
to one another.
• If the S value increases at a given distance, this implies that at that distance
it is more likely for droplets to have divergent population sizes. This may
happen if droplets that finished with large final populations were surrounded
by droplets that finished with small final populations.
• If the S value is uniform across all distances, then this implies that it is no
more or less likely for a droplet population to experience growth or death
due to another droplet population at any given distance.
As can be seen in figure 6.4 (a) and (b), the calculated S values both in the
absence and presence of streptomycin are stable across a range of inter-droplet
distances, fluctuating between both positive and negative values. The S values
in both cases do not appear to follow any consistent trend, with the majority
of standard errors spanning a value of zero. This means that we do not believe
there is any significant spatial correlation between the final population sizes of
the droplets we measured.
The S value fluctuations observed in the absence of streptomycin (figure 6.4
(a)) are roughly one order of magnitude larger than the S value fluctuations
observed in the presence of streptomycin (figure 6.4 (b)). This is unsurprising, as
bacterial population growth rates in the absence of antibiotic vary considerably.
This results in a wide distribution of final droplet population sizes and therefore
large S values due to large differences in droplet populations. In contrast to this,
bacterial population growth rates in the presence of antibiotic are suppressed.
This results in final droplet populations that do not differ significantly in size,
leading to smaller S values. For further detail regarding final population size
distributions see section 7.6.
This analysis provided us with the confidence that bacterial population growth in
our microfluidic droplets is independent of growth in any other droplets. This is
a key assumption of the work shown in chapter 7, as well as numerous studies by
other groups that use microfluidic systems and materials common to this work.
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6.6 Bacterial fluorescence does not imply life
In the work presented in chapter 7, we use bacterial fluorescence to assess pop-
ulation growth. This approach is based upon the fundamental assumption that
healthy, living bacteria fluoresce, making a measurement of fluorescence a proxy
measurement of population size. We need to be aware, however, that dead or
dying bacteria may, in principle, also fluoresce.
As discussed in section 2.4.5, fluorescent proteins are highly stable. It has been
shown that following maturation, fluorescent proteins are highly resistant to
degradation and turnover by specialist housekeeping enzymes that are able to
break down proteins and peptides[204]. As such, fluorescent proteins typically
have an in vivo degradation half-life of 24 hours[205]. Through the addition of
short peptide chains, protein variants have been developed that are highly suscep-
tible to degradation by specific intracellular proteases. The degradation half-life
of these variants are reduced significantly - as low as 40 minutes[206][207]. These
susceptible variants are used in studies exploring temporal gene expression where
rapid degradation and turnover is essential.
The fluorescent protein produced by the E. coli strain used in this thesis (RJA002)
is not an unstable, susceptible protein variant. As such, unless a bacterial cell
experiences total lysis, it can be assumed that the fluorescent proteins manufac-
tured by a bacterium before death will continue to fluoresce for the entirety of an
8 hour experimental run. This means that dead bacteria may generate fluores-
cence with sufficient intensity for detection. In summary, it cannot be assumed
that when a bacteria undergoes death due to antibiotic inhibition it will cease to
be detected as though it were still alive.
In our experimental system it is therefore not possible to distinguish between
healthy fluorescent bacteria and bacteria that continue to fluoresce following
death. This constraint impacts our interpretations of the growth dynamics dis-
cussed in chapter 7. However, it has still proven possible to draw meaningful and
interesting conclusions from our data whilst acknowledging this limitation.
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LIVE/DEAD staining
There are a number of stains available that are capable of discriminating live
bacteria from dead bacteria. A popular and commercially available epifluores-
cent staining method is the LIVE/DEAD Bacterial Viability Kit (Baclight)[208],
which consists of two stains.
The first stain, SYTO 9, binds to DNA and RNA, emits green fluorescence,
and is able to penetrate all bacterial membranes. The second stain, propidium
iodide (PI), similiarly binds to nucleic acids however is only able to penetrate
damaged cytoplasmic membranes[209]. When PI is able to penetrate a cell that
has been pre-stained with SYTO 9, the emission properties of the SYTO 9 stain
changes due to stain displacement and quenching. This stain mixture produces
red fluorescence. It is this altered emission state that is used to differentiate
between bacterial cells that are alive and dead. If the membrane of a cell is intact
- it fluoresces green and it is therefore assumed to be alive. If the membrane of
a cell has been compromised - stain-mixing causes the cell to fluoresce red and it
is therefore assumed to be dead.
Whilst this staining methodology is highly popular and used by a wide range of
researchers across many fields of microbiology, it hinges on the assumption that
cell membrane integrity is directly correlated with cell viability. This assumption
holds true for membrane-compromised cells[210], however the assumption that
cells with intact membranes are alive is not always valid[211].
There are a number of alternative techniques that can be used to determine
whether cells in a bacterial suspension are living or dead. For example cell via-
bility reagent alamarBlue uses a resazurin-based solution to assess the reducing
power of live cells, which can be used as a quantitative measure of cell viability
and health[212].
A cell viability indicator was not used in the research conducted for this thesis.
This was because it would add significant complexity to both the fabrication and
operation of our microfluidic system. Firstly, to introduce external reagents to
our microfluidic droplets after encapsulation would require the addition of com-
plex microfluidic geometries to our system. Therefore to use a viability indicator
with our current microfluidic system, it would be need to be added to the bac-
terial suspension prior to encapsulation. It is unknown how a viability indicator
would interact with the numerous components present in our microfluidic system
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(continuous oil phase, surfactant, antibiotic). These interactions could poten-
tially impact droplet stability and bacterial growth. Secondly, the additional
fluorescence channel(s) necessitated by a viability indicator would substantially
complicate imaging and analysis processes.
We did not feel that substantial complexity introduced by these indicators jus-
tified the additional information they would provide. Therefore, we decided not
to use a viability indicator such as Baclight or alamarBlue. It was found that
meaningful and novel results could be obtained with our microfluidic system de-
spite the limitations discussed in this section, but acknowledge that once the
system has been fully characterised and validated, LIVE/DEAD staining could
be implemented in future iterations of our microfluidic system.
6.7 Conclusions
In this chapter, I have discussed a number of experimental checks, assumptions
and error estimations that are necessary to consider when using the microfluidic
system we have designed to quantitatively study small bacterial populations.
To start, sources of errors in the bacterial counting process were discussed and
error estimations were made for the automated bacterial counting algorithm. The
counting algorithm was found to increasingly underestimate bacterial population
sizes as time passed. It is hypothesised that bacterial aggregation is the primary
source of this automated counting error.
This was followed by a discussion of some of the technical limitations of our mi-
crofluidic device. Droplet diameter coefficients of variation ranged from 3% to
7%, this was judged to be acceptable given the experimental objectives of our
research. Fano factors were calculated for initial bacterial population distribu-
tions. Fano factors above 1 were observed for all initial bacterial population
distributions, indicating that a small amount of bacterial growth occurred during
the delay from droplet encapsulation to droplet imaging. This growth was not
considered critical as it was extremely limited in comparison to the population
changes observed during the full experimental runs. Furthermore, this growth
was not correlated with streptomycin concentration.
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After this, droplet-to-droplet growth correlations were examined. It was shown
using a spatial correlation of growth metric that changes in droplet population
sizes over the course of an experimental run were not correlated with inter-droplet
distance. This means that the growth dynamics of any given droplet population
do not impact the growth dynamics of any other droplet populations.
Finally, the use of bacterial fluorescence as a measure of population growth and
death was reviewed. It was concluded that it is not possible to use fluorescence
microscopy to distinguish between healthy bacteria that are actively dividing,
and dead bacteria that have not lysed. This is a critical distinction that impacts
the conclusions and interpretations we can draw from the results presented in
chapter 7. Despite this limitation, we found that we were still able to identify a
number of novel growth dynamics using our microfluidic system.
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Chapter 7
Encapsulated E. coli - a growth
and inhibition study
7.1 Introduction
As discussed in chapter 1, the aim of my work was to develop an experimental
system that could be used to investigate the heterogeneity in response of small
bacterial populations to antibiotics. To this end, we have designed and fabricated
a complete microfluidic system that allows us to encapsulate small bacterial popu-
lations and antibiotic within microfluidic droplets and then track bacterial growth
on a droplet-by-droplet basis. We hope that by studying the growth dynamics of
small bacterial populations, we will be able to better understand in vivo growth,
antibiotic response and the factors that affect them.
7.2 Experimental objectives
In this chapter, the population growth dynamics of small bacterial populations
grown in the presence of streptomycin at five different concentrations is compared.
These concentrations are 0 µg ml−1, 0.05 µg ml−1, 0.5 µg ml−1, 2.5 µg ml−1 and 50
µg ml−1. Repeat experimental runs were conducted at streptomycin concentra-
tions of 0 µg ml−1 and 0.5 µg ml−1 to give seven total experimental runs suitable
for analysis.
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Details of each experimental run are given in table 7.1, with each experimental
run being given an experimental identification number as detailed in section 6.1.1.
Whilst each experimental run was imaged using comparable grid sizes, the number
of droplets successfully processed varies considerably between experiments due to
fields of view being discarded in the validation stage, as discussed in chapter 5.
Experiment Strep. Conc. Droplet
ID (µg ml−1) Count
0.00 - 1 0 687
0.00 - 2 0 1474
0.05 - 1 0.05 919
0.50 - 1 0.5 1796
0.50 - 2 0.5 883
2.50 - 1 2.5 439
50.0 - 1 50 1129
Table 7.1 Summary of details of each experimental run. Strep. Conc. gives the
final concentration (w/w) of streptomycin used in each experimental
run once added to the M9 growth medium. Droplet count refers to
the number of droplets detected within the whole microfluidic device,
averaged across all time frames.
The seven experimental runs discussed in the chapter were critically important as
they were used to validate our experimental systems as a viable platform for the
quantitative study of bacterial populations (see chapter 6 for further information).
These data sets represent preliminary studies that explore the growth dynamics
of small bacterial populations when exposed to streptomycin. Furthermore, they
highlight the flexibility and utility of our microfluidic system as a more general
tool for use in quantitative microbiology. The analyses discussed in this chapter
showcases the variety of quantitative metrics that can be extracted from the data
generated by our microfluidic system. These metrics are not possible to measure
or calculate using traditional microbiological techniques, further underscoring the
utility of our microfluidic system.
In this chapter we observe, measure and quantify a variety of novel bacterial
growth phenomena using our microfluidic system. Understanding the observed
variability between repeat data sets (0.00 - 1 and 0.00 - 2, 0.50 - 1 and 0.50 - 2)
represents a research project in itself, and further studies are already underway
to fully understand the growth dynamics in these small encapsulated popula-
tions and determine the factors that impact inter-experiment variability. It is
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hoped that this research might also provide insight into the mechanisms behind
the variable growth dynamics observed when using bulk growth techniques (see
figure 7.4). These studies are being undertaken by Nia Verdon at the University
of Edinburgh, under the supervision of Prof. Rosalind Allen and Dr. Simon
Titmuss.
Beyond these opening investigations, Nia is interested in using our microfluidic
system to study the heterogeneous response of small bacterial populations when
exposed to different classes of antibiotics. A unique feature of our microfluidic
system is the ability to image large numbers of small bacterial populations with
single cell precision. Nia hopes to analyse the large scale statistics of bacterial
growth both in the presence and absence of inhibiting agents, which has been
shown to be highly heterogeneous when using bulk growth techniques (see sec-
tion 7.5.2). Alongside this macro-scale statistical analysis, Nia will be able to
simultaneously observe the underlying behaviours that may cause this growth
heterogeneity at the single cell level.
7.3 Notable results
Where appropriate, results that we feel are particularly notable are highlighted.
Some of these notable results are important as they further validate our microflu-
idic device. In these results, growth metrics are compared to values measured
using bulk growth techniques. Other results are noteworthy as they offer insight
into unique population dynamics exhibited by small bacterial populations that
are not possible to observe or quantify using bulk growth methodologies. These
notable results are visually emphasised by a blue text box, an example of which
can be seen below.
Example notable result.
In blue text boxes such as this, the details of a notable result are discussed.
Generally, each notable result will be supported by a number of analyses
which will also be reference and summarised.
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7.4 Experimental protocol
In this section I will outline the full experimental protocol used to generate the
results discussed in this chapter. In this section, the beginning of the experiment
(t = 0) is defined as the point at which imaging/data recording begins. Whilst
every effort was made to standardise our experimental protocol, it was not pos-
sible to ensure certain processes completed within a certain time. As such, the
timings detailed below should be treated as guidelines. These timings represent
expected values based on our experience of working with the microfluidic system.
7.4.1 Device preparation, operation and image acquisi-
tion
At t = -22.5 hours, a 5 ml volume of M9 growth media supplemented with 0.4%
glucose (M9gl) was inoculated with a single colony of RJA002 E. coli taken from
an M9gl agar plate. The 5 ml volume was then placed in a shaking incubator
(37°C, 200 rpm) for 18 hours, producing a high-concentration starting culture of
E. coli.
At t = -4.5 hours, a 10 ml volume of fresh M9gl growth media was inoculated
with 25 µl of bacterial suspension taken from the starting culture. This 10 ml
volume was then placed in a shaking incubator (37°C, 200 rpm) for 1.5 hours. The
1.5 hour duration of this incubation period was found to consistently produce a
low density bacterial suspension that produced droplet populations with a mean
population size of ≈1-2 cells when encapsulated into microfluidic droplets.
By inoculating the 10ml volume of fresh M9gl growth media with the 25 µl of
starting culture, then incubating for 1.5 hours, it was intended that the bac-
terial suspension would be in the exponential growth phase during the 8 hour
observation period that would follow.
126
Logarithmic Growth
The logarithmic growth phase (or exponential phase) is a period of unin-
hibited bacterial population growth in which population doubling occurs
at a constant rate. Exponential growth is preferred in bacterial studies as
bacteria in this state reproduce most consistently. See chapter 2 for further
information regarding bacterial growth.
When appropriate, the antibiotic streptomycin was added at a pre-determined
concentration to the 10 ml volume of M9gl after the 1.5 hour incubation period. It
was then incubated again in a shaking incubator (37°C, 200 rpm) for 10 minutes
to ensure adequate mixing, and the standard experimental protocol was then
resumed.
Streptomycin
Streptomycin is a bactericidal ribosome targeting antibiotic. We chose to
use streptomycin in our research as it has been suggested that individual
E. coli cells may respond differently to streptomycin inhibition at the level
of individual cells[48]. For further information regarding antibiotics and
streptomycin, see section 2.3.
At t = -3.5 hours, 500 µl of the oil phase is drawn into a 1 ml plastic syringe and
connected to the microfluidic device via a syringe pump. This was then pumped
into the microfluidic device at 50 µl hr−1, ensuring that the oil phase reaches
the interior of the microfluidic device before the aqueous phase and purges any
remaining air from the oil inlet.
At t = -3 hours, after the 10 ml volume of M9gl had been incubated for 90
minutes, 1 ml of the bacterial suspension was drawn into a 1 ml plastic syringe and
connected to the microfluidic device using a second syringe pump, the aqueous
bacterial phase was then flowed into the microfluidic chamber at 50 µl hr−1. The
microfluidic device mount was then filled with water and brought to 37°C using
a water bath and peristaltic pump. The water level and temperature was then
adjusted regularly throughout the experiment to ensure the microfluidic device
and inlet tubing were maintained at a temperature of 37°C.
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At t = -2 hours, once both the aqueous and oil phase reached the flow focusing
junction and droplet generation had begun, the device was left for 15 minutes
so that pressure levels within the device could equilibrate. This allowed droplet
production to settle into a steady, monodisperse state. After the 15 minute equi-
libration period had concluded, the flow rates were adjusted. The flow rate of the
aqueous phase was reduced to 20 µl hr−1, whilst the flow rate of the oil phase was
increased to 80 µl hr−1. The device was then left for a second 15 minute equilibra-
tion period, ensuring the stable production of a monodisperse droplet emulsion.
Droplet production was continued until the monodisperse droplet emulsion began
to flow into the microfluidic reservoir. This process usually took between 1.5 and
2 hours.
As the monodisperse droplet emulsion travelled from the droplet generation de-
vice to the reservoir device, a number of imaging preparation processes were
completed. The imaging grid was initialised to optimally cover the microflu-
idic reservoir. Microscopy settings were then adjusted to optimise image quality.
Brightfield channel exposure was set to 10 ms, fluorescence exposure was set to
50 ms and the pixel binning of both channels was set to 2 x 2.
Once the reservoir was full of monodisperse droplets of the correct size, the syringe
pumps were stopped. The inlet and bridge tubing were then severed, arresting
all droplet movement within the microfluidic reservoir. Automatic focus was ad-
justed for optimal imaging of bacteria bacteria viewed in the fluorescence channel
across multiple fields of view, correct focus in the fluorescence channel ensured
the high image contrast required for bacterial counting whilst maintaining an ad-
equate focus for the boundary detection algorithm using the brightfield channel.
The imaging acquisition process was then started (t = 0), during the following 8
hours the images were continually monitored for imaging or automation problems.
The temperature of the water immersing the device was maintained at 37°C by
adjusting the water bath temperature to ensure optimal uninhibited growth.
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7.4.2 Image processing
Once each experimental run was completed, the data was segmented into a num-
ber of sub-sections that were processed individually (see chapter 5 for further
details regarding the segmentation process). Once each sub-section had been
passed through the image processing algorithm independently, the resultant data
was recombined to create a complete data set for each experimental run.
7.5 Growth of total bacterial population across
all droplets
A fundamental measure of the growth dynamics of a bacterial population is pro-
vided by the growth curve, which is a plot of population size/density as a function
of time.
Colony-Forming Units
Under the correct growth conditions, an individual cell placed onto an
agar growth plate will proliferate and form a macroscopic colony visible
to the naked eye. In this context, the progenitor cell is defined as a
Colony-Forming Unit (CFU). CFUs can be used to estimate the density of
viable progenitor cells in a bacterial suspension[213].
This is achieved by spotting samples from the serial dilution of a cell sus-
pension onto agar plates that have been supplemented with growth media.
After an incubation period, the agar plates are then examined and where
CFUs can be identified individually, they are counted. By correlating this
CFU count with the dilution factor of the sample, an order of magnitude
estimate of the viable cell density can be made. Determining viable cell
density by manually counting CFU’s is a time-consuming and laborious
task that is prone to error[214]. As such, indirect methods of measuring
cell density are often used, these proxy measurements are then calibrated
against CFU measurements.
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To measure the growth curve of a bacterial population, a proxy variable is usually
measured that is assumed to be intrinsically linked to population size or density,
such as fluorescence intensity or optical density. This value is then plotted ver-
sus time and the growth dynamics of large bacterial populations are able to be
quantified. With our microfluidic system, it is possible to count the bacterial
population directly in a highly accurate and time-efficient manner. So that we
could compare the growth behaviour of our droplet populations with the growth
behaviour seen in standard bulk cultures, we begin our analysis by examining
total population growth curves observed in our microfluidic device.
Bacterial Growth
As described in chapter 2, bacterial growth can be divided into four distinct
phases: an initial lag phase, an exponential growth phase, a stationary and
a death phase. Experiments are often designed such that the bacterial
population is in the exponential growth phase. In this phase growth rates
and doubling times for a bacterial population are easily calculated.
7.5.1 Total population growth curves
Results
To quantify and compare the overall growth dynamics of our droplet populations
with those observed in bulk growth experiments, total population growth curves
for each experimental run have been plotted. These were calculated by first
summing the total number of bacteria detected across all droplets at each time
frame of an experimental run. This total count was then plotted versus time to
produce a growth curve.
A sampling error estimate for each growth curve is also shown. This error esti-
mate was determined by randomly selecting a subset of droplets from the pool of
droplets that were successfully tracked across all time frames of their experimen-
tal run. The total bacterial population of this droplet subset was then calculated
for all time steps. This sampling process was then repeated multiple times, and
the standard deviation of the population size at each time step was calculated
across the droplet subsets. This standard deviation was then scaled according
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to the number of bacteria measured in each experimental run. For each experi-
mental run, each randomly selected droplet subset was one third the size of the
overall droplet set, and 10 droplet subsets were used to calculate the standard
deviation at each time frame.
Growth curves for all experimental runs can be seen in figures 7.1 and 7.2. As
discussed in section 7.4, t = 0 herein refers to the time at which the image
acquisition process is started. This is after monodisperse droplets have been
isolated in the microfluidic reservoir and fluid flow has been stopped.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
(d) 0.5 µg ml−1 (e) 0.5 µg ml−1
Figure 7.1 Total population growth curves of RJA002 E. coli populations encap-
sulated in microfluidic droplets, grown in M9 minimal media. Each
graph represents a complete experimental run.
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(a) 2.5 µg ml−1 (b) 50 µg ml−1
Figure 7.2 Total population growth curves of RJA002 E. coli populations encap-
sulated in microfluidic droplets, grown in M9 minimal media. Each
graph represents a complete experimental run.
Discussion
The experimental runs have been separated into 4 distinct classes according to
their total population growth behaviour. These are described below. The colour-
based identification system is used throughout this chapter for the purpose of
clarity.
Uninhibited - logarithmic growth
Bacteria encapsulated in the absence of streptomycin (experimental runs
0.00 - 1, 0.00 - 2) (figure 7.1) exhibited uninhibited logarithmic growth (see
figure 7.3 for further details). Experimental run 0.00 - 1 appears to enter
the stationary phase of growth around 5 hours into the experiment. This
may be due to its comparatively large initial population sizes (see section
7.6) and short population doubling times (see section 7.5.2). Experimental
run 0.00 - 2 exhibited logarithmic growth throughout the entirety of the 8
hour observation.
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Weakly inhibited - linear growth
Bacteria encapsulated in the presence of streptomycin at a concentration
of 0.05 µg ml−1 (experimental run 0.05 - 1) (figure 7.1) exhibited weak
inhibition, as characterised by a lower total population growth rate (see
section 7.5.2) and net bacterial growth. At this concentration the total
bacterial population size appears to grow in a linear fashion.
Weakly inhibited - loss of visible bacteria
Bacteria encapsulated in the presence of streptomycin at a concentration of
0.5 µg ml−1 (experimental runs 0.50 - 1, 0.50 - 2) (figure 7.1) exhibited weak
inhibition with a net loss of observable bacteria. However, a significant
sub-population of bacteria are observed to fluoresce throughout the 8 hour
observation.
Strongly inhibited - loss of visible bacteria
Bacteria encapsulated in the presence of streptomycin at concentrations of
2.5 µg ml−1 and 50 µg ml−1 (experimental runs 2.50 - 1, 50.0 - 1) (figure 7.2)
exhibited strong inhibition with an almost total loss of observable bacteria.
At these concentrations, streptomycin appears to be bactericidal, leaving
very few bacteria remaining visible.
Experiment Strep. Conc. Initial Final Percentage
ID (µg ml−1) Population Population Change
0.00 - 1 0 790 8991 + 1038.1%
0.00 - 2 0 460 6347 + 1279.8%
0.05 - 1 0.05 1267 4631 + 265.5%
0.50 - 1 0.5 468 178 - 62.0%
0.50 - 2 0.5 1350 360 - 73.3%
2.50 - 1 2.5 631 63* - 90.0%
50.0 - 1 50 377 2* - 99.5%
Table 7.2 Quantitative summary of ensemble growth behaviour for all experi-
mental runs. *Experimental runs 2.50 - 1 and 50.0 - 1 were ended
after 4 hours due to large-scale loss of visible bacteria.
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The variation in total population growth with antibiotic concentration is in line
with our basic expectations - as antibiotic concentration increased growth was in-
creasingly inhibited. At high streptomycin concentrations loss of visible bacteria
was observed, which we attribute to cell lysis. Unexpectedly, at moderate strep-
tomycin concentrations (0.5 µg ml−1) we observed a sub-population of bacteria
that did not divide, but remained fluorescent until the end of the 8 hour experi-
mental run. Counter to the literature[215] this could imply that streptomycin at
this concentration is bacteriostatic in nature for populations of this size, or it may
indicate that the bacteria have died but not lysed and are therefore still visible in
fluorescence. Both of these explanations are very interesting, as we are not aware
of any prior work that has reported two alternative death pathways for bacteria
inhibited by streptomycin: lysis or non-lysis. This phenomena is explored further
in subsequent analyses.
7.5.2 Total population growth rates and doubling times
Results
To further quantify the growth of the total population, bacterial growth rates and
doubling times have been calculated for the experimental runs that exhibited net
growth (0.00 - 1, 0.00 - 2 and 0.05 - 1). These were calculated using population
size data from the first 234 minutes of each experimental run, this ensured that
the transition to stationary phase observed in experimental run 0.00 - 1 was not
included in the growth rate calculations. Plots of the logarithm of the total
population size as a function of time are shown in figure 7.3; growth rates and
doubling times were calculated from the gradients of these plots. The plotted
errors shown in these plots is the same sampling error estimate that was calculated
for figures 7.1 and 7.2. For the non-logarithmic data the error is omitted for visual
clarity.
The calculated growth rate errors shown in table 7.3 are the standard errors
for prediction, obtained from the linear fit made to the logarithmically scaled
population size data. The calculated growth rates and associated doubling times
are tabulated in table 7.3. Whilst experimental run 0.05 - 1 did not exhibit
logarithmic growth, an approximate doubling time was still calculated for further
comparison.
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(a) - 0 µg ml−1
*
(b) - 0 µg ml−1
*
*
(c) - 0.05 µg ml−1
Figure 7.3 Logarithmically scaled ensemble growth curves of RJA002 E. coli
populations encapsulated in microfluidic droplets, grown in M9 min-
imal media at streptomycin concentrations of 0 µg ml−1 and 0.05
µg ml−1. Each graph represents a complete experimental run. *Dips
in the data are due to brightfield lighting fluctuations causing droplet
boundary detection failures. These points are removed for the calcu-
lation of growth rates and doubling times.
Experiment Strep. Conc. Growth Rate - (λ) Doubling Time
ID (µg ml−1) (min−1) (mins)
0.00 - 1 0 0.0075 ± 0.0001 93 ± 1
0.00 - 2 0 0.0053 ± 0.0001 131 ± 2
0.05 - 1 0.05 0.0042 ± 0.0001 165 ± 4
Table 7.3 Calculated growth rates and doubling times of experiments that exhib-
ited net bacterial growth.
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Discussion
The total population growth rates and doubling times were calculated for all
experiments that exhibited net bacterial growth (table 7.3).
The total population doubling time of encapsulated bacterial populations grown
in the absence of antibiotic (experimental runs 0.00 - 1, 0.00 - 2) was found
to be 93 ± 1 minutes and 131 ± 2 minutes, respectively. Despite experimental
runs 0.00 - 1 and 0.00 - 2 being performed under the same growth conditions,
they show a significant difference in growth rate. There are numerous potential
explanations for this difference. For example, each experimental run is initiated
with a bacterial culture taken from a different colony on an agar plate (see chapter
3 for more information): it is possible that one of these colonies had picked up a
mutation that affected its growth rate. In the future we would like to repeat the
experimental runs conducted in the absence of streptomycin to determine whether
the variability in growth rate between replicate runs persists. Regardless of the
observed difference in total population growth rate between experimental runs
0.00 - 1 and 0.00 - 2, they both exhibited logarithmic growth, with growth rates
larger than any other experimental run that exhibited a net increase in bacterial
population size.
The approximate total population doubling time of encapsulated bacterial popu-
lations grown in the presence of streptomycin at a concentration of 0.05 µg ml−1
was found to be 165± 4 minutes.
M9 Minimal Media
The growth media encapsulated within our microfluidic droplets was M9




Waclaw et al. at the University of Edinburgh reported a growth rate for RJA002
E. coli grown in M9gl of 0.0062 ± 0.0004 min−1, corresponding to a doubling
time of 112± 7 minutes[201]. These measurements were obtained using a 96 well
plate-reader, and the growth rate value is the mean of 24 experimental repeats.
These growth curves can be seen in figure 7.4.
Figure 7.4 Multiwell plate growth curves of RJA002 E. coli grown in M9 min-
imal media supplemented with glucose. Plotted using data provided
by Waclaw et al.[201]. Exponential growth is visible at OD < 0.1.
A significant lag phase can be seen in the growth curves obtained using a plate
reader, which were plotted using data provided by Waclaw et al.[201]. This
is not observable in the growth curves obtained using our microfluidic system.
This is primarily because measurements begin in plate reader experiments almost
immediately after the initial low-concentration bacterial suspension is produced.
In contrast, measurements begin in our microfluidic system ≈4.5 hours after the
initial low-concentration bacterial suspension is produced. During this 4.5 hours
time delay, the bacterial suspension is passed into the microfluidic device where
it is then encapsulated into a monodisperse microfluidic droplet emulsion. These
droplets are then moved into the microfluidic imaging reservoir. See section 7.4.1
for further information regarding the complete experimental protocol and the
timings associated with this process.
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The calculated doubling times for RJA002 growing in our microfluidic droplets
are 93±1 minutes (experimental run 0.00 - 1) and 131±2 minutes (experimental
run 0.00 - 2). These values are 17% shorter and 17% longer than the bulk growth
measurement of 112 minutes reported by Waclaw et al. The error value for the
growth rate obtained by Waclaw et al. was calculated by assessing the growth rate
variation across 24 experimental repeats. The error values for the growth rates
we obtained using our microfluidic system are the standard errors for prediction,
obtained from the linear fit made to the logarithmically scaled population size
data (figure 7.3). As such, the bulk measurement error estimation is significantly
higher than the errors calculated for our microfluidic system.
To accurately compare the total population growth rates (and errors) of our mi-
crofluidic system with those obtained using traditional bulk techniques, it would
be necessary to perform additional repeat experiments using our droplet system.
This would allow us to obtain a statistically significant inter-experimental error
estimation, further validating this system for use in microbiological research (see
section 7.2 for further discussion).
Logarithmic growth was observed that was consistent with bulk measure-
ments, indicating that the process of encapsulation and growth using our
microfluidic system did not inhibit growth.
In experimental runs 0.00 - 1 and 0.00 - 2 (streptomycin concentration of 0
µg ml−1) logarithmic growth was observed (figure 7.3). Growth rates and
doubling times of these experimental runs were consistent with literature
values obtained using bulk measurement techniques[201] (table 7.3). This
suggests that bacterial populations grown using our microfluidic system
are not significantly inhibited by their environment. Furthermore, access
to oxygen and the accumulation of toxic waste products does not appear
to be limiting bacterial growth inside our microfluidic system.
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7.5.3 Minimum inhibitory concentration
The MIC of streptomycin has been measured for RJA002 in glucose-supplemented
minimal media repeatedly using bulk growth techniques. Reported MIC values lie
within 1 order of magnitude, with measurements ranging from ≈0.2 µg ml−1[48]
to ≈2 µg ml−1[216]. From the experimental data presented in this section, it is
clear that the experimental MIC measured for these droplet encapsulated pop-
ulations is between 0.05 µg ml−1 (net bacterial growth) and 0.5 µg ml−1 (net
reduction in observed bacteria).
Greulich et al. have shown that the MIC value of streptomycin exhibits a depen-
dence on growth rate[48]. Given that bulk measurement growth rates differ from
our calculated growth rates presented in table 7.3, it follows that our MIC value
might also be expected to differ from the bulk measurement MIC values. By
comparing our antibiotic-free growth rate values with those found in the work of
Greulich et al. we predict a streptomycin MIC value of around 0.3 µg ml−1. This
is consistent with the observed effects of the different streptomycin concentrations
on the total population growth behaviour shown earlier in this section.
7.5.4 Analysis of individual droplet populations
Whilst the total population growth rate measurements provide insight regarding
the macro-scale behaviour of the bacterial populations, an advantage of using
our microfluidic device is the ability to accurately quantify the growth dynamics
of many small populations simultaneously. It is our goal to study the micro-
scale behaviour that occurs at the individual droplet level so that we can then
understand how the growth dynamics in these individual droplets gives rise to the
total population growth dynamics that have been described here. To do this, it
is necessary to analyse the growth in the droplet populations separately, thereby
building a more nuanced statistical picture of the overall stochastic bacterial
growth.
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7.6 Size distributions of bacterial populations
growing in droplets
7.6.1 Initial population size distribution vs. final popula-
tion size distribution
Results
As discussed in chapter 2, it is well understood that the initial population size
distribution in our droplets is expected to follow a Poisson distribution[132]. De-
spite this statistical understanding of the initial population size distribution, it
not known how the population size distribution evolves as each droplet population
undergoes stochastic growth.
Figure 7.5, 7.6 and 7.7 show histograms of the distribution of the bacterial pop-
ulation sizes at the start and end of each experimental run.
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(a) 0 µg ml−1
(b) 0 µg ml−1
(c) - 0.05 µg ml−1
Figure 7.5 Histograms showing the population distributions of droplets at t = 0
mins and t = 474 mins, grown in M9 minimal media at streptomycin
concentrations of (a,b) 0 µg ml−1 and (c) 0.05 µg ml−1. The number
of detected, populated droplets included in each histogram at [t = 0
mins, t = 474 mins] is (a) [357, 355], (b) [309, 339], (c) [547, 522].
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(a) - 0.5 µg ml−1
(b) - 0.5 µg ml−1
Figure 7.6 Histograms showing the population distributions of droplets at t = 0
mins and t = 474 mins, grown in M9 minimal media at a strepto-
mycin concentration of 0.5 µg ml−1. The number of detected, pop-
ulated droplets included in each histogram at [t = 0 mins, t = 474
mins] is (a) [282, 127] and (b) [507, 226].
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(a) - 2.5 µg ml−1
(b) - 50 µg ml−1
Figure 7.7 Histograms showing the population distributions of droplets at t = 0
mins and t = 234 mins, grown in M9 minimal media at streptomycin
concentrations of (a) 2.5 µg ml−1 and (b) 50 µg ml−1. The number
of detected, populated droplets included in each histogram at [t = 0
mins, t = 234 mins] is (a) [268, 43] and (b) [311, 2].
The mean and standard deviation was calculated for the initial and final popu-
lation size distributions. These are plotted in figure 7.8
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(a) t = 0 mins
(b) t = 474 mins*
Figure 7.8 Bar plots of the initial and final mean droplet population size. (a)
displays the initial mean population size for each experimental run,
(b) displays the final mean population size for each experimental
run. Error bars represent standard deviation. *t = 234 mins for
experimental run 2.50 - 1 and 50.0 - 1.
For a Poisson distribution, the mean and variance are equal. The Fano factor
for the initial and final population size distributions was plotted as a function of
streptomycin concentration. This can be seen in figure 7.9.
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To further this analysis, a “predicted” final population distribution was calcu-
lated for each experimental run. This was achieved by calculating a deterministic
growth rate for each experimental run, using the initial and final total bacterial
population size. Each of the initial population distributions were then “grown”
using the deterministic growth rate to produce a predicted final population dis-
tribution. The mean, variance and Fano factor for each of these predicted final
population distributions was then calculated, and then compared to the observed
final population distributions. These predicted Fano factor values are also plotted
in figure 7.9.
(a) t = 0 mins (b) t = 474 mins*
Figure 7.9 Scatter plot showing the Fano factor for each experimental run as
a function of streptomycin concentration. (a) Displays the initial
experimental population distribution Fano factors, (b) displays the
final experimental and predicted population distribution Fano fac-
tors. *t = 234 mins for experimental run 2.50 - 1 and 50.0 - 1.
Discussion
For experimental run 0.00 - 1 (streptomycin concentration of 0 µg ml−1) the
mean population size increases dramatically over the course of the experimental
run, consistent with the observed logarithmic growth. The initial Fano factor
is 2.07, indicating the population distribution has a Poisson character, although
the variance is ≈2x greater than the mean population size would predict given a
Poisson encapsulation process. This discrepancy was discussed in chapter 6. The
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final Fano factor is 33.70, indicating a large increase in variance with respect to
the mean. This variance can be seen clearly in the extended distribution tail at
large population sizes.
In experimental run 0.00 - 2 (streptomycin concentration of 0 µg ml−1) the mean
population size also increases significantly over the course of the experimental
run. The initial Fano factor is 1.52, again indicating a higher variance than
would be anticipated given the starting mean. The final Fano factor is 44.44,
again indicating that uninhibited logarithmic growth raises increases the variance
away from that predicted by Poisson statistics. Despite experimental run 0.00 -
2’s lower growth rate, the final Fano factor of experimental run 0.00 - 2 is greater
than the final Fano factor of experimental 0.00 - 1. This means that the variance
in experimental run 0.00 - 2 increases more than experimental run 0.00 - 1 (over
the course of an experimental run) when normalised by the mean population size.
Experimental run 0.00 - 1 was, however, observed to enter the stationary phase
of growth after around 5 hours, this could explain the decreased Fano factor of
this experimental run with respect to experimental run 0.00 - 2.
For experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1), the
mean population size increases during the run, but not to the same degree as the
experimental runs completed at 0 µg ml−1. A key difference can be seen in the
final distribution - the tail is much shorter (failing to extend beyond 70 cells),
despite the initial distribution being skewed to larger populations than other
experimental runs. The initial Fano factor is 1.89, consistent with the values
obtained in the absence of streptomycin. The final Fano factor is 13.25, again
implying a comparatively large increase in variance with respect to the mean.
Although the final Fano factor indicates an increased variance with respect to
the mean, it is less than half of the final Fano factors calculated for experimental
runs 0.00 - 1 and 0.00 - 2, indicating even low antibiotic concentrations may
significantly limit the growth of high population droplets.
For experimental runs 0.50 - 1 and 0.50 - 2 (streptomycin concentrations of
0.5µg ml−1), the mean droplet population size decreases over the course of each
8 hour experimental run. Interestingly, despite the loss of observable bacteria in
these experimental runs, a number of droplets with moderate bacterial popula-
tions continue to visibly fluoresce and these populations appear to remain stable
in size. The Fano factor for experimental run 0.50 - 1 increases from 1.78 to 1.84
over the course of the experimental run. This indicates that the droplet popula-
tion size variance doesn’t change significantly over the course of the experimental
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run, when normalised according to the mean. The Fano factor for experimental
run 0.50 - 2 increases from 2.26 to 3.34 over the course of the experimental run,
indicating a small increase in variance with respect to the mean.
For experimental runs 2.50 - 1 and 50.0 - 1 (streptomycin concentrations of 2.5
µg ml−1 and 50 µg ml−1), the final population mean decreases significantly during
the run, consistent with the net bacterial death observed in their total population
growth curves. The initial Fano factor for experimental run 2.50 - 1 is 1.85, which
is consistent with the previously discussed experimental runs. This decreases to
1.65 after the 4 hour experimental run, indicating a decrease in variance with
respect to the mean. The initial Fano factor for experimental run 50.0 - 1 is 1.13,
indicating a population size distribution that has a strong Poisson character. This
Fano factor decreases to 1.00, however this is misleading as the vast majority of
droplets contain 0 bacteria, with only 2 droplets containing 1 bacteria each.
Aside from the initial Fano factors being higher than anticipated given a Poisson
process (see chapter 6), some of the most interesting results from this data are the
Fano factors calculated for experimental runs 0.50 - 1 and 0.50 - 2. For context,
in experimental runs that exhibited net bacterial growth (0.00 - 1, 0.00 - 2, 0.05 -
1), the Fano factors increased over the course of the experimental run, indicating
an increase in variance with respect to the mean. In experimental runs that
exhibited a significant net loss of total visible bacteria (2.50 - 1, 50.0 - 1), the Fano
factors decreased over the course of the experimental run, indicating an decrease
in variance with respect to the mean. Counter to these trends, experimental
runs 0.50 - 1 and 0.50 - 2 exhibited a net loss of total visible bacteria, but the
Fano factors increased over the course of these experimental runs. This implies
that whilst the mean droplet population size decreased, the variance normalised
with respect to this mean increased. An explanation for this increase in Fano
factor could be that whilst on average the droplet populations decreased in size,
streptomycin at this concentration does not inhibit droplet populations equally.
It could be that droplet populations with large initial populations are inhibited
less than droplet populations with small initial populations, driving an increase
in Fano factor. This hypothesis is supported by further analysis that will be
described later on in this section.
The predicted Fano factor values for the deterministic final population distribu-
tions can be seen in figure 7.9(b). The predicted final population Fano factor
values are all lower than their respective experimental values. This implies that
the variance of the final population distributions are larger than would be ex-
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pected given the initial population distributions and deterministic growth. In the
experimental data, increased growth results in an increased Fano factor value.
This generally holds true for the predicted data too, however they do not scale
linearly with their associated experimental value. For example, the final exper-
imental Fano factor for run 0.00 - 1 is 33.66 and its predicted value is 23.58
(70%), whereas the final experimental Fano factor for run 0.00 - 2 is 44.44 and its
predicted value is 20.98 (47%). The concept of comparing the exhibited growth
with deterministic growth is explored in further detail in section 7.6.3, where the
final experimental population distributions are compared with their deterministic
counterparts.
7.6.2 Time evolution of population size distribution
Results
Figures 7.10 and 7.11 are 3-dimensional colour plots that show the evolution of
each experimental run’s population distribution as a function of time. At each
point in time (x-axis), it is possible to see how many droplets were observed
(z-axis) with a given population size (y-axis).
These colour plots were created by binning each droplet according to its popu-
lation size (at a given time frame). This process was then repeated for all time
frames of each experimental run. This allowed the frequency of droplets with a
given population size to be measured, and the 3-dimensional colour plots were
then generated. Note that the droplet frequency colour-scale (z-axis) of each plot
is scaled logarithmically, allowing low frequency populations to remain visible
whilst also allowing more general high frequency trends in the distributions to be
visualised.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
(d) 0.5 µg ml−1 (e) 0.5 µg ml−1
Figure 7.10 Colour plots showing the evolution of population size distribution
across the course of an experimental run. Bacteria grown in M9
minimal media at streptomycin concentrations of (a,b) 0 µg ml−1,
(c) 0.05 µg ml−1 and (d,e) 0.5 µg ml−1. Each graph represents a
complete experimental run.
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(a) 2.5 µg ml−1 (b) 50 µg ml−1
Figure 7.11 Colour plots showing the evolution of population size distribution
across the course of an experimental run. Bacteria grown in M9
minimal media at streptomycin concentrations of (a) 2.5 µg ml−1
and (b) 50 µg ml−1. Each graph represents a complete experimental
run.
Discussion
For experimental runs 0.00 - 1 and 0.00 - 2 (streptomycin concentration of 0
µg ml−1), droplet population sizes increase dramatically over the 8 hour experi-
mental run. The red band visible in figure 7.10(a) indicates that in experimental
run 0.00 - 1 a large number of droplet populations initially grow at the same rate.
However after approximately 300 minutes these populations diverge in growth
rate.
For experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1), the
droplet population sizes increase steadily over the course of the 8 hour experi-
mental run. This experimental run uniquely exhibits a subset of droplets with
stationary bacterial populations. The number of visible bacteria in these popu-
lations does not change over time, resulting in horizontal bands of colour that
can be seen against the background of the evolving population distribution be-
yond 120 minutes. This can be seen most prominently for bacterial populations
between 1 and 10 bacteria. These populations do not significantly diverge in size
over the course of the experimental run. Example growth curves of individual
droplets that exhibit this behaviour can be seen in figure 7.12.
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0.05 µg ml−1
Figure 7.12 Example growth curves of individual droplets with near-stationary
populations in experimental run 0.05 - 1. Bacteria grown in M9
minimal media at a streptomycin concentration of 0.05 µg ml−1.
It is not clear why this subset of bacterial populations remain roughly station-
ary in size. Streptomycin is classified as a bactericidal antibiotic. It acts by
binding irreversibly to bacterial ribosomes, inhibiting their function. The static
growth behaviour observed in this subset of droplet populations is therefore not
anticipated according to this classification. This band of static/slow-growing bac-
teria may be connected to the bistable dependence of growth rate on antibiotic
concentration at the individual cell level predicted by Greulich et al.[48] (see sec-
tion 2.3.2). To further explore this phenomena, additional techniques would be
required to discern whether these static bacterial populations are alive but not
dividing, or if they are dead but not lysed (see section 6.6). If we confirmed
that the observed subset of static/slow-growing droplet populations were indeed
alive, it would be possible to quantify the exact conditions under which this
bi-stable growth rate dependence existed. This would not be possible using tra-
ditional bulk growth techniques. Furthermore, we may be able to isolate bacteria
from these fast-growing and static/slow-growing subpopulations, allowing us to
perhaps understand the microbiological mechanisms behind this heterogeneous
response.
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For experimental runs 0.50 - 1 and 0.50 - 2 (streptomycin concentration of 0.5
µg ml−1), we also obtain interesting results. There is a net loss of visible bacteria
throughout the first 120 minutes of each experimental run. After the first 120
minutes, the number of low population droplets slowly decreases, but the number
of large population droplets does not seem to decrease significantly in this time.
This can be seen in figure 7.11 (d) and (e), where the orange bands decrease with
time whilst the teal bands do not.
For experimental runs 2.50 - 1 and 50.0 - 1 (streptomycin concentrations of 2.5
µg ml−1 and 50 µg ml−1), the number of visible bacteria in all droplets decreases
rapidly over the course of the 4 hours of observation.
7.6.3 Final population size - measured vs. predicted
Results
By evolving the initial population size distribution of an experimental run ac-
cording to its total population growth rate, it is possible to calculate a predicted
final population size distribution, for a given initial size distribution, based upon
an assumption of deterministic growth. This predicted final distribution can then
be compared directly to the observed final distribution, similar to the analysis
detailed in section 7.6.
This was achieved by first calculating a total population growth multiplier for an
experimental run, e.g. the initial population size for experimental run 0.00 - 1
is 790, the final population size is 8991, therefore the growth multiplier for this
experimental run is 11.381. Each initial droplet population was then artificially
“grown” using this growth multiplier, e.g. droplets that began with 1 bacteria
are predicted to end with 11.381 bacteria, droplets that began with 2 bacteria are
predicted to end with 22.762, and so on. The predicted final droplet populations
were then binned and plotted in a histogram alongside the measured final values.
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This prediction assumes deterministic growth, meaning that all populations that
start with the same population size will end with the same population size. There-
fore, if there are only 6 distinct initial population sizes, there will only be 6 pre-
dicted final population sizes. So that the predicted and measured population
distributions could be compared, the number of bins they were both separated
into was matched. The number of bins was chosen to equal the number of initial
population sizes, e.g. if an experimental run starts with 6 population sizes, the
predicted and measured final populations are separated into 6 bins.
The predicted and measured final population sizes are plotted and quantitatively
compared in figures 7.13, 7.14 and 7.15. Error bars are derived from the sampling





Figure 7.13 (left) Measured and predicted final droplet population distribu-
tions of RJA002 E. coli populations encapsulated in microfluidic
droplets, grown in M9 minimal media at streptomycin concentra-
tions of (a,b) 0 µg ml−1 and (c) 0.05 µg ml−1. (right) Difference
in droplet frequency between the measured and the predicted distri-
butions, positive ∆ values imply the measured droplet frequency is




Figure 7.14 (left) Measured and predicted final droplet population distribu-
tions of RJA002 E. coli populations encapsulated in microfluidic
droplets, grown in M9 minimal media at a streptomycin concentra-
tion of 0.5 µg ml−1. (right) Difference in droplet frequency between
the measured and the predicted distributions, positive ∆ values im-





Figure 7.15 (left) Measured and predicted final droplet population distribu-
tions of RJA002 E. coli populations encapsulated in microfluidic
droplets, grown in M9 minimal media at streptomycin concentra-
tions of (a) 2.5 µg ml−1 and (b) 50 µg ml−1. (right) Difference
in droplet frequency between the measured and the predicted distri-
butions, positive ∆ values imply the measured droplet frequency is
greater than the predicted droplet frequency.
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Discussion
For experimental runs 0.00 - 1 and 0.00 - 2 (streptomycin concentration of 0
µg ml−1), the predicted final droplet population distribution appears similar to
the measured distribution. For the majority of population size bins, a decrease
in measured droplet frequency is mirrored by a decrease in predicted droplet fre-
quency. However, there are some key differences. In experimental run 0.00 - 1,
the predicted data overestimates the number of low population droplets (<26
bacteria). In experimental run 0.00 - 2, the predicted data this time underesti-
mates the number of low population droplets (<26 bacteria) whilst overestimat-
ing the number of moderate population droplets (26-52 bacteria). Common to
both experimental runs, the predicted distribution significantly underestimates
the number of high population droplets, both in number of droplets and in the
maximum population size. This observation indicates that a number of droplets
contain populations that grow significantly faster than the mean total population
growth rate would predict.
For experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1), the
predicted and measured distributions differ more significantly than any other ex-
perimental run that exhibited net growth. The predicted population distribution
estimates the number of droplets with population sizes between 0 and 6 bacteria
at the end of the run to be 187, whilst the measured number is 259 - under-
estimating the actual value by 28%. Counter to this, the predicted population
distribution estimates the number of droplets with population sizes between 7 and
13 bacteria at the end of the run to be 250, whilst the measured number is 136 -
overestimating the actual value by 84%. We believe this is linked to the subset of
populations visible in figure 7.10(c) that seem to have static population sizes with
bacterial counts below 6. This would explain why the number of moderate sized
bacterial populations at the end of the run (7 - 18 bacteria) is underestimated
by the deterministic growth, as deterministic growth predicts that the smaller
of these static bacterial population bands (0 - 6 bacteria) would grow into the 7
- 18 bacteria band, were they not static. Similar to experimental runs 0.00 - 1
and 0.00 - 2, the predicted population distribution significantly underestimates
the number of high population droplets. We also note that although the initial
droplet population distribution features a large step (figure 7.5), in the measured
final droplet population distribution this step has been completely smoothed out
over the 8 hour experimental run.
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For experimental runs 0.50 - 1 and 0.50 - 2 (streptomycin concentration of 0.5
µg ml−1), the predicted distributions dramatically overestimate the number of
droplets containing 1 bacterium that are present at the end of the run. Conversely,
the number of droplets measured with bacterial population sizes greater than
1 exceeds the predicted values. It appears at this streptomycin concentration,
which is close to the estimated MIC, that droplets beginning with relatively large
population sizes (2-7 bacteria) manage to maintain their population size. In
contrast, the deterministic assumption predicts mass inhibition of the majority
of droplets to small but non-zero values.
For experimental runs 2.50 - 1 and 50.0 - 1 (streptomycin concentrations of 2.5
µg ml−1 and 50 µg ml−1), the measured droplet populations exceed those pre-
dicted across all population sizes. Unfortunately, the measured data is extremely
limited as very few droplets are populated by the end of each experimental run.
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In the absence of streptomycin, final droplet population distributions fea-
tured extended tails at high population values. These extended tails were
due to high population droplets that grew significantly faster than the
population mean. At a streptomycin concentration of 0.05 µg ml−1, this
extended distribution tail was still present, but significantly reduced in
magnitude.
The final population distributions for experimental runs 0.00 - 1 and 0.00
- 2 (streptomycin concentration of 0 µg ml−1) featured extended tails
consisting of large population droplets. These extended distribution tails
can he seen in the histograms plotted in figure 7.5.
As seen in section 7.6.1, experimental runs 0.00 - 1 and 0.00 - 2 exhibited
final Fano factors of 33.7 and 44.44, respectively. This indicates that
the final population variance increased significantly relative to the mean.
Experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1)
exhibited a final Fano factor value of 13.25 This indicates that the final
population size distribution has a moderately increased variance relative
to the mean. This difference can be seen in the largest population droplets
of each experiment: whilst experimental runs 0.00 - 1 and 0.00 - 2 featured
multiple droplet populations stretching out to ≈150 bacteria in size, in
experimental run 0.05 - 1 the maximum final population size was less than
70 bacteria in size. This implies that even at the low concentration of
0.05 µg ml−1, streptomycin limited the growth rate of fast growing droplet
populations.
In section 7.6.3, the total population growth rate was used to predict the
final droplet population size distribution. This prediction consistently un-
derestimated the number of droplets that were found at large population
sizes, whilst overestimating the number of droplets that were found with
low-moderate population sizes. This again emphasised the large subset
of droplet populations that routinely outperformed the growth rate of the
population when it was treated as a total growth measurement.
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At a streptomycin concentrations of 0.5 µg ml−1, there is a bias against
lysis for large droplet populations.
In experimental runs 0.50 - 1 and 0.50 - 2 (0.5 µg ml−1), it appears that
droplets beginning with large numbers of visible bacteria were more likely
to maintain their population size, suggesting a bias against lysis for large
droplet populations at this antibiotic concentration.
This can be seen in their colour plots (figure 7.10 (d) and (e)), where
the number of droplets with small populations slowly decreased after 120
minutes, whereas the number of droplets with larger population sizes
stayed more static.
This is supported by the predicted final distribution plots for these
experimental runs (figure 7.14). In these plots, the frequency of large
population droplets was consistently underestimated by the prediction,
implying that the bacteria in large population droplets consistently
remained visible when the total population bacterial death rate suggested
that their populations should have decreased considerably in size.
This result is further underpinned by the mean and variance measurements
for these experimental runs, which is detailed in section 7.6.1. It was found
that whilst the mean population size decreased over the course of both
experimental runs, the Fano factors actually increased. This means that
the variance of the final droplet population sizes increased relative to their
respective means. This behaviour is counter to all other experimental runs,
and implies there is a process driving an increase in the Fano factor despite
the mean population size decreasing. We believe this process is the bias
against lysis for large population droplets.
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7.7 Time of droplet death
Results
A unique metric that we are able to extract from our experimental data is the
time of droplet death. Here I define the time of droplet death as the time frame
when a droplet which initially had a non-zero population size is reduced to a
population size of zero. It is important to remember here that this only occurs
when all bacteria in a droplet population have lysed (as opposed to bacteria dying
but remaining fluorescent). To mitigate against counting errors at low bacterial
counts, a droplet death is only recorded when the visible population in a droplet
is reduced to 0, and remains zero for the following 4 time steps (i.e. droplet
population is recorded as 0 for 5 consecutive time steps).
Time of death distributions for each experimental run are shown in figure 7.16 and
7.17. Only droplets tracked across all 80 times frames are used in this analysis.
In each plot, the droplet death frequency is normalised with respect to the total
number of initially populated droplets. The data is binned using a bin width of
18 minutes, or 3 time frames.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
(d) 0.5 µg ml−1 (e) 0.5 µg ml−1
Figure 7.16 Histograms showing how droplet death times are distributed over
the course of an experimental run. Bacteria grown in M9 min-
imal media at multiple streptomycin concentrations. Each graph
represents a complete experimental run.
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(a) 2.5 µg ml−1 (b) 50 µg ml−1
Figure 7.17 Histograms showing how droplet death times are distributed over
the course of an experimental run. Bacteria grown in M9 minimal
media at streptomycin concentrations of (a) 2.5 µg ml−1 and (b)
50 µg ml−1. Each graph represents a complete experimental run.
Discussion
The time of death distributions for experimental runs 0.00 - 1 and 0.00 - 2 (strep-
tomycin concentration of 0 µg ml−1), show a number of droplet deaths within
the first 60 minutes of both experimental runs. After this, there are essentially
no droplet deaths for the remainder of the 8 hour experimental run. This seems
reasonable: given a finite probability that a bacterium lyses instead of dividing,
there is a reasonable possibility that the bacteria of a small bacterial population
of 1 or 2 bacteria in a droplet could stochastically fail to divide and lyse, causing
the population in that droplet to become extinct. However, once a population
reaches a critical value, it is highly unlikely that all bacteria in that droplet will
consistently fail to divide across multiple generations without the influence of ex-
ternal factors. The small fraction of bacteria that fail to divide therefore become
insignificant and the droplet survives.
Another point of interest when examining the time of death distributions for
experimental runs 0.00 - 1 and 0.00 - 2, is that ≈15% of all tracked droplets
go extinct (even though they are being grown in the absence of antibiotic). It
is not clear why these droplets are going extinct without an inhibiting agent
present. Unfortunately, it is not possible to compare this bacterial death rate to
bulk growth measurements. This is because it is not possible to accurately track
the deaths of individual bacteria in a bacterial suspension using traditional bulk
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growth techniques. Furthermore, any deaths that occur in low density regimes
such as this will quickly be obscured by the rapid growth of the rest of the
population.
We are not concerned by these droplet deaths, primarily because the total pop-
ulation growth rate observed when using our microfluidic system is comparable
to the total population growth observed when using bulk growth techniques (see
section 7.5.1). We believe this fact indicates that the bacteria we are using are
not significantly stressed by the process of droplet encapsulation and subsequent
storage within our microfluidic system.
Experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1) exhibits
a unique droplet death profile. In all growth metrics shown so far, experimental
runs performed at streptomycin concentrations of 0 µg ml−1 and 0.05 µg ml−1
exhibit similar dynamics. However, there are significant differences in the droplet
death time distributions of these experimental runs. Experimental runs 0.00 -
1 and 0.00 - 2 displayed initial droplet death followed by essentially zero death,
whereas experimental run 0.05 - 1 displays a uniform, low rate of droplet death
over the course of an experimental run. Examining this data further raises more
questions: experimental run 0.05 - 1 exhibits consistent and uniform droplet
death, but the total population is increasing linearly (see figure 7.1). This appears
contradictory, but can be explained if the lysing droplet populations are small and
have been small for a significant period of time before death. If this is the case,
then these droplet deaths would not significantly affect the total population size,
allowing the total population size to steadily increase as large population droplets
continue to grow. This is supported by the colour plot of experimental run 0.05 - 1
(figure 7.10) which shows a subset of droplets with small populations that do not
increase in size. If these droplets populations were to slowly but steadily reduce
to zero, it would produce the droplet death distribution described here whilst
also not significantly affecting the total population growth. These observations
additionally imply that streptomycin inhibits the bacterial populations in some
droplets differently to others. Whilst some droplets remain static and their visible
populations very slowly decrease over time, some droplets experience relatively
uninhibited and rapid growth.
For experimental runs 0.50 - 1 and 0.50 - 2 (streptomycin concentration of 0.5
µg ml−1), the droplet death times follow a consistent pattern: droplet death
initially increases to a maximal value over the first 60 minutes, then slowly tails
off over the following 7 hours. This is noteworthy as the total population shows a
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small amount of growth in the first 30 minutes of these experimental runs. This
suggests that whilst a number of droplets undergo droplet death early in the
experimental run, a number of droplet populations are also increasing in size at a
rate that outstrips this droplet death, resulting in a short burst of total bacterial
growth.
Finally, in experimental runs 2.50 - 1 and 50.0 - 1 (streptomycin concentrations
of 2.5 µg ml−1 and 50 µg ml−1) droplet death is observed almost immediately
from the beginning of each experimental run. Although droplet death is initially
moderate, it increases to a maximum after approximately 80 minutes. Droplet
death decreases drastically after 100 minutes at a streptomycin concentration of
50 µg ml−1; however this is simply because almost all droplet populations at this
stage in the experimental run have been reduced to zero - there are no populations
left to undergo death.
Interestingly, the number of droplet deaths in experimental run 2.50 - 1 reaches
a maximal value at around 80 minutes, and then seems to maintain a steady
rate until the experiment ends after 4 hours. This behaviour may appear to be
contradictory to the total population growth curve shown in figure 7.2, where
the total population declines sharply from 30 to 180 minutes and then declines
much more slowly from 180 to 234 minutes. The number of droplet deaths are
constant, whilst the rate of loss of bacteria slows down considerably. This implies
that early on in the experiment, low population droplets are becoming extinct
whilst higher population droplets are also being reduced in size, therefore the
total population size is decreasing significantly with time. In contrast, later on
in the experiment, a subset of low population droplets are still being driven to
extinction, but as the total population is only declining slowly at this point, the
rest of the droplet populations must be static in population size.
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At streptomycin concentrations of 0.5 µg ml−1 and 2.5 µg ml−1, which is
above the estimated MIC value, streptomycin appeared to be either bacte-
riostatic or non-lytic.
It can be seen in the growth curves for experimental runs 0.50 - 1 and 0.50
- 2 that bacterial populations were significantly inhibited at a streptomycin
concentration of 0.5 µg ml−1 (figure 7.1). This inhibition results in a
net loss of visible bacteria. Despite this, a significant number of droplet
populations remained visible throughout the entire 8 hour observation
period. This could be due to streptomycin acting in a bacteriostatic
fashion, or because at this concentration streptomycin induced cell death
but not lysis (allowing the bacteria to continue to fluoresce in death).
It is not possible to distinguish between these two possibilities using
our current microfluidic system, but it is entirely conceivable that an
additional process could be integrated into our microfluidic system that
tests bacterial metabolic function and/or viability after extended antibiotic
exposure.
In figure 7.2, it can be seen for experimental run 2.50 - 1, at a higher strep-
tomycin concentration of 2.5 µg ml−1, the rate of bacterial lysis changed
over the course of the experimental run. However in figure 7.17, the rate
of droplet death can be seen to remain relatively constant. Early on in
the experimental run, rate of bacterial lysis was high, implying that low
population droplets were being driven to extinction whilst higher popula-
tion droplets were being reduced in size. Later on in the experiment, low
population droplets were still undergoing droplet death however the total
population was declining very slowly. This implies that almost all higher
population droplets were static in population size.
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At a streptomycin concentration of 0.05 µg ml−1, streptomycin was both
non-inhibiting and bacteriostatic/non-lytic.
In experimental run 0.05 - 1 (streptomycin concentration of 0.05 µg ml−1),
there was a significant subset of droplets whose population sizes appeared
to remain static.
This can be seen in the colour plot for this experimental run (figure
7.10(c)), which showed a horizontal band of droplets with populations that
remained stationary between roughly 1 and 10 bacteria.
This was further emphasised in the prediction plot for experimental run
0.05 - 1, which can be seen in figure 7.13(c). In this plot, the number
of measured droplets with population sizes between 0 and 6 bacteria far
outweighed the number of predicted droplets (which was based on the
total population mean growth). This stationary behaviour contrasts with
a number of high population droplets that exhibited large growth rates,
and the total population size which increased linearly with time. We
believe these two conflicting behaviours can be reconciled if one subset of
droplet populations is inhibited by streptomycin, whilst another subset is
mostly unaffected.
This conclusion is supported by the droplet time of death distribution for
experimental run 0.05 - 1 (figure 7.16(c)). This distribution exhibited a
uniform, low rate of droplet death throughout the entire observation period.
This droplet death distribution again initially appeared to contradict the
total population growth data - how was the total droplet population of
the experimental run increasing linearly with time whilst also experiencing
consistent droplet death? We suggest that droplet death occurred only in
the stationary droplets with small populations. These droplet deaths would
not impact the total population size significantly, as each droplet death
would only deduct a small number of bacteria from the total population
size. Furthermore it means that growth of the large population droplets
responsible for the linear increase in total population are not as strongly
inhibited.
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7.8 Time of droplet death versus initial popula-
tion size
Results
In this section, we are able to further utilise the droplet time of death metric.
Here, droplet time of death is plotted versus initial droplet population size for
each experimental run. Only droplets tracked across all 80 times frames are used
in this analysis. The first 5 time frames of each droplet were then averaged to
give an initial droplet population size. This was done to smooth out counting
fluctuations which can be prominent at low and high bacterial populations. These
plots can be seen in figures 7.18 and 7.19.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
(d) 0.5 µg ml−1 (e) 0.5 µg ml−1
Figure 7.18 Scatter plots showing droplet time of death as a function of initial
droplet population size. Bacteria grown in M9 minimal media at
a streptomycin concentration of (a,b) 0 µg ml−1, (c) 0.05 µg ml−1
and (d,e) 0.5 µg ml−1. Each graph represents a complete experi-
mental run.
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(a) 2.5 µg ml−1 (b) 50 µg ml−1
Figure 7.19 Scatter plots showing droplet time of death as a function of initial
droplet population size. Bacteria grown in M9 minimal media at a
streptomycin concentration of (a) 2.5 µg ml−1 and (b) 50 µg ml−1.
Each graph represents a complete experimental run.
Discussion
Droplet time of death is plotted versus initial droplet population size for experi-
mental runs 0.00 - 1 and 0.00 - 2 in figure 7.18 (a) and (b). In these runs bacterial
droplet populations are grown in the absence of streptomycin. Droplet death can
be seen to occur almost exclusively in the first 66 minutes. Furthermore, the vast
majority of these droplet deaths are the result of droplet populations with ini-
tial droplet population sizes of <2 bacteria, despite both experiments featuring a
significant proportion of droplets with initial population sizes of >2 bacteria (see
figure 7.5). In section 7.7, it was postulated that droplet deaths that occurred in
the absence of streptomycin were the result of small population droplets stochas-
tically dying off. This is supported by the results shown here.
Plots showing droplet time of death versus initial droplet population size for
experimental runs conducted in the presence of antibiotic can be seen in figures
7.18 (c,d,e) and 7.19 (a) and (b). In all of these plots, it is apparent that droplets
with large initial populations are driven to extinction later in an experimental run
than droplets with small populations. In each of the experimental runs conducted
in the presence of streptomycin, droplets with initial population sizes ≤2 undergo
droplet death almost continually throughout the experimental run. In contrast
to this, droplets with initial population sizes >2 undergo droplet death later on
in the experimental run, generally beyond 60 minutes.
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This absence of high population droplet deaths early on in each experimental run
can be seen as an empty triangle in each plot above and to the left of the main
cluster of droplet deaths. See figure 7.20 for a visualisation of this empty space.
0.05 µg ml−1
Figure 7.20 Scatter plot showing droplet time of death as a function of initial
droplet population size for experimental run 0.50 - 1. Bacteria
grown in M9 minimal media at a streptomycin concentration of
0.5 µg ml−1. The shaded light orange area highlights an area of the
graph where no droplet deaths are observed. This triangular area
is observed in all experimental runs conducted in the presence of
streptomycin.
The cause of this consistently empty space in the death time versus initial popu-
lation plots is not clear. It may be that some form of inoculum effect is present,
allowing droplets with large initial populations to survive longer than droplets
with small initial populations. Likewise, it may simply be the result of stochas-
tic droplet death: given a set probability of droplet death per unit time, large
populations of droplets are more likely to contain bacteria that are not killed
or lysed quickly. Although it would require further experimental runs to judge
the significance of this effect and discern the cause of these empty triangles, this
analysis nonetheless highlights the utility of our microfluidic device in comparison
to bulk growth techniques, and the power of population tracking with single cell
precision.
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7.9 Initial droplet population size as a growth
predictor
7.9.1 Initial droplet population versus final droplet pop-
ulation
Results
We were also interested in testing if there is a correlation between an individual
droplet’s initial population size and its final population size. To measure this
effect, droplets were screened to ensure suitability for the study - only droplets
that were detected for more than 70 time frames were included. The first and
final 5 time frames of each droplet were then averaged to give an initial and
final droplet population size. This was done to smooth out counting fluctuations
which can be prominent at low and high bacterial populations. A scatter plot
was then made to detect correlations between initial and final droplet population
size. Using a linear regression model, a line of best fit was then calculated for
each data set. This was completed for experimental runs 0.00 - 1, 0.00 - 2 and
0.05 - 1 as these all exhibited net total population growth.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
Figure 7.21 Scatter plots of initial droplet population sizes vs. Final droplet
population sizes for experimental runs (a) 0.00 - 1, (b) 0.00 - 2
and (c) 0.05 - 1.
From these plots, a gradient and correlation coefficient is calculated for each data
set.
Experiment Strep. Conc. Gradient R2
ID (µg ml−1)
0.00 - 1 0 7.9426 0.4548
0.00 - 2 0 8.4348 0.2986
0.05 - 1 0.05 3.2504 0.4329




A large correlation coefficient (R2) suggests a strong correlation between the ini-
tial and final droplet populations sizes. If growth was purely deterministic then
this value would equal 1. The R2 values shown in table 7.4 indicate a weak,
but positive correlation between initial and final droplet population sizes. This
correlation strength varies considerably from one experimental run to the next
and appears to be independent of antibiotic concentration. The implication of
this weak, positive correlation is that droplets with an initially large population
size are more likely to grow into droplets with a large final population size (as
expected); but there is significant variability in this trend. In only one experi-
mental run (0.00 - 2) did the largest initial droplet population end as the largest
final droplet population, and in another experimental run (0.05 - 1), the largest
initial droplet population barely managed to survive the 8 hour observation.
A large measured gradient suggests strong growth from the initial to the final
population size (if every droplet was tracked correctly across all time steps and
included in this analysis, the gradients calculated in this section would equal eλt,
i.e. they would be proportional to the total population growth rate). As antic-
ipated from the growth curves shown previously in this chapter, the measured
gradient values for experimental runs that underwent logarithmic growth (0.00
- 1 and 0.00 - 2, streptomycin concentration = 0 µg ml−1) are large in compar-
ison to the experimental run that exhibited lesser and linear growth (0.05 - 1,
streptomycin concentration = 0.05 µg ml−1).
A positive but weak correlation was found between initial and final droplet
population size in experimental runs that exhibited net growth.
As can be seen in table 7.4, in all experimental runs that exhibited net
growth (0.00 - 1, 0.00 - 2 and 0.05 - 1) a positive correlation was found
between initial droplet population size and final droplet population size.
Calculated correlation coefficients for this relationship ranged from 0.30-
0.45 and were independent of antibiotic concentration. This showed that
whilst droplets with large initial populations would generally grow to be-
come larger in number than droplets with small initial populations, there
were a significant number of droplets that both under- and over-performed




Figure 7.22 shows box plots that compare initial and final population size, for
droplets grouped by their initial population size. The data used to generate these
box plots is summarised in table 7.5. This analysis is only completed for droplets
that started with an initial population size of 1 - 5 bacteria (1 - 4 bacteria for
experimental run 0.00 - 2) as there were only a small number of droplets with
initial populations larger than these. The median final population sizes are shown,
alongside their 25th and 75th percentile. Values deemed statistical outliers with
greater spread than would be anticipated from the whole population are shown
as red crosses.
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(a) 0 µg ml−1 (b) 0 µg ml−1
(c) 0.05 µg ml−1
Figure 7.22 Box plots of initial droplet population sizes vs. final droplet popu-
lation sizes for experimental runs (a) 0.00 - 1, (b) 0.00 - 2 and (c)
0.05 - 1.
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Experimental Initial Median final 25th 75th Inter -
ID population population percentile percentile quartile
size size value value range
0.00 - 1 1 8.1 1.0 17.8 16.8
0.00 - 1 2 14.2 6.9 25.8 18.9
0.00 - 1 3 23.6 10.7 38.8 28.1
0.00 - 1 4 26.2 19.2 45.3 26.1
0.00 - 1 5 48.3 19.9 100.9 81
0.00 - 2 1 3.1 1.0 13.5 12.5
0.00 - 2 2 6.4 2.0 25.5 23.5
0.00 - 2 3 20.9 3.1 50.3 47.2
0.00 - 2 4 23.6 14.4 41.8 27.4
0.05 - 1 1 3.0 1.0 6.2 5.2
0.05 - 1 2 5.6 2.2 9.6 7.4
0.05 - 1 3 8.8 3.2 15.0 11.8
0.05 - 1 4 12.8 5.5 19.3 13.8
0.05 - 1 5 17.1 10.5 27.0 16.5
Table 7.5 Quantitative summary of data displayed in box plots shown in figure
7.22
Discussion
This final box-plot analysis quantitatively evaluates the data presented in the
previous section, seen in figure 7.21. In all experiments the median final popu-
lation increases as initial population size increases. This is consistent with the
positive correlation observed between initial and final population sizes. The fi-
nal population size inter-quartile range also increases with initial population size
(apart from in droplets of initial size 4 in experimental runs 0.00 - 1 and 0.00
- 2) suggesting increased variation in the final population of droplets with large
initial populations.
Whilst a general positive correlation exists between initial and final population
size, it appears that droplets with low population sizes (1 - 2 bacteria) regularly
exceed the average growth of their counterparts. This can be seen in the numerous
outliers that are present at these initial population sizes.
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Finally, it is apparent that whilst the overall growth of experimental run 0.05 -
1 (0.05 µg ml−1) is suppressed in comparison to experimental runs 0.00 - 1 and
0.00 - 2 (0 µg ml−1), growth patterns and trends appear to be more uniform.
Only at this streptomycin concentration of 0.05 µg ml−1 do the median final
population size, 25th percentile value, 75th percentile value and inter-quartile
range all consistently increase with initial population size.
7.10 Summary
In this work, small bacterial populations were encapsulated within microfluidic
emulsion droplets both in the absence and presence of the antibiotic streptomycin.
The droplets were incubated and imaged over the course of an 8 hour observa-
tion period. The growth dynamics of the incubated droplets were measured and
recorded. Experimental runs were conducted at streptomycin concentrations of
of 0 µg ml−1, 0.05 µg ml−1, 0.5 µg ml−1, 2.5 µg ml−1 and 50 µg ml−1. The results
of these experimental runs were presented in detail in this chapter, and their
analysis consisted of 5 primary studies:
• In the first analysis, we investigated how the total bacterial population
changed over the course of each experimental run. Total population growth
curves were plotted. Growth rates and doubling times were calculated for
all experimental runs that exhibited net growth.
• In the second analysis, we studied how the distribution of droplet population
sizes evolved over the course of each experimental run. The initial and final
droplet population distributions were plotted and compared. The mean
and variance for each distribution was calculated. Colour plots were used
to visualise how each initial population distribution evolved across its 8 hour
experimental run. A deterministic final droplet population distribution was
predicted for each experimental run and compared with the final measured
population distribution.
• In the third analysis, we explored how time of droplet death changed with
antibiotic concentration. For each experimental run, droplet death fre-
quency was plotted as a function of time.
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• In the fourth analysis, we looked at the relationship between droplet death
time and initial droplet population. For each experimental run, droplet
death time was plotted versus initial droplet population.
• In the fifth and final analysis, we investigated the correlation between initial
droplet population size and final droplet population size. Initial population
size was plotted versus final population size for each experimental run.
Using a linear regression model, a line of best fit was then calculated for each
data set. Box plots were used to further compare the spread of bacterial
growth from droplets sorted by their initial population size.
7.11 Concluding remarks
Using our microfluidic system, we successfully encapsulated a large number of
small bacterial populations in monodisperse emulsion droplets. These droplets
were incubated at 37°C and their encapsulated bacterial populations were mea-
sured and tracked with single cell accuracy every 6 minutes for a total of 8 hours.
Bacterial populations were encapsulated both in the absence of and presence of
streptomycin at a range of antibiotic concentrations.
Using this data, a number of novel statistical studies were completed that were
designed to investigate the stochastic growth dynamics of bacterial populations
growing in the presence of streptomycin. There is strong evidence to support the
notion that small bacterial populations can be heterogeneous in their response to
moderate concentrations of antibiotic, and whilst the observed growth dynamics
were statistically diverse, distinct trends and common behaviours emerged from
the large volume of data we acquired.
Whilst there are numerous examples of experimental systems that can study
small bacterial populations with a higher throughput than we have shown here,
they are generally not able to track population size as a function of time with
single cell accuracy. Conversely, there are many systems that are capable of
measuring the growth dynamics of single bacteria in extensive detail, tracking
advanced growth metrics such as cell motility, morphological information and
the populations genealogical tree. Unfortunately these systems tend to rely on
extensive manual corrections and are not capable of analysing more than a handful
of populations at once.
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We have confidence that the results obtained in this chapter successfully validate
our microfluidic system and image processing workflow, the development of which
is detailed in chapters 3, 4 and 5. We have successfully observed numerous novel
behaviours in large numbers of small bacterial populations that were not previ-






This thesis details the design and fabrication of a microfluidic device that is
used to quantitatively measure the growth dynamics of small Escherichia coli
populations encapsulated in emulsion droplets in the presence and absence of
streptomycin.
In chapter 3 the materials, techniques and protocols that are used to construct
our microfluidic device are detailed. A number of key decisions regarding the
material and techniques used in the fabrication of our microfluidic system are
discussed. These decisions are explained in the context of our specific experimen-
tal objectives, as well as in the wider context of fabricating a versatile system
that is compatible with a wide variety of biological systems.
Polydimethylsiloxane was chosen as the base elastomer for our microfluidic system
as it possesses a number of favourable physical characteristics that complemented
our research objectives. Ancillary experimental materials and processes were
tested and selected. Additionally, a microfluidic device mount was designed and
3D printed. This mount is used to hold our microfluidic system in place during
imaging whilst also maintaining the temperature of the experimental assembly at
37°C.
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In chapter 4, the iterative design process of our microfluidic system is outlined.
Focus was placed on the development of a microfluidic system that would be
straightforward to fabricate and accessible to researchers that did not possess
extensive experience in the field of microfluidics. One of the primary benefits
of PDMS-based microfluidics is the ability to rapidly prototype and fabricate
experimental systems. Through the continued testing and improvement of our
microfluidic system, we developed a number of guiding principles that were used
to produce our final microfluidic design.
The microfluidic system consists of two devices. The first device is a microflu-
idic droplet generator, this is used to encapsulate small bacterial populations in
aqueous emulsion droplets suspended in a fluorocarbon oil. These droplets are
passed to the second device, a microfluidic droplet reservoir. This reservoir stores
the droplets so that they can be imaged using both brightfield and fluorescence
microscopy. This microfluidic system is easy to fabricate and operate, whilst also
being robust across a wide range of experimental conditions.
In chapter 5, the image processing and analysis workflow that we developed to
be used in conjunction with our microfluidic system is outlined. The work flow
comprises three stages: image validation and stitching, droplet detection and
tracking, and finally image thresholding and bacterial counting.
A number of manual pre-processing validation steps are undertaken to ensure
that images with experimental defects are not passed forward to subsequent image
processing algorithms. After this, brightfield microscopy images are used to detect
and track microfluidic droplet boundaries and positions throughout the course of
each experimental run. Finally, fluorescence images are thresholded and analysed
to detect bacterial population sizes for each droplet with single cell precision. This
workflow was designed from the ground up to measure the growth dynamics of
1000+ independent small bacterial populations with single cell accuracy.
In chapter 6, a number of experimental validations, checks and caveats are exam-
ined to ensure that the conclusions drawn from the results presented in chapter 7
are accurate. Error measurements and calculations are presented that establish
the limitations of our bacterial counting algorithm.
Automated bacterial counting errors have been quantified, and the trends in these
errors are discussed. It was hypothesised that bacterial aggregation was the pri-
mary source of bacterial counting error. Bacterial aggregation causes population
sizes to be increasingly underestimated as time passes. The impact of further
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experimental limitations such as droplet polydispersity and imaging delays are
discussed. An investigation into growth correlation between droplets based on
their relative spatial proximity was conducted. No significant correlation between
droplet population growth and relative droplet proximity is observed, validating
our assumption that each bacterial population existed independently with no
transfer of information or resources between droplets.
In chapter 7, the growth dynamics of small E. coli populations were measured
both in the absence and presence of the ribosome targeting antibiotic strepto-
mycin. A number of statistical measurements were extracted from the data that
detailed the growth dynamics of the droplet-based bacterial populations. Total
population growth rates and doubling times were calculated. Droplet population
size distributions were measured, and it was explored how these distributions
evolved as a function of time. The time at which visible bacterial populations
were driven to extinction was investigated as a function of antibiotic concen-
tration, and also as a function of initial droplet population size. Finally, the
relationship between initial and final droplet population size was investigated.
The uninhibited growth rate that we measured for RJA002 E. coli was found to be
in agreement with those measured in bulk growth experiments[201]. Likewise, the
MIC value for RJA002 grown in the presence of streptomycin was consistent with
reported measurements using bulk growth techniques [48]. These measurements
imply that the process of encapsulation and growth in microfluidic droplets does
not inhibit bacterial growth in of itself.
A number of interesting and novel growth dynamics were observed. It was found
that in experimental runs that exhibited net growth, the correlation between
initial and final population size was weakly positive and independent of antibi-
otic concentration. This indicates a highly stochastic growth process. In the
absence of streptomycin, the final droplet population size distributions exhib-
ited extended tails due to the presence of droplets containing large populations.
These extended tails were also observed at streptomycin concentrations below
the MIC, however their length was reduced in comparison. This implies that at
low concentrations, streptomycin limits the growth rate of fast growing droplet
populations. At moderate streptomycin concentrations both around and above
the MIC value, it was found that streptomycin inhibited some bacterial popula-
tions in a non-lytic manner (resulting in fluorescent but non-growing bacteria),
whereas other bacterial populations underwent lysis. Also at moderate strepto-
mycin concentrations around the MIC value, a bias against lysis for large droplet
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populations was observed. At low streptomycin concentrations below the MIC
value, it was found that streptomycin inhibited some bacterial populations with-
out lysing them, whereas other bacterial populations were uninhibited.
8.2 Outlook
In the immediate future, there are a number of experimental studies that would
be very interesting to carry out using our microfluidic system. Firstly, the unin-
hibited total population growth rate we measured was inconsistent between two
experimental runs. The cause of this heterogeneity is unknown, and we would
like to know if this growth rate variability persists across multiple replicate runs.
Secondly, we are keen to understand why some droplets exhibit growth rates
that far exceed the average growth rate observed across the total population.
We believe it would be possible to use our microfluidic system to rapidly iden-
tify bacterial populations with large growth rates and then more closely observe
their behaviour. Finally, it would be interesting to determine why certain droplet
populations are inhibited strongly by streptomycin whilst others are unaffected.
This could be achieved by categorising droplet populations according to their
growth behaviour and further investigating if a common trait or behaviour links
these categories. This type of study benefits from the use of a microfluidic device
such as ours that can study large numbers of near identical bacterial populations
simultaneously, with a high degree of accuracy.
A source of experimental error that may have been inadvertently introduced
during our research was in the use of streptomycin that had been refrozen after
being allowed to thaw (see section 3.2.8 for further information). It has been
shown that numerous classes of antibiotics can lose efficacy over time whilst stored
frozen. Furthermore, thawing and then re-freezing antibiotics has been shown to
additionally degrade the activity of certain antibiotics[217]. To ensure that this
variability does not impact the reliability of future repeat studies, any antibiotics
used should only be thawed once and then disposed of.
More generally, we believe our system successfully bridges the gap between mi-
crofluidic devices that can quickly extract rudimentary growth metrics from large
numbers of small bacterial populations[43][131], and microfluidic devices that can
extract detailed growth metrics and parameters from a small number of small bac-
terial populations[137]. We hope that the modular and adaptable nature of this
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microfluidic system allow it to be used for a wide variety of biological applica-
tions. In its current form, testing is already underway that could allow the device
to be used in conjunction with flow cytometry techniques to screen for growth in
samples comprising bacteria that have proven difficult to culture using standard
procedures.
I believe that microfluidic technology has the power to dramatically and posi-
tively impact a wide range of academic fields. The benefits afforded by microflu-
idic systems are too numerous and significant to ignore, and given time I hope
that the incorporation of microfluidic systems into bacterial studies will accel-
erate research that has the very real possibility of improving the lives of people
outside the laboratory. Despite this, there is still a sizable barrier to entry to
the non-specialist academic who is interested in using microfluidic systems. Cur-
rent research appears to be trending toward the design and use of increasingly
elaborate and complex microfluidic systems, when the widespread adoption of
microfluidic technology is still limited by a lack of accessible information and re-
search. In this thesis, we have developed a microfluidic system that is accessible
to the non-specialist, both in fabrication and operation. The two microfluidic
devices that constitute the system are modular and adaptable, with exceptional
bio-compatibility. Using our microfluidic system we have observed novel bacterial
growth behaviours in the presence of antibiotic that would not have been possi-
ble to see using bulk growth techniques. Further development of our microfluidic
system will focus on refining and further simplifying our current microfluidic de-
sign. This will allow us to better understand and more accurately quantify the
interesting growth dynamics that we have observed in small bacterial populations
inhibited by streptomycin.
The work conducted in this thesis demonstrates that exciting and novel biological
phenomena can be accurately quantified using a microfluidic system that is easy
to understand and simple to operate. We hope this work will inspire others
to integrate microfluidic systems and processes into their experimental arsenal,
furthering the widespread adoption of microfluidic technology.
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